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hyaluronic acid (HA) macromers into more complex, fibrous networks with spatiotemporal control. First,
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manner and in vivo in a subcutaneous mouse model using transdermal fluorescent imaging to monitor
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patterning of multiple molecules. Spatial control over cell adhesion and morphology was also
demonstrated as cells responded to fiber organization and patterns of cell adhesive peptides. Finally,
protease-degradable and non-degradable fluorophores were developed to visually detect protease-activity
on NorHA scaffolds from both exogenously added and cell-secreted (HT-1080 cells) proteases. Overall,
this work represents unique approaches to generate fibrous hydrogels with previously unrealized
biocomplexity for the fields of tissue engineering and regenerative medicine.
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ABSTRACT

ENGINEERING EXTRACELLULAR MATRIX SIGNALS INTO FIBROUS
HYALURONIC ACID HYDROGELS
Ryan J. Wade
Jason A. Burdick, Ph.D.

Hydrogels have gained widespread use in biomedical applications for their
ability to mimic certain features of the natural extracellular matrix (ECM) including
tissue-like

mechanics,

water-swollen

environments,

and

biodegradability.

Despite these advantages, hydrogels typically do not present the fibrous
architecture of natural ECM, even though this structure can guide cell behavior
and tissue function. With this in mind, the overall goal of this dissertation is the
translation of hydrogels from hyaluronic acid (HA) macromers into more complex,
fibrous networks with spatiotemporal control. First, HA macromers that contain
protease-cleavable and fluorescent peptides were synthesized and shown to
form both isotropic hydrogels and electrospun fibrous hydrogels through a
photoinitiated polymerization. These scaffolds were susceptible to proteasemediated cleavage in vitro in a protease dose dependent manner and in vivo in a
subcutaneous mouse model using transdermal fluorescent imaging to monitor
degradation. Importantly, materials containing an alternate and non-proteasecleavable peptide sequence were stable in both in vitro and in vivo settings.
Next, the ability to spatially pattern fibrous hydrogels with biomolecules was
vi

investigated using thiol-ene reactions of thiolated molecules to electrospun
norbornene modified HA (NorHA). This approach permitted pattern features as
small as 50 µm and patterning of multiple molecules. Spatial control over cell
adhesion and morphology was also demonstrated as cells responded to fiber
organization and patterns of cell adhesive peptides.

Finally, protease-

degradable and non-degradable fluorophores were developed to visually detect
protease-activity on NorHA scaffolds from both exogenously added and cellsecreted (HT-1080 cells) proteases.
approaches

to

generate

fibrous

Overall, this work represents unique
hydrogels

with

previously

unrealized

biocomplexity for the fields of tissue engineering and regenerative medicine.

vii

TABLE OF CONTENTS
DEDICATION....................................................................................................ii
ACKNOWLEDGEMENT................................................................................iii
ABSTRACT......................................................................................................vi
LIST OF TABLES..........................................................................................xii
LIST OF FIGURES........................................................................................xiii
CHAPTER 1
Introduction: Engineering ECM signals into Biomaterials.........................1
1.1 Introduction...........................................................................................1
1.2 Topography and Mechanics.................................................................3
1.3 Dimensionality......................................................................................6
1.4 Structure and Porosity..........................................................................9
1.5 Biocomplexity......................................................................................12
1.6 Conclusions........................................................................................17
References................................................................................................19

CHAPTER 2
Specific Aims and Research Overview......................................................25
2.1 Introduction and Specific Aims............................................................25
2.2 Research Overview.............................................................................28

CHAPTER 3
Nanofibrous Scaffolds for Biomedical Applications.................................31
3.1 Introduction.........................................................................................31
3.2 Electrospinning...................................................................................35
3.2.1 Chemical and structural features of electrospun scaffolds.........37
3.2.2 Applications of electrospun scaffolds.........................................48
3.2.3 Alternatives to electrospinning...................................................54
3.3 Phase Separation...............................................................................56
3.4 Self-Assembly.....................................................................................60
3.4.1 β-sheet and β-hairpin forming peptides......................................61
viii

3.4.2 α-helical forming peptides..........................................................62
3.4.3 Peptide-amphiphiles...................................................................64
3.4.4 Applications of self-assembling nanofibrous materials...............65
3.4.5 Alternative self-assembling nanofibrous materials.....................69
3.5 Conclusions........................................................................................70
References...............................................................................................73

CHAPTER 4
Synthesis of Photopolymerizable, Protease-Degradable Hyaluronic Acid
Macromers and Hydrogel Formation.........................................................88
4.1 Introduction.........................................................................................88
4.2 Materials and Methods.......................................................................91
4.2.1 Solid-phase peptide synthesis....................................................91
4.2.2 Degradation kinetics...................................................................93
4.2.3 MePHA synthesis.......................................................................94
4.2.4 Hydrogel fabrication...................................................................95
4.2.5 Degradation studies...................................................................96
4.2.6 Statistical analysis......................................................................97
4.3 Results and Discussion......................................................................97
4.3.1 Design of protease-sensitive photocrosslinkable HA.................97
4.3.2 Isotropic hydrogel formation and characterization....................105
4.4 Conclusions.......................................................................................108
References..............................................................................................111

CHAPTER 5
Protease-Degradable Electrospun Fibrous Hydrogels...........................114
5.1 Introduction.......................................................................................114
5.2 Materials and Methods......................................................................117
5.2.1 Methacrylated peptide HA (MePHA) synthesis.........................117
5.2.2 Scaffold fabrication...................................................................117
5.2.3 Fiber characterization...............................................................118
5.2.4 Degradation studies..................................................................119
ix

5.2.5 Subcutaneous mouse model....................................................120
5.2.6 Statistical analysis....................................................................121
5.3 Results and Discussion.....................................................................121
5.3.1 Electrospun fibrous hydrogel formation and characterization...121
5.3.2 In vitro degradation...................................................................124
5.3.3 In vivo degradation...................................................................129
5.4 Conclusions.......................................................................................131
References..............................................................................................134

CHAPTER 6
Nanofibrous Hydrogels with Spatially Patterned Biochemical Signals to
Control Cell Behavior.................................................................................138
6.1 Introduction.......................................................................................138
6.2 Materials and Methods......................................................................141
6.2.1 NorHA synthesis.......................................................................141
6.2.2 Peptide synthesis......................................................................142
6.2.3 Glass coverslip preparation for electrospinning........................143
6.2.4 Electrospun scaffold formation.................................................143
6.2.5 Crosslinking and patterning of NorHA nanofibrous hydrogels..144
6.2.6 Scaffold characterization..........................................................146
6.2.7 Cell culture................................................................................146
6.2.8 Statistical analysis....................................................................147
6.3 Results and Discussion.....................................................................147
6.3.1 NorHA synthesis and electrospun scaffold formation...............147
6.3.2 NorHA scaffold patterning.........................................................148
6.3.3 Cell response to nanofibrous topography and spatial
presentation of RGD..........................................................................155
6.4 Conclusions......................................................................................,161
References..............................................................................................163

CHAPTER 7
Detection of Protease Activity on Nanofibrous Hydrogels...................167
x

7.1 Introduction......................................................................................167
7.2 Materials and Methods.....................................................................171
7.2.1 NorHA synthesis......................................................................171
7.2.2 Peptide synthesis and characterization...................................171
7.2.3 Electrospun scaffold formation and peptide attachment..........173
7.2.4 Peptide fluorophore degradation..............................................174
7.2.5 Cell culture................................................................................174
7.2.6 Statistical analysis....................................................................172
7.3 Results and Discussion.....................................................................175
7.3.1 Peptide fluorophore synthesis..................................................175
7.3.2 Peptide fluorophore attachment and degradation....................177
7.3.3 FRET peptide synthesis and characterization..........................182
7.4 Conclusions.......................................................................................189
References..............................................................................................192

CHAPTER 8
Summary, Limitations, and Future Directions.........................................195
8.1 Summary...........................................................................................195
8.2 Limitations and Future Directions......................................................200
8.3 Conclusions.......................................................................................207
References..............................................................................................208

xi

LIST OF TABLES
Table 4.1 - Kinetic parameters for peptide crosslinkers....................................102

xii

LIST OF FIGURES
Figure 1.1 Schematic of the extracellular matrix...................................................4
Figure 1.2 Topography directs cell behavior......................................................5
Figure 1.3 Fibrillar scaffold structures..............................................................10
Figure 1.4 Degradation control over cell morphology in 3-dimensions.............16
Figure 3.1 Schematic of electrospinning process...............................................37
Figure 3.2 Degradation of poly(α-hydroxy ester) electrospun scaffolds...........39
Figure 3.3 Incorporation of biological molecules into electrospun scaffolds.....41
Figure 3.4 Differentiation of neural stem cells on electrospun
polyethersulfone................................................................................................44
Figure 3.5 Electrospun polycaprolactone.........................................................47
Figure 3.6 Electrospun polycaprolactone vascular grafts.................................52
Figure 3.7 Mesenchymal stem cells on electrospun hyaluronic acid................53
Figure 3.8 Rotary jet spinning and airbrushed polymer fibers..........................55
Figure 3.9 Phase separation schematic...........................................................56
Figure 3.10 Comparison of phase separated gelatin and Gelfoam®...............59
Figure 3.11 Self-assembling nanofibrous systems...........................................63
Figure 3.12 TGFβ-1 binding peptide-amphiphile for articular cartilage repair..67
Figure 3.13 Self-assembling ABA copolypeptide.............................................69
Figure 4.1 Maleimide HA (MaHA) synthesis.......................................................98
Figure 4.2 Methacrylated peptides and fluorophores.....................................100
Figure 4.3 Mass spectrometry of methacrylated peptides and fluorophores..100
Figure 4.4 1H NMR of methacrylated peptides...............................................101
Figure 4.5 Lineweaver-Burke plots of methacrylated peptide degradation....102
Figure 4.6 Methacrylated peptide hyaluronic acid (MePHA) synthesis..........104
Figure 4.7 1H NMR characterization of MePHA synthesis.............................105
Figure 4.8 Rheology of isotropic hydrogels....................................................106
Figure 4.9 In vitro release profiles of isotropic hydrogels in collagenase and
rhMMP-2.........................................................................................................107
Figure 5.1 Schematic of MePHA electrospun scaffold formation.....................122
xiii

Figure 5.2 Scanning electron microscopy of electrospun MePHA.................123
Figure 5.3 Confocal microscopy of electrospun MePHA................................124
Figure 5.4 In vitro release profiles of electrospun hydrogels in collagenase and
rhMMP-2..........................................................................................................125
Figure 5.5 Mass spectrometry of UV light exposed methacrylated peptide and
analysis of uronic acid release of electrospun MePHA...................................127
Figure 5.6 Fluorescent images of electrospun MePHA degradation..............128
Figure 5.7 Co-electrospun MePHA and fluorescent images of co-electrospun
scaffolds..........................................................................................................128
Figure 5.8 In vivo erosion of electrospun MePHA in a subcutaneous mouse
model..............................................................................................................130
Figure 5.9 Histology of explanted tissue sections..........................................131
Figure 6.1 Norbornene HA (NorHA) synthesis and 1H NMR.............................149
Figure 6.2 Schematic of electrospun NorHA and scanning electron microscopy
of NorHA scaffolds..........................................................................................149
Figure 6.3 Schematic of crosslinking and patterning in electrospun NorHA
scaffolds..........................................................................................................150
Figure 6.4 Mass spectrometry of thiolated fluorophores................................151
Figure 6.5 Patterning of electrospun NorHA scaffolds...................................152
Figure 6.6 Changes in thiolated fluorophore attachment with different
processing parameters....................................................................................153
Figure 6.7 Patterning of multiple thiolated fluorophores on the same NorHA
scaffold............................................................................................................154
Figure 6.8 Pattern fidelity through the depth of NorHA scaffolds...................156
Figure 6.9 Images of 3T3 fibroblast response to patterned thiolated RGD....157
Figure 6.10 Quantification of fibroblast response to patterned thiolated
RGD................................................................................................................158
Figure 6.11 Human umbilical vein endothelial cell response to patterned
RGD................................................................................................................158
Figure 6.12 3T3 fibroblast response to alignment on NorHA scaffolds..........159
xiv

Figure 6.13 3T3 response to lines of RGD patterned perpendicular or parallel
to fiber alignment............................................................................................160
Figure 7.1 Structure and mass spectrometry of protease-degradable and nondegradable peptide fluorophores.......................................................................176
Figure 7.2 Peptide fluorophore degradation on NorHA scaffolds from
exogenously added collagenase.....................................................................178
Figure 7.3 Degradation of peptide fluorophores after 7 days of HT1080 cell
culture..............................................................................................................181
Figure 7.4 Confocal images of HT1080 cells on NorHA scaffolds with peptide
fluorophores....................................................................................................181
Figure 7.5 Schematic and mass spectrometry of FRET-VPMS peptide.........182
Figure 7.6 Comparison of FRET-VPMS degradation in solution with two other
FRET systems.................................................................................................184
Figure 7.7 FRET-VPMS on NorHA scaffolds..................................................187
Figure 7.8 DQ-gelatin electrospun into NorHA scaffolds................................189
Figure 8.1 Modular synthesis of hydrazide modified and adamantine modified,
protease-degradable HA....................................................................................202

xv

CHAPTER 1

Introduction: Engineering ECM Signals into Biomaterials

Adapted from: Wade RJ, Burdick JA. Engineering ECM signals into biomaterials.
Materials Today 15, 454-459 (2012).

1.1 Introduction
The natural extracellular matrix (ECM) is a complex, heterogeneous
network of soluble and insoluble proteins, growth factors, and polysaccharides
that provides physical structure and a biochemical context to the cellular
microenvironment. Structurally, just as the steel and concrete of a skyscraper
provides the framework for a high-rise building, ECM provides the mechanical
framework to permit cell-cell interactions for healthy tissue formation and
maintenance. However, unlike the static structure of a skyscraper, ECM is
dynamically degraded, synthesized, and produced by cells, in both healthy and
diseased states. This dynamic interplay between cells and the ECM has
significant effects on cell adhesion, migration, proliferation, and differentiation1.
Even the mechanical properties and orientation of the ECM can affect cell fate,
further increasing the complexity of the cellular microenvironment2-4.
Consequently, after beginning with synthetic materials that neglected
much of this complexity in design, tissue engineers often turned to either
collagen or de-cellularized natural ECM scaffolds (e.g., Matrigel™ – de1

cellularized extracellular matrix isolated from mouse sarcoma cells) to study
directed cellular behavior; however, these materials have several limitations. For
example, purification techniques create batch-to-batch inconsistencies and can
damage the native structure of the isolated ECM components and insufficient
characterization of the specific material components complicates controlled
experimentation5-6. Most importantly, purified materials may suffer from
immunogenic responses when implanted into a foreign host, limiting their utility
for in vivo application5. Consequently, tissue engineers continue to use and
develop new synthetic materials and synthetic modifications of materials since
they limit the unknown variability present in isolated, natural ECM, can be
engineered to mimic a number of different structural and biologic features of
native ECM, and can be screened to ensure host biocompatibility. The field is
increasing in the ability to truly mimic features of the ECM, bridging the gap
between the benefits of natural and synthetic materials.
This introduction highlights both structural and biologic features of the
ECM, their importance in the cellular microenvironment, and efforts to design
materials that replicate these features. Focus is placed on basic structural
considerations and builds towards increasing biocomplexity in material design.
These highlights will allow the reader to appreciate the progress and
considerable challenges in material design for recapitulation of ECM, which
motivates the following work of this thesis towards engineered fibrous hyaluronic
acid hydrogels to address these challenges.
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1.2 Topography and Mechanics
Natural ECM components are arranged into a 3-dimensional, anisotropic,
fibrous architecture where nanoscale fibers (10-300 nm diameters) provide
topographical signals to cells at the microscale (10-100 µm)7-8 (Fig. 1.1). The
importance of these topographical cues was appreciated in 2-dimensional culture
systems where topography is controlled through a number of mechanisms
including photolithography and reactive ion etching, electron-beam lithography,
microcontact printing, diamond cutting, and nanoimprint lithography9-11. For
example, keratocytes (cells found in the stroma of the cornea) showed
preferential elongation parallel to 400-800 nm spaced gratings on a silicon
substrate12. Similar behavior was observed in smooth muscle cells and epithelial
cells cultured on polydimethylsiloxane (PDMS) substrates nanoimprinted with
700 nm spaced ridges10. Doyle et al. even showed that cell tracking and
migration along one dimensional fibers replicates cell migration through native 3D ECM as compared to traditional flat, tissue culture polystyrene (TCPS)
surfaces13. Stem cells, a target for both research and translation in regenerative
medicine, have also shown directed responses to topographical cues14 (Fig. 1.2).
Human mesenchymal stem cells (hMSCs) selectively differentiated towards
either adipogenic (fat-like) or osteogenic (bone-like) lineages when cultured on
wrinkling patterns created through differential UV induced crosslinking15.
Meanwhile, Oh et al. differentiated hMSCs on TiO2 nanotubes by solely
controlling the nanotube diameter16.

3
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Figure 1.1: Schematic of the extracellular matrix. Fibrous matrix proteins (e.g., collagen,
fibrin, elastin) provide structural and mechanical cues to direct cell behavior; soluble
signals are sequestered by proteoglycans (proteins with polysaccharide moieties) and
interact with cell surface receptors to direct cell migration, proliferation, and
differentiation; integrins (transmembrane receptors) bind to matrix proteins for cell
adhesion; ECM degradation enzymes (e.g., matrix metalloproteinases, serine
proteinases, plasmin) cleave matrix components during cell motility and matrix
remodeling.
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Figure 1.2: Topography directs cell behavior. Schematic and confocal image of human
mesenchymal stem cells cultured on 350nm wide, 350 nm deep, 700 nm spaced
gratings of polydimethylsiloxane (PDMS) (A) or flat PDMS (B). The actin cytoskeleton is
stained green while phosphorylated Focal Adhesion Kinase (a primary intracellular
protein present at cell-matrix adhesions) is stained red. Inset is a higher magnification.
Inset scale bar: 10 µm. Confocal images adapted and reprinted with permission from14.

Structural considerations of native ECM also include the mechanics of the
matrix. Tissue elasticity ranges from soft tissues such as brain (~0.1 kPa) to
stiffer tissues like muscle (~10 kPa) and pre-calcified bone (~80 kPa)17. While the
range of soft tissue elasticity (0.1-100 kPa) may seem small compared to the
range of traditional engineering materials (kPa-GPa), variations in stiffness can
have profound effects on cell spreading and migration18, cell signaling19, cell
differentiation2-3, and tumor formation20. Engler et al. cultured hMSCs on
collagen-coated polyacrylamide gels of varying stiffness (elasticity controlled
through differing bis-acrylamide concentrations during polymerization)2 and
differentiation into neurogenic (neuron), myogenic (muscle), or osteogenic
5

lineages was observed when cells were cultured on the corresponding substrate
elasticity of ~0.1-1, 8-17, or 25-40 kPa, respectively2. Similar matrix effects were
observed with neural stem cells cultured on interpenetrating polymer networks of
10-10 000 Pa where softer matrices (100-500 Pa) promoted neural differentiation
and stiffer matrices (1-10 kPa) promoted glial differentiation (nerve cells that
support neurons)3. These in vitro observations have implications for in vivo
applications as well. Muscle stem cells cultured on ~12 kPa (elasticity of native
muscle) poly(ethylene glycol) gels engrafted at a significantly higher efficiency in
mice when compared to traditional culture on tissue culture polystyrene,
indicating the role of matrix elasticity in translational stem cell therapeutics21.

1.3 Dimensionality
These 2-D culture systems demonstrated the importance of topography
and mechanical elasticity on cell behavior; however, they lack the 3-dimensional
physiochemical cues present in much of the native microenvironment. For
example, integrins (transmembrane proteins that bind to ECM components and
transmit signals for cytoskeletal reorganization) function dramatically different in
3-dimensional environments than on flat surfaces22. Additionally, diffusional
transport of cytokines (small signaling proteins) and larger proteins is also
markedly different with the addition of a third dimension23-25. This added
dimensionality has implications in everything from normal breast tissue
homeostasis26, to cell spreading and differentiation4, to tumor infiltration by T
cells27.
6

Hydrogels are one class of materials that have emerged to synthetically
address the dimensionality of native ECM. These water-swollen networks can be
made of natural and synthetic polymers, crosslinked through non-covalent or
covalent mechanisms, and exhibit a number of properties (e.g., soft tissue
elasticity, diffusional transport of soluble signals) that mimic features of natural
ECM28-30. Most importantly, covalent crosslinking strategies like Michael-type
addition and photopolymerization, or physical crosslinking strategies like chargecharge interactions and hydrophobic aggregation are mild enough to permit
viable cell encapsulation29-30. This feature has rendered hydrogels as the most
common synthetic scaffold for both in vitro 3-dimensional cell culture and in vivo
as a cellularized construct to promote endogenous tissue repair29-30. From a
materials perspective, controlling the crosslinking density and polymer backbone
charge can tailor diffusional transport of proteins based on pore size and physical
interactions between solutes and the hydrogel. For example, alginate (a natural
anionic polysaccharide derived from algae) crosslinked through divalent Ca2+
ions has different diffusional properties for positively charged proteins compared
to negatively charged proteins of similar mass28. For uncharged networks,
increasing the polymer weight percent, increasing the number of crosslinks, or
decreasing the molecular weight between crosslinks can all effectively limit
diffusion of proteins through the matrix24-25.
One limitation of hydrogels is the general lack of spatial and temporal
heterogeneity, which may be present in natural environments. To overcome
these limitations, photopatterning, two-photon techniques, and 3-dimensional
7

sacrificial printing have shown promise in spatial patterning of hydrogels to
promote structured cell interactions31-33. Photopatterning spatially restricts UV
light using a photomask so that polymerization only occurs in UV permissible
regions31. In contrast, 2-photon techniques use computer-aided programs to
combine two lower energy photon sources with precise spatial control to pattern
polymerization or sever photocleavable reactive groups32. 3-dimensional
sacrificial

printing

is

another

promising

technique

for

creating

spatial

heterogeneity. In this approach, a carbohydrate glass network is printed as a
vascular template33. A hydrogel is then polymerized within the network and
removal of the sacrificial template yields a 3-dimensional network for
vascularized tissue engineering33. Although these methods have shown
incredible spatial control over 3-dimensional structures34, the evolution of
hydrogels with time is also important. Material changes with time are inherent to
degradable materials, yet advances in the design of materials that either
decrease32 or increase35 with light exposure permit changes in network
crosslinking and resulting mechanics with user defined inputs. Despite these
advances, hydrogels generally lack the native fibrillar structure and suffer from
relatively small porosity when compared to natural ECM. Small pore sizes can
limit diffusion of larger proteins and can also impede cell infiltration in vivo without
engineered enzymatic degradability within the hydrogel.
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1.4 Structure and Porosity
To address limitations in structure and porosity, three techniques have
been developed to create 3-dimensional scaffolds (either with hydrogels or
alternative materials) with both nanofibrillar structure and macroporosity (Fig.
1.3). First, phase separation is a familiar technique for creating nanostructures
that has been applied toward creating fibrous polyester scaffolds36-37. In this
technique, a polymer is dissolved in a solvent and either thermal cooling or nonsolvent exchange induces gelation so that a polymer rich phase develops within
the solution36. The solvent is exchanged with water and then the entire scaffold is
frozen and lyophilized to yield the final macroporous architecture36-38. Using this
technique, fibril diameters have been achieved (50-500 nm) that readily mimic
the length-scale of natural ECM6,36,37. Poly(L-lactic acid) (PLLA) scaffolds
produced through this method have supported neural stem cell (NSC) growth
and differentiation39. To enhance complexity for bone tissue engineering, Wei
and Ma incorporated nano-hydroxyapatite (NHA) (a main constituent in native
bone) to form composite NHA/PLLA matrices through thermally induced phase
separation40. These nanocomposite NHA/PLLA systems showed enhanced
protein adsorption and increased the compression modulus 2-fold when
compared to PLLA matrices40.
Self-assembly is another way of inducing a 3-dimensional, nanofibrous
architecture. The most common approach is the use of peptide-amphiphile (PA)
molecules that contain a hydrophilic, bioactive head and a hydrophobic, lipid-like
tail to form cylindrical micelle-like structures41-43 (Fig. 1.3). These PAs support cell
9
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Figure 1.3: Fibrillar scaffold structures. Schematic of current techniques (i.e., phase
separation, self-assembly, and electrospinning) to create fibrillar structures in synthetic
scaffolds. Scale bar: 10 µm (A, C), 500 nm (B). SEM images adapted and reprinted with
permission from 38(A) and 42(B).
Unaligned(

encapsulation, are injectable (for minimally invasive applications), and can be
made with a number of different bioactive peptide sequences (e.g., adhesion,
degradation, signaling)43. This versatility has supported a number of different
tissue engineering applications including neural stem cell differentiation42, blood
vessel formation44, and cartilage regeneration45. Other systems include selfassembling star shaped PLLA dendrimers46, molecularly engineered interacting
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complimentary peptides47, and beta sheet forming peptides using alternating
hydrophobic and hydrophilic amino acid sequences48.
Electrospinning, the third and widely researched technique for creating
nanoscale fiber dimensions (Fig. 1.3), was first described in the 1930s but has
received renewed interest in tissue engineering for its ability to produce
nanoscale fibers (100 nm-several microns) from a number of different natural and
synthetic polymers6,49,50. Briefly, an electric field is placed between a grounded
target and a polymer solution flowing through a capillary. A droplet forms as the
polymer solution is ejected, and once the charge interactions of the solution
overcome the surface tension of the droplet, the polymer is pulled to the
grounded collection target and produces a fiber as the solvent evaporates. The
process is widely studied because of its scalability, conduciveness to an array of
polymers, and the ability to control fiber diameter through multiple engineering
inputs (e.g., viscosity, voltage, collection distance)

6,50

. Electrospun hydrophobic

polymers such as PLLA-CL (caprolactone) are able to support smooth muscle
cell proliferation and alignment similar to 2-dimensional topographical studies51.
Neural stem cells follow a similar trend on laminin coated polyethersulfone
electrospun scaffolds (fiber diameter controlled between 280-1500 nm) as cell
proliferation and cell spreading increases in response to decreasing fiber
diameter52. In contrast to crystalline and hydrophobic scaffolds, electrospun
hydrophilic polymers require crosslinking (e.g., gluteraldehyde vapor deposition,
photopolymerization) to stabilize the structure upon hydration53,54. The fibers
swell in response to water and are still able to topographically induce the cell
11

shape, alignment, and migration changes found in 2-dimensional culture
systems54.
While these three techniques have had success in creating nanofibrous
scaffolds that mimic the length scale of physiochemical interactions in natural
ECM, each suffers particular drawbacks. Phase separation requires organic
solvents (limiting cell and growth factor encapsulation), is limited in scalability
and polymer compatibility, and requires implantation for in vivo relevance. On the
other hand, self-assembling systems are injectable, but are typically limited in
mechanical strength (~10 kPa)55 and are costly in their synthesis. Electrospinning
is the most conducive to scalability, but requires physical implantation and suffers
from poor cell infiltration into the 3-dimensional architecture. Several techniques
including

salt

leaching56,

sacrificial

hydrophilic

fiber

incorporation57,

photopatterning54, and even simultaneously electrospraying cells onto the
collection target during nanofiber formation have been explored to address this
issue58; however, cell infiltration remains the primary challenge in creating
cellularized 3-dimensional tissue structures.

1.5 Biocomplexity
Moving beyond the ability of the physical structure to influence cell
behavior, natural ECM has a significant biochemical role in modulating a number
of cellular processes such as wound healing, angiogenesis (blood vessel
formation), and immune cell migration. Proteins such as fibronectin and laminin
are known to facilitate cell adhesion through conserved amino acid sequences,
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RGD (Arginine-Glycine-Aspartic Acid) or IKVAV (Isoleucine-Lysine-ValineAlanine-Valine),

respectively59.

glycosaminoglycans

(unbranched

Other

ECM

components

polysaccharides)

and

such

as

proteoglycans

(glycosylated proteins) sequester and activate growth factors and soluble signals
within the ECM to influence cell response60. Even the ECM itself is dynamically
‘remodeled’ through cell-responsive enzymatic degradation and subsequent cell
synthesis and secretion of new ECM. Synthetically replicating this biocomplexity
is an obviously daunting task, but as our understanding of physiochemical and
biochemical cell signaling has increased, so has our ability to engineer these
complexities into tissue engineering scaffolds.
Cell adhesion is the most commonly incorporated biomimetic function in
material design. Since the majority of synthetic materials do not promote cell
adhesion or spreading (except for non-specific serum protein adsorption to
hydrophobic materials), they must be modified to enable their utility in tissue
engineering. Initially, this was achieved by merely coating scaffolds with proteins
(e.g., fibronectin, laminin) known to induce cell adhesion and spreading. Yet,
further understanding of cellular response to surface chemistry61,62 and cellbinding domains (e.g., RGD, IKVAV)59 has permitted covalent incorporation of
these sequences into synthetic systems59. Modulating the density and spacing of
these adhesion domains can then direct cell spreading in both 2-dimensional and
3-dimensional culture systems4,31,63.
In addition to providing cell adhesive ligands, natural ECM interacts with
soluble signals to sequester and alter their biologic activity60. For example,
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anionic glycosaminoglycans (GAGs) and proteoglycans can interact with
positively charged cytokines and growth factors, causing oligomerization and
increased local concentrations64,65. One particular proteoglycan, heparin sulfate,
has been extensively incorporated into materials to alter growth factor release66.
Tanihara et al. covalently crosslinked heparin into an alginate matrix, drastically
reducing the initial burst release of encapsulated basic fibroblast growth factor
and sustaining release over a month as compared to unmodified alginate where
release timescales are less than a day67. Synthetic analogues of heparin have
also been incorporated into fibrin68, hyaluronic acid and chondroitin sulfate69, and
PEG matrices70 to control release profiles of growth factors. These approaches
can also be used to down-regulate unwanted signals like pro-inflammatory
cytokines that hinder endogenous tissue repair71. Advances in peptide
engineering have also enabled designed amino acid sequences to interact with a
multitude of growth factors72. From a clinical perspective, engineered growth
factor interactions can sustain the release of therapeutics while simultaneously
limiting the quantity of growth factor required to modulate cellular responses.
Enzymatic degradation is another area that has received considerable
attention. Traditional scaffolds are designed to degrade hydrolytically (with rates
typically controlled by altering the ratios of polymers within copolymer systems);
however, natural ECM is degraded enzymatically, by matrix metalloproteinases
(MMPs) and serine proteinases (proteolytic enzymes) that facilitate cell migration
and signaling through the fibrous network. To obtain materials that mimic this
proteolytic degradation, West and Hubbell fabricated crosslinkable, triblock
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copolymers (BAB) where the B unit is a long polyethylene glycol chain and the A
units are short peptides sensitive to either MMPs or plasmin (an enzyme
important in clot degradation)73. Acrylate groups on the end of each A block
allowed photocrosslinking into enzymatically degradable hydrogels73. Lutolf et al.
extended this proteolytic susceptibility to a Michael addition crosslinking
mechanism by using di-thiol MMP-sensitive peptides that crosslink vinyl-sulfone
terminated multiarm PEG macromers74. The inclusion of adhesion sequences
permits biomimetic cell infiltration and supports stem cell proliferation and
differentiation31,74. The significant effect of proteolytic susceptibility on cell
morphology is apparent in Fig. 1.4, where encapsulated cells within a hyaluronic
acid matrix can either elongate and form actin stress fibers within MMPdegradable materials or remain rounded within hydrogels that restrict cellmediated degradation31. Hanjaya-Pura et al. applied this proteolytic degradability
in vivo, using hyaluronic acid crosslinked with MMP sensitive peptides to support
vascular network formation of endothelial colony-forming cells and vascularized
networks upon transplantation into mice75. Notably, this bioinspired degradation
mechanism can be tuned by altering the crosslinking density or the MMPsensitive peptide specificity76, affording even more engineering control for
different

applications

such

as

bone74,

cardiac77,

and

vascular

tissue

engineering75,78.
Combining this enzymatic degradation with on-demand release of molecules has
further increased the biocomplexity of synthetic scaffolds. In this approach,
growth factors or synthetic analogues are covalently tethered to the matrix
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through proteolytically degradable sites to enable cell-mediated delivery, in
contrast to standard encapsulation where delivery is based solely on diffusion
through the matrix. Investigations using this strategy have included release of βneural growth factor in response to plasmin79, release of VEGF (vascular
endothelial growth factor)80 or cancer therapeutics81 in response to MMPs (which
are highly elevated in tumor formation). In fact, this idea of enzymatic-based
delivery has expanded into a whole field of stimulus-mediated delivery systems
including glucose responsive systems for insulin delivery in diabetic patients82.

A

B

Figure 1.4: Degradation control over cell morphology in 3-dimensions. Human
mesenchymal stem cells encapsulated in hyaluronic acid hydrogels crosslinked with
either proteolytic sensitive peptides (A) or with the addition of non-degradable kinetic
chains (B). hMSCs stained with FITC-Phalloidin to show actin cytoskeleton. Scale bars:
50 µm (top row) and 10 µm (bottom row).
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1.6 Conclusions
Advances in our understanding of the cell microenvironment over the past
decade have undoubtedly led to remarkable advances in synthetic replication of
natural ECM. One of the major challenges in designing future synthetic scaffolds
will be to incorporate the structural cues provided by fibrous architecture with the
biochemical cues provided by enzymatic interaction. For example, the majority of
structurally engineered scaffolds do not contain a biochemically relevant
degradation mechanism. Likewise, the majority of growth factor sequestering and
enzymatically degradable matrices have been constituted into hydrogels, and
thus lack the fibrillar architecture achieved by structurally designed scaffolds.
Certain strides have been made toward addressing this concern by including
MMP-sensitive domains in self-assembling systems83 or including MMP mediated
release of DNA in electrospun systems84.
Even structural complexity of synthetic scaffolds, an unquestionably more
attainable design goal compared to our evolving understanding of biochemical
cues, can be improved. Natural ECM elasticity and architecture has readily been
mimicked, yet, many ECM components like fibrin (a protein involved in blood clot
formation) display more complex strain stiffening in response to tensile forces85.
To incorporate these structural and biochemical cues, one can imagine a design
approach that features a multitude of the aforementioned strategies into a single
synthetic scaffold. While the utility of such an exceedingly complex scaffold is yet
to be fully understood, creating the next generation of advanced synthetic ECM
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mimics will require close collaboration between cell biologists, bioengineers, and
materials scientists to push the frontiers of possibility in tissue engineering.
In this regard, this thesis aims to engineer ECM signals into hyaluronic
acid hydrogels towards next generation scaffolds for tissue engineering and
regenerative medicine. Particular focus is placed on incorporating biophysical
features (fibrous architecture, soft-tissue mechanics, tissue alignment) with
biological features (protease-mediated degradation, cell-adhesion, spatial
organization of biomolecules) to generate advanced materials for biomedical
applications.
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CHAPTER 2

Specific Aims and Research Overview

2.1 Introduction and Specific Aims
The importance of structural features in the extracellular matrix (ECM) has
motivated the development of nanofibrous scaffolds for the fields of tissue
engineering and regenerative medicine.

Electrospinning is perhaps the most

common technique to generate these scaffolds due to its low-cost setup,
scalability, and compatibility with both natural and synthetic polymers. Despite
efforts in the field, electrospun scaffolds remain limited in their ability to replicate
much of the biophysical and biochemical complexity of natural tissues.

In

particular, electrospun scaffolds from natural polymers suffer from animal
sourcing, purification, and stability concerns that limit there applications, while
electrospun scaffolds from synthetic polymers are often stiff, hydrophobic/semicrystalline polymers that lack bioactivity and water-swollen environments
characteristic of natural ECM.
Given these current limitations, the goal of this thesis is to engineer ECM
features into fibrous hydrogels towards their utility in the fields of tissue
engineering and regenerative medicine.

Hyaluronic acid (HA), a natural

polysaccharide, is chosen as the starting polymer for all materials developed
herein as it is naturally found in the ECM, is microbially sourced to limit animal
purification concerns, and may be chemically modified for crosslinking into water25

swollen networks.

The general objective of this work was to use chemical

modification of HA to allow for specific ECM signals (e.g. fibrous structure,
degradation, spatial localization of biomolecules) to be introduced into HA
hydrogels with previously unrealized biocomplexity. Specifically, the following
four aims were developed to evaluate the utility of these materials as biomedical
scaffolds.

Specific Aim 1: Design and synthesize photocrosslinkable, proteasedegradable HA macromers to form isotropic and electrospun fibrous
hydrogels.
Hypothesis: Conjugating methacrylated peptides and fluorophores to HA through
thiol-maleimide Michael addition will generate HA macromers that are
fluorescent, crosslinkable through UV light (for isotropic and fibrous hydrogel
formation), and protease-degradable based on the sensitivity of the incorporated
amino acid sequence.
To address this hypothesis, HA was modified with maleimide groups to
create a Michael addition acceptor and peptides were solid-phase synthesized
with a thiol (cysteine) at the C-terminus and either a methacrylate or fluorophore
at the N-terminus to create Michael addition donors.

Synthesis and Michael

addition conjugation of peptides to maleimide HA was characterized through 1H
NMR, MALDI-TOF, and UV absorption/emission spectra. Meanwhile, proteasemediated degradation of two peptide sequences (protease-degradable and nondegradable) was analyzed through Lineweaver-Burke plots (using a modified
26

fluorescamine assay) while isotropic hydrogel formation and degradation was
analyzed through in situ rheology and fluorescence release of covalently labeled
fluorescent HA.
Next, protease-degradable HA macromers were electrospun with PEO as
a carrier polymer and I2959 as a UV radical initiator to allow for fiber formation
and UV-light crosslinking after fiber formation.

Scaffolds containing either a

protease-degradable or non-degradable sequence were analyzed for physical
properties (compressive modulus, porosity, swelling) and protease-degradation
in vitro (fluorescent HA release, uronic acid release) and in vivo (transdermal
fluorescence in a subcutaneous implant).

Specific Aim 2: Spatially pattern biochemical signals within electrospun,
fibrous HA hydrogels to control cell behavior.
Hypothesis: Norbornene modified HA (NorHA) may be electrospun, crosslinked
with a thiol-ene reaction, and subsequently patterned with thiolated fluorophores
and cell adhesion sequences to control cell attachment and morphology.
To address this hypothesis, Norbornene modified HA was synthesized
and electrospun with PEO (carrier polymer), I2959 (UV radical initiator), and
dithiothreitol (di-thiol crosslinker) and then crosslinked in the presence of UVlight. The ability to spatially localize biomolecules through photolithography was
evaluated using solid-phase synthesized thiolated fluorophores and thiolated
RGD (amino acid sequence derived from fibronectin commonly used to induce
cell adhesion). Cell morphology (measured by cell density, area, and elongation)
27

was altered in response to biochemical patterns of RGD on scaffolds with
randomly aligned fibers. On scaffolds with aligned fibers, cell adhesion was
localized to RGD patterns (100 µm wide lines) while fiber alignment dictated cell
elongation, further demonstrating the importance of biochemical and biophysical
cues in guiding cell-material interactions.

Specific Aim 3: Design and evaluate protease-sensing electrospun, fibrous
HA hydrogels to investigate cellular protease activity.
Hypothesis: Inclusion of protease-degradable fluorophores on electrospun
NorHA fibers will permit visualization of protease activity.
To address this hypothesis, protease-degradable and non-degradable
peptides with a terminal fluorophore were synthesized and immobilized onto the
surface of electrospun NorHA scaffolds. The protease-mediated degradation of
these peptide fluorophores was evaluated in the presence of exogenously added
proteases and in detecting protease-activity on cell-seeded scaffolds.

An

alternative system was also developed that uses a custom Förster resonance
engery transfer (FRET) peptide to detect protease activity, and this peptide was
compared to commercially available protease-detecting systems to evaluate its
utility.

2.2. Research Overview
Chapter 1 presents the general motivation for engineering ECM features
into biomedical scaffolds (fibrous and non-fibrous) and highlights recent progress
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towards these goals.

Building from this generality, Chapter 3 provides an

extensive review on the methods of fibrous scaffold formation, advantages and
disadvantages to each method, and the application of these materials towards
tissue engineering and regenerative medicine. Specifically, Chapter 3 discusses
electrospinning processing parameters and current limitations in regards to
replicating ECM features that will be expanded upon in this thesis.
Chapter 4 develops a synthetic strategy to generate photocrosslinkable,
protease degradable HA macromers (Methacrylated Peptide HA – MePHA) that
can be formed into isotropic or electrospun hydrogels. Notably, this chapter also
describes the development of a non-degradable amino acid sequence that will
serve as a control for the studies presented in Chapter 5 and 7. Translating from
isotropic to fibrous hydrogels, Chapter 5 uses the material development from
Chapter 4 and explores the formation of electrospun hydrogels to assess their
protease-mediated degradation in vitro and in vivo, a previously unrealized
engineered degradation mechanism in electrospun networks.
Chapter 6 then uses NorHA to create fibrous hydrogels with spatially
localized biomolecules to control cell behavior.

The chapter demonstrates

patterns as small as ~50 µm, the ability to pattern multiple biomolecules onto a
single scaffold, and pattern fidelity through the depth of scaffolds. Additionally,
different cell types including 3T3 fibroblasts and human umbilical vein endothelial
cells (HUVECs) are shown to respond to both fibrous topography and spatially
patterned adhesion sequences within the scaffolds.
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Next, Chapter 7 utilizes the development of protease-degradable and nondegradable peptide sequences from Chapter 4 and generates peptide
fluorophores that can be used to visually monitor protease activity in NorHA
fibrous hydrogels. The degradation of peptide fluorophores on NorHA scaffolds
is first analyzed by the addition of proteases in the presence and absence of
serum, and then as a cell culture substrate in the presence of HT1080 cells
(human fibrosarcoma cell line). An additional FRET fluorophore is also designed
and evaluated against commercially available protease substrates for its ability to
detect protease activity and translate to fibrous scaffolds.
Lastly, Chapter 8 provides a summary and the conclusions of the work
presented in this thesis. Limitations and future directions are also discussed to
further utilize the material development described herein towards understanding
cell-material interactions and as scaffolds for tissue engineering and regenerative
medicine applications.
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CHAPTER 3

Nanofibrous Scaffolds for Biomedical Applications

Adapted from: Wade RJ, Burdick JA. Advances in Nanofibrous Scaffolds for
Biomedical Applications: From Electrospinning to Self-Assembly. Nano Today 9,
722-742 (2014).

3.1 Introduction
The cellular microenvironment provides a wide range of signals that can
guide and direct cell function1-4. These include biophysical and biochemical cues
that exist in natural extracellular matrices (ECM), and if understood, can be
implemented into tissue engineering scaffolds and biomedical devices to improve
outcomes. The last decades have led to widespread understanding of a range of
microenvironmental signals and there is a recent focus on the importance of
structural features in the extracellular microenvironment. The ECM structure is
characterized by a distinctly nanofibrous architecture with subcellular (10-300
nm) diameters1-4. These structural features not only provide architectural and
mechanical support for cellular interactions, but also have specific biological
functions in cellular processes such as migration, differentiation, proliferation,
and paracrine signaling.
To understand the origin and importance of these structural features, I first
turn to one of the most abundant proteins in the human body, collagen. Collagen
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first forms a triple helix structure within the cell through the assembly of three
separate alpha strands (procollagen)5. After vesicle transport to the outside of
the cell, the procollagen is enzymatically cleaved to form tropocollagen and then
aggregates and crosslinks with other tropocollagen molecules to form the
characteristic 67 nm banded fibrils5. This fibrillar structure is conserved in type I
collagen (skin, tendon, bone), type II collagen (cartilage), and type III collagen
(skin, muscle)5. Meanwhile, other proteins such as fibronectin6, elastin7, and
fibrillin8, also form subcellular diameter fibers, contributing to the structural
heterogeneity found in the ECM. The fibrous architecture is even observed
during blood clotting when fibrin is formed after a glycoprotein, fibrinogen, is
cleaved by thrombin, assembles, and crosslinks through Factor XIII9. In turn, the
ECM fibrous structure has a direct impact on cellular response. For example,
studies have indicated that fiber contact guidance dictates cell migration and
morphology10-12, while fiber alignment directs polarized cell migration during
tissue formation13.
Building from the structure of ECM proteins, the body elegantly arranges
these components into complex tissues to direct specific function through
biomechanical and biochemical signals. This begins as early as gastrulation
when fibronectin assembly guides mesoderm formation14 and continues to
healthy adult tissue structure, where cardiac tissue is composed of elongated
cardiomyocytes within a highly aligned, striated ECM15,16. Here, orientation of
cardiomyocytes and the surrounding matrix helps drive contractility to pump
blood throughout the body15-17. This structural complexity is increased within
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certain fibrocartilage tissues, such as the intervertebral disc where a multilamellar structure is maintained by layers of aligned fibers (elastin, lubricin, type
IV collagen) stacked in planes oriented at 30 degrees to one another18,19.
Articular cartilage is also characterized by a complex alignment with parallel type
II collagen fibers along the planar joint surface, proceeding to an unaligned
interior, and then a fibril layer with radial alignment out of the plane of contiguous
calcified matrix20,21.

Tendon provides another example of tissue structure

dictating function22. Parallel bundling of a distinct type of fibroblast (tenocytes)
and type I collagen contributes to mechanical stability through the strainstiffening behavior of collagen fibers (above ~3% strain) as a direct result of the
uncrimping of the banded collagen fibers23.
Perhaps the importance of structural characteristics within the ECM is
most striking when these structural features are altered during maladaptive
processes.

For instance, genetic mutations in the genes responsible for the

formation of fibrillar collagen results in Ehlers-Danlos syndrome, characterized by
overly flexible joints, distinct facial features, and irregular healing of external and
internal tissues after injury24.

Conversely, formation of excessive unorganized

collagen after tissue injury (fibrosis), or exogenous factors like Vitamin C
deficiency (scurvy) may also directly affect healthy tissue structure25. Cancer is
another disease where fibrillar ECM proteins have been implicated in
pathological processes26-31. Mechanical stiffening of the ECM through increased
lysyl oxidase crosslinking of collagen fibers affects the PI3K signaling pathway
and enhance malignancy of breast tumorigenesis30, whereas ECM alignment of
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collagen fibers directs epithelial migration in malignant tumors29. Other proteins
like fibronectin have also been researched for their role during malignant
progression in pancreatic and lung cancer28.

Fibrous structures can further

influence viral transport within tissues as fibrillar degradation significantly
enhances oncolytic vector transfection32.

Although these examples are all

indicative of the loss of normal tissue structure, it is important to state that
irregular amyloid fibrillar formation of typically non-fibrillar protein/protein
fragments such as beta amyloid (Alzheimer’s disease)33, alpha-synuclein
(Parkinson’s disease)33, and huntingtin (Huntington’s disease)34 are also
indicated in pathological processes.
Given the growing literature on the importance of structure in the cellular
microenvironment, tissue engineers are actively seeking to recapitulate the
complex spatial features of natural ECM.

Some of these structural features

include fiber chemistry, diameter, spatial arrangement (aligned, unaligned,
helical, etc.), porosity, and morphology. This chapter will highlight the different
ways that these signals are incorporated into tissue engineering scaffolds and
biomedical devices as well as exciting recent advances in the field. Specifically,
the processes of electrospinning, phase separation, and self-assembly are
discussed.

Particular attention is given to electrospinning since there is

significantly more literature within this particular technique and is the primary
technique used in the following chapters of this thesis. The reader is directed to
pertinent reviews where possible as the large field of research within this topic
precludes a comprehensive review of all investigations. Consequently, the focus
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of this chapter will be on the most recent advances to give the reader a better
appreciation for the current state of this field.

3.2 Electrospinning
Although electrospinning originates from the early 20th century, increases
in our understanding of the importance of structural features on cell-matrix
interactions within the past two decades has renewed interest in the technique.
The electrospinning process involves a polymer solution that is extruded from an
electrically conductive spinneret (often a metal needle) (Fig. 3.1). Concurrently,
voltage is applied between the spinneret and a grounded target that is placed at
a fixed distance (often 5~25 cm) from the tip of the spinneret. As the electric
potential within the polymer solution overcomes the surface tension of the formed
droplet, the polymer ejects from the spinneret, the solvent is evaporated, and the
polymer fibers collect onto the grounded target. The result is an unwoven fibrous
polymer mesh with typical fibers ranging from a hundred nanometers to a few
microns in diameter depending on the particular polymer solution and
electrospinning parameters.
With the increased focus on electrospinning for tissue-engineered
scaffolds, it is worth discussing some of the important processing parameters
that relate to fiber formation and fiber features. Most importantly, stable fiber
formation requires extensive polymer chain entanglement within the initial
polymer solution. Otherwise, the polymer solution is electrosprayed into small
droplets or forms fibers with large beaded polymer aggregates. Consequently, it
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is often difficult to electrospin low molecular weight polymers since their ability to
entangle correlates with their molecular size.

Conversely, higher molecular

weight polymers often cause large changes in solution viscosity, thus increasing
the surface tension of the droplet and limiting the ability to electrospin certain
high molecular weight polymers. Therefore, researchers have often turned to
amphiphilic molecules to decrease surface tension within the solvent35 or addition
of a second polymer to increase chain entanglement36 without the corresponding
large viscosity increase. The choice of solvent is another important processing
parameter.

The solvent must not only dissolve the polymer, but must also

evaporate within the distance from the spinneret to the grounded collector. This
requirement for adequate solvent volatility often necessitates harsh organic
solvents like dimethylformamide, tetrahydrofuran, and hexafluoro-2-propanol.
The toxicity of these solvents makes it important that residual solvent is not
retained within the collected fibers.

Other processing parameters such as

voltage intensity (~a few kV-40kV), spinneret outlet diameter, distance between
spinneret and collector, solution flowrate, and humidity should also be considered
when electrospinning to obtain the desired fiber size and uniformity. The reader
is referred to a number of excellent reviews37-43 for more information on the
technique.
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Figure 3.1: Schematic of electrospinning process and SEM images of fibers from
different synthetic and natural polymers produced by electrospinning. Scale bar: 10 µm.
PGA (polyglycolic acid)50, PLLA (poly L-lactic acid)50, PCL (polycaprolactone)50, PEO
(polyethylene oxide)52, PNIPAM (poly N-isopropylacrylamide)57, PVA (polyvinyl
alcohol)56, Collagen59, and Dextran63 image reprinted with permission.

3.2.1 Chemical and structural features of electrospun scaffolds
The low cost and ease of setup has in part helped drive the renewed
research focus on electrospinning; however, possibly the most compelling
feature of electrospinning is its widespread compatibility with a variety of
polymers. Synthetic polymers including polyesters (polycaprolactone – PCL44,45,
polylactic acid – PLA46-49, polyglycolic acid – PGA50, copolymer PLGA47,50,
polyglycerol sebacate – PGS51), polyethers (polyethylene oxide – PEO52,
polyethersulfone – PES53), polyurethanes54,55, and functionalized polyolefins
(polyvinyl

alcohol

–

PVA56,

poly

N-isopropylacrylamide

–

PNIPAAM57,

polystyrene – PS58) have all been electrospun for biomedical applications (Fig.
3.1). The diversity in these polymers allows the researcher to alter the bulk
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chemistry of the fibrous scaffold depending on the particular application. For
example, PCL is hydrophobic with semi-crystalline domains that give it high
tensile strength and slow degradation (Fig. 3.2), making it an excellent choice for
applications requiring mechanical robustness.

Meanwhile, for applications

requiring faster degradation rates and natural degradation products, PGA and
PLA scaffolds may be more appropriate50. PGA degrades into glycolic acid at a
faster rate than PLA degrades into lactic acid and their combination in copolymer form can lead to tailored degradation rates (Fig. 3.2)50. For applications
requiring soft tissue like mechanics, hydrophilic polymers like PEO are a
promising alternative but require crosslinking post electrospinning to avoid
dissolution of the fibrous architecture upon hydration. Other synthetic polymers
have different properties including temperature responsiveness (PNIPAAM),
electrical conductivity (polyaniline), or toughness (polyethersulfone) that make
them attractive candidates for tissue engineering.
Electrospinning is also compatible with a number of natural polymers (Fig.
3.1), including native structural proteins like collagen59, gelatin (hydrolyzed
collagen)60, fibrinogen61, and elastin62, and polysaccharides like hyaluronic acid
(HA)36, chondroitin sulfate56, dextran63, alginate64, and chitosan65.

By

electrospinning natural polymers, researchers aim to exploit the biocompatibility
and natural biophysical and biochemical cues of natural polymers. For example,
natural collagen has binding sites for integrin mediated cellular adhesion and
proteolytically degradable substrate sites for matrix metalloproteinases (MMPs),
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PGA
PDLLA
PLGA
50/50
PLGA
85/15
PLLA
PCL

Figure 3.2: Degradation of various poly(α-hydroxy ester) electrospun scaffolds in PBS
for up to 42 days. Scaffolds were punched from electrospun mats into 8 mm circular
constructs. PDLLA and PLLA refer to the D and L enantiomers lactic acid, respectively.
PLGA 50/50 and PLGA 85/15 refer to the lactic acid/glycolic acid ratio of the copolymer,
respectively. Scale bar: 1cm. Figure adapted with permission50.

cell-secreted enzymes that degrade natural ECM. Similarly, fibrinogen contains
multiple cell-binding motifs including the most ubiquitously referenced amino acid
sequence for cell adhesion, RGD. Meanwhile, polysaccharides like chondroitin
sulfate and HA have shown anti-inflammatory effects and are known to signal
through cell receptor pathways including MAP kinases (chondroitin sulfate)66 and
CD44 and CD168 (HA)67.

As with hydrophilic polymers, dissolution of the

electrospun architecture upon hydration is an issue with many natural polymers,
requiring researchers to develop crosslinking schemes to improve long-term
stability. For instance, collagen is often crosslinked by formaldehyde or
gluteraldehyde vapor deposition; however, toxicity issues have led researchers to
explore milder crosslinking schemes including citric acid, EDC, and genipin to
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enhance fiber stability and improve cytocompatibility39,68-70. Another strategy to
improve fiber stability is to modify the polymer with a photo-crosslinkable
chemical group (i.e. methacrylates) prior to electrospinning so that the fibers may
be crosslinked post electrospinning with light exposure in the presence of an
initiator36. This crosslinking step post processing may seem a nuisance
compared to hydrophobic or semi-crystalline polymers; however, once stabilized,
these hydrophilic natural polymers assume a water-swollen environment with soft
mechanics more mechanically similar to soft tissue environments. It is important
to note that although the primary structure of these proteins typically remains
intact after electrospinning, the processing often disrupts higher level folding
conformations. In fact, recent studies have demonstrated that collagen retains
about 42% of its initial characteristic spacing between each polyproline-II helix
after electrospinning71. This higher-level structure may not be as important for
structurally

disordered

polysaccharides,

but

should

be

considered

for

understanding the bioactivity of electrospun protein scaffolds.
Bulk chemical properties of electrospun polymers such as hydrophilicity,
crystallinity, density, and degradation rate are important to the bioactivity of the
scaffold, but often it is the surface chemistry that dominates the cell-scaffold
interface. In this regard, non-cell adhesive polymers are limited by their ability to
interact directly with cells.

Therefore, surface modification has become a

common technique to increase cell interactions with non-cell adhesive scaffolds
(Fig. 3.3)43. The simplest method is non-specific surface adsorption of cell-
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Fig. 4 Fabrication
of bioactive electrospun
scaffolds. a physical
adsorption; b blend
electrospinning; c coaxial
electrospinning; dmolecules
covalent immobilization.
Figure
3.3:techniques
Schematic
of different
strategies
to incorporate
biological
and the
resulting fiber structures. (A) Post processing adsorption of a biomolecule to the surface
of a fiber. (B) Inclusion within the initial electrospinning solution entraps the biomolecule
in the fiber. (C) Co-axial spinning gives a core with the biomolecule and a shell from a
second component. (D) Post processing chemical treatment covalently attaches the
biomolecule to the surface of the fiber. Figure reprinted with permission43.
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adhesive proteins like collagen, fibronectin, or laminin. While simple, the method
is not mechanically robust since relatively weak, non-covalent interactions govern
the interactions between the adsorbed proteins and the scaffold. An attractive
alternative is to blend the polymer of interest with a cell adhesive protein in the
initial formulation, thus entrapping the protein within the entire fibrous
architecture.

This approach has been used to blend PCL/collagen72,

PCL/gelatin73, PCL/decellularized ECM74, PGA/collagen75, PGS/gelatin51, and
PVA/chondroitin sulfate56 with correlated improvements in the bioactivity of the
scaffold. In contrast to physical interactions, covalent grafting can be used to
improve long term surface retention of proteins like gelatin, collagen, and the cell
adhesive amino acid sequence, RGD. Using this approach, Kim et al. have
tethered DNA through enzymatically degradable linkers to electrospun
polyethyleneimine for targeted DNA transfection76. One final approach is the
production of core-shell fibers77. Forming core-shell fibers requires a flowing
polymer solution within a core spinneret that is contained inside a second, larger
spinneret such that the liquids meet at the outlet of the device. Notably, this
technique allows independent control of the central fiber composition and the
surface chemistry.
Besides chemistry, fiber diameter is an additional structural feature of
electrospun scaffolds that can influence cellular interactions. From a materials
perspective, fiber diameter can be decreased by addition of a surfactant35
(decreasing surface tension), decreased polymer concentration (provided fibers
are still formed) or alterations in the voltage or distance to grounded collector78.
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Conversely, increasing the polymer concentration can increase the fiber diameter
of collected fibers79. Although the diameters of most electrospun fibers (hundred
nanometers to a few microns) are subcellular in size (10-50 microns), these
differences can influence cellular processes like differentiation, morphology, and
gene expression. For example, on PES electrospun scaffolds with adsorbed
laminin, rat neural stem cells showed a 40% increase in oligodendrocyte
differentiation when cultured on smaller fibers (283 nm) and a 20% increase in
neuronal differentiation on larger fibers (749 nm) when compared to culture on
laminin coated tissue culture polystyrene (Fig. 3.4)53.

Similarly, mouse

embryonic fibroblasts cultured on larger diameter (>2 microns) polyester
urethane urea (PEUU) fibers with adsorbed fibronectin showed increased
scleraxis gene expression (tendon/ligament marker) compared to smaller
diameter fibers (<1 micron)55. Fiber diameter has also been shown to influence
in vitro and in vivo macrophage phenotype from M1 (proinflammatory) on smaller
diameter (690 nm) unmodified PCL nanofibers to an M2 (immunomodulatory)
phenotype on larger diameter (5.6 micron) fibers80, suggesting that fiber diameter
is an important characteristic for promoting biocompatibility and altering
inflammation.
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Figure 3.4: Differentiation of rat hippocampus-derived neural stem cells (rNSCs) on
laminin-adsorbed polyethersulfone (PES) electrospun nanofibers of different diameters.
(A) Immunofluorescence staining for Nestin (neural progenitor marker), Tuj-1 (neuronal
marker), or RIP (oligodendrocyte marker) shows differences in differentiation between
culture on TCPS, 283 nm fibers and 749 nm fibers. (B,C,D) representative images of
immunofluorescence staining. Scale bar: 100 µm. Error bars are mean ± standard error.
*Indicates significant difference from other samples (p<0.05, unpaired 2-tail Student’s ttest). Figure adapted with permission53.

Spatial organization of electrospun fibers is another structural feature that
has been actively researched. Fibers from electrospinning are often randomly
aligned due to the inherent whipping of the fiber jet as the polymer ejects from
the spinneret. To align fibers, researchers have developed different grounded
collectors, the most common being a high velocity, rotating mandrel that can
align fibers parallel to the direction of rotation. Using this method of alignment,
researchers have shown that cell morphology and cytoskeletal organization
closely parallel fiber alignment81. Other groups have used this technique to build
more complex 3-dimensional structures. For example, by rotating an aligned
scaffold 30 degrees with respect to the collecting mandrel, and then collecting
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aligned fibers on top of this scaffold, researchers are able to mimic the structure
of the annulus fibrosus and subsequently culture and instruct mesenchymal stem
cells (MSCs) to deposit an aligned collagen structure with the native multilamellar structure19. Alternatively, collectors with large airgaps between flat metal
prongs have produced aligned fibers by directing fiber deposition parallel to the
direction of the airgap82. A different approach from altered collection targets has
been to mechanically stretch unaligned fibrous scaffolds in uniaxial tension so
that fibers align parallel to the direction of tension47. By applying this mechanical
stretching to PLA and PGLA scaffolds, cardiomyocytes show greater cell
alignment and organized sarcomere formation after 7 days of culture47. Notably,
these methods are limited to planar spatial alignment of fibers while certain
native tissues contain more 3-dimensional arrangements, such as in articular
cartilage as discussed above, where collagen fibers emanate perpendicularly
from the calcified bone and then orient parallel to the bone at the articulating
surface21. The complex 3-dimensional alignment of this native tissue motivates
strategies to control alignment to fully recapture natural tissue architectures.
One of the advantages of electrospun scaffolds is the larger pore size
between fibers when compared to the molecular-scale porosity of traditional
hydrogels. In theory, larger pore sizes should aid in diffusion of soluble growth
factors and metabolites; yet, cellular infiltration within electrospun scaffolds is still
one of the greatest challenges to clinical translation.

The pores typically

observed within electrospun scaffolds are typically smaller than the size of a cell
and most scaffolds do not contain mechanisms for cell-mediated degradation
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(unless formed from natural proteins). In addition, studies of cell behavior have
indicated that cellular migration and morphology in three dimensions more
closely mimics one-dimensional rather than two-dimensional cell migration10,11.
Consequently, cells tend to track fiber alignment during migration and adopt
pseudo one-dimensional morphologies, limiting their inclination to penetrate into
the interior of a scaffold, even when presented with a gradient of growth factors83.
Several techniques have been developed to address limited cellular
infiltration within electrospun scaffolds.

Primarily, these techniques can be

categorized into two strategies: inclusion of cells during the electrospinning
process and increasing the porosity of the scaffold to encourage cellular
infiltration. The first strategy is accomplished by simultaneously electrospraying
cells from a second spinneret directly onto the collector as the fibrous scaffold is
being formed, or inclusion of the cells directly within a polymer solution. A variety
of different cell/material combinations have been investigated including
electrospraying smooth muscle cells into PEUU84, MSCs into polyester carbonate
urethane urea (PECUU)85, and coaxial spinning of brain astrocytoma (core) and
polydimethylsiloxane (PDMS) (shell)86, and smooth-muscle cells (core) and
PDMS (shell)87.

These studies have indicated that careful control over the

voltage parameters allows for adequate cell viability; however, long-term viability,
gene expression, and differentiation may be limited by the physical entrapment
and high voltages required for this technique.
The second strategy of increasing scaffold porosity has been applied in a
number of different ways including multilayering of larger diameter fibers79,
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specialized collection targets56,88-90, and post processing techniques like porogen
leaching91, laser ablation92, photopatterned channels36, and sacrificial fibers93.
Blakeney et al. developed a collector that is a network of stainless steel needles
that are on the concave side of a foam half-sphere shell so that fiber collection is
randomly directed between the array of needles (Fig. 3.5)89. This technique has
generated fluffy, “cotton ball-like” PCL scaffolds that have enhanced cellular
infiltration of pancreatic cells after 7 days compared with scaffolds produced from
traditional flat collectors89. Similarly, air gap spinning, where the collector is two
needles spaced equidistant from the tip of the spinneret, has produced scaffolds
with increased porosity90.
A

B

Figure 3.5: Schematic of PCL scaffolds electrospun into two different collectors.
(A) A plate collector produces traditional flat scaffolds. (B) A custom collector
with conductive needles attached to a metal sphere produces an uncompressed
nanofiber scaffold. Figure adapted with permission89.
Electrospinning into aqueous media is another attractive method. In this
technique, the collector is a charged liquid so that collected fibers form across
the surface of the liquid and subsequently sink into the liquid56,88.

Surface

tension and polymer solubility within the liquid collector should be considered for
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this method, since high surface tension limits fiber movement into the collection
media and solubility within the collection media causes the fibers to dissolve.
One interesting area of recent research has shown that fibers with extremely high
surface charge will begin to spontaneously repel one another upon collection,
thus building extremely porous 3-dimensional structures without any specialized
collectors64,94,95.

This phenomena has been explored in electrospun zein (a

natural protein derived from corn) and SDS (25:25 wt%, respectively) in 70%
ethanol94, and a blend of alginate, PEO, and Pluronic F127 (10.6:0.8:1.5 wt%) in
water64, forming large porous structures on the order of a few centimeters in size.
This technique is limited to polymer solutions that form fibers with high density
surface charges; however, recent studies by Lee et al. have generalized the
technique to coaxial electrospinning of a charge carrying shell, polystyrene, and
a mechanically stable PCL (core) in THF:DMF solvent and then selectively
removing the polystyrene component by mechanical agitation and dissolution in
DMF95.

These exciting advances have enhanced cellular infiltration into

electrospun scaffolds and their success will certainly push research forward in
numerous biomedical applications.

3.2.2 Applications of electrospun scaffolds
With such a diverse array of chemistries and structural parameters,
electrospinning has been applied to an equally diverse array of biomedical
applications including in the engineering of skin75,96,97, cardiac tissue47,51,65,85,98,99,
skeletal tissue19,48,49,56,73,74,100, dental and craniofacial tissue101, vascular
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grafts70,72,102,103, corneas104, and vocal chords105. One area of growing interest is
the use of electrospun scaffolds as dermal patches to promote angiogenesis,
potentially due to the planar structure of skin tissue when compared to larger
tissues. Kumbar et al. showed upregulation of Collagen III by human skin
fibroblasts within PLGA nanofiber matrices with diameters between 350-1100
nm96.

Meanwhile, Jin et al. demonstrated the ability of electrospun PLA-co-

PCL/collagen to enhance bone marrow human stem cell proliferation and
expression of keratin 10 and filaggrin compared to PLA-co-PCL alone97.

To

provide a pro-angiogenic signal, Del Gaudio et al. incorporated VEGF within
genipin crosslinked electrospun collagen scaffolds and reported superior new
vessel formation in a chick embryo chorioallantoic membrane assay compared
with VEGF supplementation alone70.

Likewise, Sekiya et al. compared

commercial collagen (Terudermis®) and electrospun PGA/collagen scaffolds
within mouse skin defect and microcirculation angiogenesis models, with results
indicating significantly higher cell density and functional capillary density,
respectively, with the electrospun scaffold75.

Since multiple FDA approved

materials for wound dressings exist, this allows researchers to readily compare
the efficacy of electrospun scaffolds with current clinical standards.
Cardiac muscle is another attractive application for electrospun scaffolds,
as native striations and contractility are indicative of functional sarcomeres and
may be regulated by material structure.

Numerous in vitro studies of

cardiomyocyte culture have demonstrated that sarcomere formation is aided
through fiber alignment and that contractility is enhanced on a number of different
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PCL99,

Chitosan/fibronectin65,

PGS/gelatin51) compared to culture on flat surfaces.

In vitro cultures with

electrospun

scaffolds

(PLA47,98,

PLGA47,

PGS/gelatin have also indicated the importance of fiber stiffness, as a 560kPa
modulus PGS/gelatin scaffold induced more regular, periodic contractile beating
of cardiomyocytes compared to stiffer substrates of gelatin (720 kPa) – although
chemical composition varied between groups51.

Since native cardiac tissue

transduces electrical signals into coordinated cell contractions, Borriello et al.
incorporated a conductive polymer (PANI) into fibers and showed that human
MSCs could differentiate into cardiomyocyte-like cells with formation of
sarcomeric α-actinin106. Translating electrospun scaffolds in vivo into a cardiac
infarct model, Guex et al. demonstrated that implanted plasma functionalized
PCL scaffolds with bone marrow derived MSCs maintained relative ejection
fraction and fractional shortening levels at 4 weeks99. The mechanism behind
this in vivo improvement (i.e. biophysical, biochemical, paracrine signaling, etc) is
not well understood, therefore, more studies are required to elucidate the
mechanism and clinical benefits of electrospun scaffolds for cardiac engineering.
The patency failure of commercially available graft materials like Dacron® (PET)
or Gortex® (ePTFE) in small-diameter vascular grafts (<6mm) has motivated the
development of new materials, such as electrospun vascular grafts103. In this
application, thrombosis is the primary cause of graft failure; thus, electrospun
scaffolds are often modified to impart anti-thrombotic properties into the graft103.
For example, Tillman et al. implanted PCL/collagen electrospun vascular grafts in
a rabbit aortoiliac bypass model for 1 month and reported limited inflammation
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and full patency72.

Other studies have reduced thrombotic responses in

electrospun grafts by loading with anti-proliferative drugs (paclitaxel)107,
modifying fibers with polyethylene glycol (PEG)108 or biomolecules such as
hirudin (anticoagulant)108, RGD109, or mucin (glycoprotein)110, or pre-culturing
with bone marrow stem cells111 or endothelial cells112,113. Taking a cue from
native signaling within ECM, Yu et al. covalently attached heparin to electrospun
PCL to not only suppress a thrombogenic response, but to also bind and
sequester SDF-1α (stromal derived factor-1α – a natural recruiter of endogenous
progenitor cells) onto the scaffold (Fig. 3.6)114. With this approach, Yu et al.
reported a higher elastic modulus, greater endothelialization of the lumen, and
enhanced smooth muscle cell recruitment to the exterior of the graft compared to
heparin alone treated PCL scaffolds114.

These studies highlight the material

complexity that is required to limit a thrombotic response at the graft-lumen
interface, while simultaneously encouraging endothelialization and neo-vessel
formation within the scaffold. Indeed, longer patency studies are required to
confirm the clinical promise of the aforementioned studies since previous longterm studies (18 months) of unmodified electrospun PCL scaffolds indicated
calcification and cellular regression from the graft wall at later time points (>6
months)102.
Researchers

have

also

applied

electrospun

scaffolds

towards

regeneration of skeletal tissues, illustrating that nanoscale cues provided by
electrospun fibers direct cell differentiation down lineages important to the
engineering of tendons48,74,115, cartilage100, and bone116. Yin et al. observed that
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Figure 3.6: Electrospun PCL with covalently attached heparin immobilizes SDF-1α in a
vascular graft to improve outcomes at 1 month in a rat. (A) Chemical modification of
PCL. (B) SEM image of electrospun fibers (Scale bar: 100 µm). (C) Immunostaining in
the middle of the graft after one week of implantation of Untreated, Heparin conjugated,
or Heparin and SDF-1α treated grafts. CD45 (green – peripheral blood mononuclear cell
marker) and CXCR7 (red – SDF-1α receptor) staining suggests SDF-1α mediates
endothelial cell recruitment within the graft. Scale bar: 40 µm. (D) H&E staining after 4
weeks showed thrombus formation within untreated scaffolds (arrows in first image) but
not in heparin modified grafts. Figure adapted with permission114.

human tendon stem/progenitor cells cultured on aligned PLA nanofibers
expressed significantly higher tendon-specific genes (Eya 2, SCX, and Col 14)
compared to unaligned scaffolds48.

For cartilage applications, Kim et al.
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demonstrated that human MSCs cultured on photocrosslinked hyaluronic acid
electrospun scaffolds respond to mechanics and cell adhesion cues, with softer
fibers and lower cell adhesion (controlled through RGD conjugation) enhancing
chondrogenesis (Fig. 3.7)100. Understanding the importance of these cues in
vitro, researchers have developed strategies for tissue regeneration in vivo. In
bone tissue engineering, for example, current strategies include pre-culturing
scaffolds with MSCs44, functionalizing the scaffold with an inductive growth factor
(BMP-2)116,117, pre-mineralization with hydroxyapatite69,116, and promoting
endogenous homing of progenitor cells through SDF-1α release73. Recently, Ji
A

B

Figure 3.7: Mesenchymal stem cell (MSC) response to electrospun hyaluronic acid
fibers with differences in adhesion and mechanics. (A) F-actin (red), vinculin (green)
and nucleus (blue) staining of MSCs indicate greater cytoskeletal organization and focal
adhesion on scaffolds with greater cell adhesion (controlled through the amount of RGD
within the scaffold) for both mechanics. (B) Gene expression of chondrogenic markers
after culture of MSCs for 14 days in chondrogenic media. * denotes significance (P <
0.05) between groups, v denotes significance (P < 0.05) compared to fibers with the
same mechanics but different RGD densities. Figure adapted with permission100.
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et al. investigated a PCL/type B-gelatin electrospun scaffold with adsorbed SDF1α and discovered a 6-fold increase in bone formation in a rat cranial defect
when compared to scaffolds lacking SDF-1α73. In vitro studies indicated that
released SDF-1α was effective in recruiting bone marrow stem cells; however,
the mechanism of in vivo bone regeneration warrants further investigation73. In
vivo studies of cartilage regeneration have also demonstrated the promise for
electrospun scaffolds.

Coburn et al. evaluated the regenerative potential of

PVA/chondroitin sulfate nanofibers collected within an ethanol solution (wetelectrospinning) for articular cartilage repair within an osteochondral defect in a
rat56. Nanofiber scaffolds revealed higher proteoglycan content compared with
empty defects (albeit, significantly less than native cartilage) and a chondroitin
sulfate specific increase in type II collagen56. These results suggest the promise
of electrospun scaffolds for structural tissue engineering.

3.2.3 Alternatives to electrospinning
Since electrospinning requires high voltages, researchers have developed
related methods of shearing polymer solutions into fibers using milder processing
conditions. Rotary jet spinning118,119 and Forcespinning®120 are two techniques
where a polymer solution or melt is fed from a high-speed rotating reservoir
through a small nozzle so that centrifugal forces elongate the polymer into
nanofibers that collect onto a stationary collector (Fig. 3.8). The method does not
require any electrical charge and has been used to create nanofibers from
several different polymers including PLA118, PEO118, polyacrylic acid118,
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gelatin118, polypropylene120, polystyrene120, and PCL-collagen blends119.

An

alternative method uses a commercial airbrush paint gun to airblow fibers from a
polymer solution onto a surface (Fig. 3.8)121. This method is notable since it
produces fibers with similar morphology to those produced by electrospinning,
but does not require high voltages and fibers can be deposited onto any surface.
Tutak et al. airbrushed polymers including polystyrene, PDLLA (poly L,D lactic
acid), and PCL onto a variety of surfaces for bone marrow stem cell culture121,
and current studies are promising for direct PLGA fiber deposition into tissues as
a biocompatible surgical sealant122.
A

B

C

Figure 3.8: Schematic of rotary jet spinning and airbrushed polymer fibers. (A) Rotary
jet spinning involves high velocity spinning of a polymer solution through a small orifice
to produce nanofibers without electrostatic interactions. (B) Airbrushing uses an airassisted paintbrush to shear polymers into fibrous form. (C) Different nanofibers formed
from airbrushing different polymers (PS – polystyrene, pDTEc – polydesaminotyrosyltyrosine ethyl ester carbonate, PDLLA – poly D,L-lactic acid, PCL – polycaprolactone).
Figure 8A reprinted with permission118. Figure 8B and 8C reprinted with permission121.
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3.3 Phase Separation
Phase separation is another technique that has been used to create
nanofibrous scaffolds. In this technique, a polymer solution is driven to phase
separate through cooling or non-solvent exchange, such that the polymer is no
longer thermodynamically miscible and forms polymer-rich domains within the
solvent (Fig. 3.9). Next, the solvent is extracted and the scaffold is frozen to
maintain the structure.

Finally, lyophilization yields a highly porous fibrous

scaffold with diameters between 50-500 nm123.

One particular advantage to

using the phase separation process is the ability to form custom 3-dimensional
scaffolds through the use of molds with defined dimensions.

In particular,

computer aided design of molds allows for the fabrication of complex structures
like a human ear or jawbone124.

Gela4on"

Lyophiliza4on"

Solvent"
Exchange"

Figure 3.9: Schematic of the phase separation process and an example of the final
fibrous structure obtained with this technique (Scale bar: 10 µm). Fiber image reprinted
with permission125.

Compared to fibrous electrospun scaffolds, scaffolds made through phase
separation resemble more conventional foams with larger pore sizes, suggesting
they may be more amenable to cell infiltration for tissue engineering. Ma and
Zhang, and Nam and Park pioneered this method in 1999 to create nanofibrous
polyester based scaffolds (PGA123, PLLA – poly L-lactic acid123,125, PLGA125) with
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extremely high porosity and sub-micron fiber dimensions. The interested reader
is referred to several excellent reviews that discuss the technique in further
detail42,126,127.
The scaffold architecture and material properties of nanofibrous scaffolds
from phase separation are controlled through a number of inputs. For example,
Ma and Zhang found that increasing the polymer weight percent of PLLA in THF
from 1.0 wt% to 7.5 wt% decreased the porosity from 98.5% to 92.9%,
respectively123. Concurrently, increasing the polymer weight percent increased
the modulus of the scaffold from 4 MPa at 2.5 wt% to 20 MPa at 10 wt%123.
Interestingly, the fiber diameter (160-170 nm) was unchanged by the increase in
polymer weight percent, thus allowing independent tuning of the porosity from
fiber diameter123. To further increase porosity, porogens like paraffin or sugar
can be embedded and then selectively removed128,129. The gelation temperature
controls fiber formation, with higher gelation temperatures favoring platelet-like
fibers, whereas smoother nanofibers are formed with equivalent diameters when
the cooling temperature is below a critical temperature123. Varying the solvent
can also affect fiber formation. Using 1,4-dioxane as a solvent, Liu and Ma
discovered that polyhydroxyethyl methacrylate-g-PLLA fibers formed a ladderlike tubular scaffold, compared to a porous mesh when THF was used130.
Beyond macroscopic structure and general porosity, fiber diameters are
often much smaller within phase separated scaffolds compared to chemically
equivalent electrospun scaffolds, more closely replicating the size scale of
natural ECM fibers. This may aid in cell infiltration and rapid diffusion of any
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encapsulated therapeutics.

Although fiber diameters are smaller, it is quite

difficult to control fiber diameter compared with electrospun scaffolds, since
increasing the initial polymer concentration does not correspond to larger fiber
diameters in phase separated scaffolds123.

In addition, phase separation is

compatible only with particular polymer/solvent systems and requires careful
study of gelation parameters to achieve fibrous scaffolds. For example, inclusion
of increasing amounts of hydroxyalkyl (meth)acrylates (HAA) within PHAA-gPLLA scaffolds caused microspheres to form through discontinuities within the
system130.
Given

the

aforementioned

complexity

required

to

design

new

polymer/solvent systems capable of forming nanofibers, perhaps some of the
most exciting recent advances have been to extend the technique to a wider
scope

of

polymers

PCL131,

including

polyhydroxyalxanoates132,

polyesterurethanes133,134, polypropylene carbonate (PPC)135, PHEMA-g-PLLA130
and PEG-PLLA136 copolymers, gelatin128,137, and chitosan135. Liu et al. created a
type B gelatin scaffold by thermally induced phase separation of a gelatin/ethanol
solution around a paraffin porogen, selectively removed the paraffin with hexane,
and then stabilized the scaffold through EDC crosslinking128. This scaffold had a
higher surface area (700 times greater) and higher compressive modulus (10
times greater) when compared to commercially available Gelfoam® and retained
mechanical stability throughout 14 days of osteoblast culture (Fig. 3.10)128. To
further functionalize these scaffolds, apatite particles were adsorbed to the
surface and resulted in enhanced osteogenic differentiation and mechanical
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Figure 3.10: Comparison of phase separated gelatin (crosslinked with EDC) and a
commercially available gelatin scaffold, Gelfoam®. SEM images of phase separated
gelatin (A and B) reveal a nanofibrous structure distinct from the foamed structure of
Gelfoam® (C and D).
(E) Differences in DNA quantities of MC3T3-E1 osteoblasts
cultured on Gelfoam or nanofibrous (NF) gelatin. (F) Differences in sizes of scaffolds
after culture with MC3T3-E1 osteoblasts. (Scale bar: A and C: 500µm, B and D: 20 µm).
*denotes statistically different (P < 0.05). Figure adapted with permission128.

strength compared to unadsorbed scaffolds128.
scaffolds

through

phase

separation

of

Zhao et al. created dual phase
a

poly(propylene

carbonate)

(PPC)/dioxane solution around a paraffin porogen, and then a second phase
separation within a chitosan/acetic acid solution in liquid nitrogen135.

The

incorporation of chitosan had an effect on in vivo remodeling of a cylindrical
defect in a rabbit femoral chondyle, showing greater bone density after
implantation with BMSCs when compared to BMSCs on a PPC scaffold alone at
16 weeks135. For intervertebral disc engineering, Feng et al. fabricated PLLA
scaffolds formed around a sugar porogen by either solvent evaporation (solidwalled) or phase separation and compared the two scaffolds ability to sustain
nucleus pulposus cell proliferation in vitro and function as a nucleus pulposus
replacement in vivo in a rat caudal disc repair model129.
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Scaffolds formed

through phase separation induced higher GAG production and proliferation when
compared to solid-walled scaffolds and maintained a disc height greater than
80% of the normal height compared to 50% of the normal height in solid-walled
scaffolds after 12 weeks in vivo129. Together, these studies demonstrate the
potential for phase separation scaffolds in structural tissue engineering
strategies.

3.4 Self-Assembly
Taking a cue from the natural process of forming ECM fibers, researchers
have engineered molecular interactions into materials such that these
components self-assemble into fibrillar structures.

These interactions occur

through complex, highly specific non covalent interactions including hydrogen
bonding, van der waals forces, electrostatic forces, hydrophobic interactions, and
π stacking of aromatic rings42,138. Together, these interactions drive assembly of
many native structures including micelle and bilayer assembly of lipids, and αhelix and β-sheet structural motifs of proteins. Often, these native structures are
only tens of nanometers in diameter, which is traditionally smaller than the
diameters capable through electrospinning. Therefore, engineers have designed
materials that replicate the primary sequences of these natural structural units,
so that the designed materials may self-assemble with dimensionality and
structural conformations similar to naturally assembled biomolecules. The selfassembly mechanisms are often triggered through mixing of two components or
an external stimulus (pH, ionic strength, temperature) so that these materials
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may be either injectable or used to directly encapsulate cells, giving them
advantages over the complex processing required to make electrospun or phase
separated scaffolds. Conversely, the mechanisms that govern the formation of
self-assembled nanofibers are generally more complex than other methods and
thus require careful molecular design and more complex synthesis compared to
electrospinning and phase separation. A number of studies over the past two
decades have driven increased interest in these molecularly assembled materials
and as such, several reviews are available for the reader138-142.

3.4.1 β-sheet and β-hairpin forming peptides
Proteins comprise the majority of fibrillar components within the ECM, so it is not
surprising

that

oligopeptides

nanofibrous systems143.

were

the

first

developed

self-assembling

β-sheet forming nanofibers (Fig. 3.11) were first

implemented with an amino acid sequence (AEAEAKAKAEAEAKAK, or EAK16
for short)143 that is now indicative of a broader range of sequences including
RAD16-I

(RADARADARADARADA-PuraMatrix™)144,

(RARADADARARADADA)145,

and

KLD12

(KLDLKLDLKLDL)146

RAD16-II
that

also

assemble through β-sheet formation. These sequences share a common motif
of alternating hydrophilic and hydrophobic amino acids that stabilize into βsheets, associate to form nanofibers with high aspect ratios, and macroscopically
form free-standing fibrous hydrogels.

Other fibrous peptides have similarly

structured sequences that contain a central linker between two complimentary
amino acid sequences (VKVKVKVK-VDPPT-KVKVKVKV – termed MAX1,
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VKVKVKVK-VDPPT-KVEVKVKV – termed MAX8) so that a β-hairpin structure
can form within the same oligopeptide147. Since the molecular interactions that
govern their structure are non-covalent, the self-assembly of these systems can
be sensitive to changes in concentration, pH, temperature, ionic strength, and
solvent composition148-151. For example, Aggeli et al. developed β-sheet forming
11 amino acid oligopeptides termed P11-I and P11-II that form ribbons at low
concentrations (<0.9mM) but form more rigid, self supporting fibers at higher
concentrations (>4mM)151.

Later work demonstrated that these oligopeptides

sharply lose their structural features when titrated above pH 7, illustrating the
sensitivity of self-assembly to the external environment148. This sensitivity allows
the researcher to trigger gelation through external factors, but unless stabilized
through other interactions, also renders the fibrous structure sensitive to
perturbations from the initial gelation conditions.

3.4.2 α-helical forming peptides
One of the most common structural motifs in native proteins is the alpha
helix, most ubiquitously found in collagen where it is assembled through the coil
of GPX repeat amino acid units, where X represents a variable amino acid5. This
structure was developed into a self-assembled peptide by Pandya et al. through
the mixture of two 28 amino acid sequences (Fig. 3.11), each consisting of two
consecutive similar sequences of 7 amino acids followed by two consecutive
similar sequences of 7 complimentary amino acids152. The inspiration for this
design derives from coiled formation of sticky ends in DNA fragments, such that
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Figure 3.11: Schematic of self-assembling nanofibrous systems. (A) β-sheet forming
peptides are typically formed from alternating hydrophobic and hydrophilic amino acid
sequences. RADA-II assembles from single peptides into nanofibers through β-sheet
formation between complimentary sequences forming an interconnected network shown
by the SEM image. (B) α-helical forming peptides consist of a repeating 7 amino acid
motif of HPP-HPPP, where H is a hydrophobic amino acid and P is a polar amino acid.
Association of two complimentary strands drives α-helix formation strand assembly into
long fibrils. A corresponding TEM image of nanofibers is shown. (C) Peptideamphiphiles (PAs) contain 4 distinct engineered regions. Alkyl chain tails help cylindrical
micelle assembly, and the stabilization domain is often a β-sheet forming sequence of
amino acids. The polar domain aids in solubility, and although not required, the
bioactive domain can be included to aid in cell adhesion, degradation, or growth factor
presentation. An SEM image of PAs is shown. Scale bars: A and C: 500 nm, B: 1 µm.
Figure 11A adapted with permission145. Figure 11B adapted with permission154. SEM
image of Figure 11C reprinted with permission166.

when mixed, the two 28 amino acid sequences assemble through complimentary
strand associations152. The structure of these α-helical nanofibers can be altered
through variations in the initial sequences or addition of shorter complimentary
peptides to disrupt the linear formation of fibers, causing differences in fiber
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morphology and stability153,154.

The length of these oligopeptides currently

precludes their widespread use; however, increased research into the molecular
assembly of these gels has since led to more generalized heptad155, diblock156,
and pentablock157 polypeptides, suggesting their use as more prevalent
nanofibrous materials.

3.4.3 Peptide-amphiphiles
Peptide-amphiphiles

(PAs)

are

another

class

of

self-assembling

nanofibrous materials whose design derives from natural molecular interactions.
In this case, lipids and the hydrophobic interactions that govern lipid bilayer
formation are the inspiration for PAs. The design and molecular composition can
be broken down into four domains (Fig. 3.11)139. First, a hydrophobic alkyl tail
acts like the tail of a surfactant and helps drive cylindrical micelle formation.
Second, a central domain contains amino acids capable of disulfide formation158
or hydrogen bonding, typically through β-sheet formation139 to stabilize the
structure upon assembly. Mechanistic studies of PA assembly have indicated
that hydrogen bonding between the first four amino acids adjacent to the
hydrophobic tail are most important to maintain the fibrous structure159. Thus,
altering these amino acids can influence both mechanical properties and gelation
rate160-162. Third, a charged amino acid or short sequence of charged amino
acids is adjacent to the hydrogen bonding domain and aids in solubility and
gelation kinetics of the PAs139.

Importantly, more charged amino acids help

solubility but may limit micelle aggregation, while fewer charged amino acids
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diminish the amphiphilic nature of the molecule139. Charged amino acids are
sensitive to changes in both pH and ionic strength so that this region can also be
used to trigger gelation and alter mechanical properties163 through external
changes in the solution. Recent studies have also found that by cooling from an
elevated temperature, certain PAs can align into highly ordered nanofibers164,
furthering the ability to engineer controlled architecture. Although not required,
the fourth and final domain is a bioactive region that can be designed for
degradability165, cell adhesion158,166, or growth factor presentation167.

The

assembly mechanism dictates that this fourth domain is displayed on the surface
of the PA; therefore, this region is important in regulating protein adsorption and
cell-fiber interactions139. The variability in the design of each domain, triggered
gelation, and relatively facile production through solid-phase synthesis makes
PAs an attractive scaffold for biomedical applications.

3.4.4 Applications of self-assembling nanofibrous materials
Since their initial discovery, these three types of self-assembling peptide
based systems have been used in various applications including bone158,168-170,
nerve166,171, cartilage172, cardiac tissue173, angiogenesis167,174,175, and as cell
culture substrates144,176,177. As previously mentioned, one of the novel aspects of
these nanofibrous systems is their injectability through mixing of components
(i.e., complimentary peptides that form β-sheets) or physiological stimulus (e.g.,
pH, temperature, ionic concentration). Therefore, some of the most promising
research of these materials derives from their use in vivo as minimally invasive
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injectable materials. Mata et al. engineered a two component PA system that
contained one PA with a cell adhesive sequence (RGDS) and one with a
phosphorylated serine residue (known to nucleate hydroxyapatite crystals) to
enhance in vivo bone formation170. After injection into a critical sized femoral
defect in a rat, the PAs induced statistically equivalent bone formation as a
common allograft (demineralized bone matrix)170. To sustain growth factor
release, Davis et al. functionalized a RAD16-II peptide with biotin, demonstrated
its ability to form nanofibers, and then adsorbed biotinylated IGF-1 (insulin-like
growth factor 1) to the surface of the nanofibers through a tetravalent
streptavidin173.

This RADA16-II/IGF-1 conjugate was injected with neonatal

cardiomyocytes into a rat model of myocardial infarct and significantly improved
fractional shortening and ventricular dilation at 21 days when compared to
untreated, only cardiomyocyte injections, or cardiomyocytes and nonbiotinylated
RADA16-II/IGF-1 treatments173. Rajangam et al. adopted a similar strategy by
forming PAs with a heparin-binding domain in the bioactive domain174. After
mixing with FGF-2 (fibroblast growth factor 2) and VEGF (vascular endothelial
growth factor), the heparin domain tethers the two growth factors to the PA
through each component’s affinity for heparin binding174.

This system was

injected into a rat cornea model of angiogenesis and was able to induce
extensive neovascularization when compared to treatment with growth factors
within a collagen gel or growth factors within soluble heparin174, further indicating
the synergistic effects of growth factor presentation from nanofibrous systems.
Recent studies also indicated that the self-assembled systems alone might be
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beneficial for tissue regeneration. Shah et al. engineered a bioactive domain
with a high binding affinity for TGF-β1 (transforming growth factor β1) into PAs to
regulate its release within a microfracture chondral defect in a rabbit172. They
found that the TGF-β1 binding PAs displayed similar articular cartilage
regeneration after 12 weeks, even when injected without exogenous TGF-β1
(Fig. 3.12)172. This suggests that biofunctionalization of the materials alone may
be able to promote tissue regeneration.
A

B
C

D

Figure 3.12: A TGFβ-1 binding PA evaluated for articular cartilage repair within a rabbit
microfracture surgery model. (A) Chemical structure of the TGFβ-1PA shows the TGFβ1 binding peptide site in blue, separated by a glycine space from the polar domain
shown in red. (B) Chemical structure of the Filler PA that does not contain an epitope
for binding TGFβ-1. (C) Model of the molecular structure after nanofiber formation. (D)
ELISA quantification of TGFβ-1 release from filler PA or TGFβ-1PA indicates greater
retention of TGFβ-1 within TGFβ-1PAs. Figure adapted with permission172.

New strategies are being developed to incorporate bioactive domains
directly into nanofibrous peptide materials.

For example, Webber et al.

engineered a 15 amino acid sequence (previously shown to mimic VEGF
signaling) directly into the bioactive domain of a PA and investigated its in vitro
signaling to endothelial cells and in vivo angiogenic potential in a mouse hind
limb ischemia model167.

In vitro, the VEGF mimicking PAs signaled through
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phosphorylation of VEGF receptors, while in vivo, these fibrous materials
enhanced tissue perfusion, functional recovery, and treadmill endurance when
compared to exogenous VEGF or non-VEGF mimicking PA treatments167. This
strategy of including growth factor domains within self-assembling materials limits
the need for full growth factor synthesis and purification, retains the bioactive
domain at the material-cell interface, and facilitates a high density of growth
factor within the nanofibrous structure167.

Another target of interest is the

incorporation of amino acid sequences susceptible to degradation by MMPs. Jun
et al. first incorporated an amino acid sequence derived from collagen
(GTAGLIGQ) in the bioactive domain of PAs to show targeted degradation in
response to type IV collagenase (a mixture of MMPs)165.

Since then, MMP

degradable sequences have been incorporated into other self-assembling
nanofibrous materials like β-sheet forming RADA178, VEVK179, amphiphilic ABA
polypeptides180 β-hairpin forming oligopeptides181, and collagen mimetic
peptides182. Galler et al. designed an ABA copolypeptide system with both cell
adhesion sites (RGD) and MMP cleavable sites (LRG) that formed 6 nm
nanofibers upon β-sheet formation180. This material demonstrated differences in
MSC spreading, proliferation, and migration within the fibrous matrix when
compared to nanofibrous gels formed with non-degradable sequences (Fig.
3.13)180, making these systems an attractive platform for in vitro cell studies.
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Figure 3.13: ABA copolypeptide system enzymatic degradation. (A) MMP degradable
sequences incorporated into β-sheet forming peptides (Blue) leads to increased
degradation in response to type IV collagenase and Trypsin. (B) MSC response to MMP
degradability after seeding on peptide scaffolds. (B1, B2) Without MMP degradable
sequences, cells remain on top of scaffolds. (B3,B4) With MMP degradable sequences
(SLRG) MSCs migrate into the interior of the scaffold. Reprinted with permission180.

3.4.5 Alternative self-assembling nanofibrous materials
Although most of the aforementioned self-assembling peptides are
synthesized via solid phase resins (simpler and cheaper than bacterial derived
synthesis), there is still interest in building self-assembled, nanofibrous materials
through simpler mechanisms to reduce the cost of synthesis and speed up
clinical translation.

With this goal in mind, Mishra et al. were able to form

supramolecular nanofibers from ultrashort peptides (3-7 amino acids) by
synthesizing peptides with decreasing hydrophobicity from the N-terminus to the
C-terminus and then including a charged or polar amino acid at the Cterminus183. This molecular design formed α-helical pairs that assembled into
temperature stable (up to 50 °C) nanofibers with diameters similar to native
collagen (50-60 nm)183. This class of materials (ultrashort peptide hydrogels) is
now being explored for a number of biomedical applications including drug
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delivery184 and wound healing185. An approach that avoids the use of peptidebased strategies completely is interfacial polyelectrolyte complexation (IPC). In
this technique, anionic and cationic polymer solutions are first carefully layered to
limit mixing. Next, a fiber is drawn from the interface such that the electrostatic
interactions and mechanical force drive complexation of the polyions into micron
sized fibers, larger than the diameters typically obtained through peptide-based
assembly.

After Ohkawa et al. demonstrated this phenomena using a

chitosan/poly(α,L-glutamic acid) system186, Wan et al. used this technique to
create chitosan/alginate fibers to sustain the release of NGF (nerve growth
factor), immobilize NGF through an avidin/biotin linker, and encapsulate
endothelial cells, fibroblasts, and MSCs with high viability187,188. One concern
with this technique is that fibers tend to clump and lose their porosity upon
drying; therefore, Wan et al. combined a silica phase through sol-gel processing
with IPC to stabilize the fibrous architecture189.

More recent work has

investigated the entrapment of biological proteins190, covalent modification of
fiber surfaces190, and the patterning of endothelial cells within IPC fibers191.

3.5 Conclusions
Our understanding of the importance of structural features in the cellular
microenvironment has resulted in remarkable developments in synthetically
recreating the nanofibrous architecture of natural ECM. These developments are
described above in the processes of electrospinning, phase separation, and selfassembly to fabricate nanofibrous materials. Despite these advances, several
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areas exist for improving nanofibrous materials to better mimic natural ECM. For
example, many ECM components are viscoelastic, displaying complex non-linear
responses to tensile stress192; however, this mechanical deformation is largely
undeveloped within structural scaffolds. Within electrospinning, challenges still
persist for enhancing cellular infiltration and unless formed from natural proteins,
electrospun scaffolds degrade through hydrolytic degradation, not through a
more biochemically relevant mechanism like MMP degradation.

Phase

separated scaffolds are generally more porous than electrospun scaffolds, but
also require complex processing that precludes their use for cell encapsulation,
and the technique has only been explored in a limited number of polymers. Selfassembled materials form through milder processing conditions, are injectable,
and can directly encapsulate cells; yet, their mechanical properties are weaker
than most electrospun or phase separated scaffolds163, and their kinetics of
formation can be slower than current shear-thinning injectable hydrogels193 which
may cause self-assembled systems to diffuse in vivo before gelation.
Given the limitations of the various nanofibrous materials, perhaps their
utility could lie in hybrid systems that take advantage of the beneficial properties
of the individual components. Indeed, studies are currently looking at various
hybrid systems including PAs within PCL sponges194 or collagen gels168,
electrospun PAs195, PAs within electrospun PCL196,197, and hydrogel/electrospun
composites198,199.

In addition, fibrous materials may offer platforms to study

disorders related to changes in fibrous structure and also provide insight into the
mechanisms of maladaptive protein aggregation (i.e., amyloid formation)200. To
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fully realize the potential of nanofibrous scaffolds in biomedical applications,
engineers, biologists, and medical doctors will need to collaborate closely on the
design of next-generation materials. Ultimately, the utility of these scaffolds will
be judged by their successful clinical translation and ability to provide novel
treatments for patients.
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CHAPTER 4

Synthesis of Photopolymerizable, Protease-Degradable
Hyaluronic Acid Macromers and Hydrogel Formation

Adapted from: Wade RJ, Bassin EJ, Rodell CB, Burdick JA. Protease-degradable
electrospun fibrous hydrogels. Nature Communications 6, 6639 (2015).

4.1 Introduction
As discussed in Chapter 1, hydrogels have emerged as a promising class
of materials to replicate features of natural extracellular matrix1. One hydrogel
property of particular interest towards the fields of tissue engineering and
regenerative medicine is the ability to engineer hydrogel degradation.

The

erosion profiles of hydrogels may be tailored to the particular application through
careful design of the crosslinking chemistry, degree of crosslinking, and polymer
chemistry2-6. For example, covalently crosslinked hydrogels require hydrolysis of
the network to generate erosion products such that degradation is controlled
through the hydrolytic susceptibility of the crosslinker or polymer backbone5-6.
While this degradation mechanism facilitates a wide range of erosion profiles,
this hydrolytic degradation fails to capture the protease-mediated degradation
indicative of natural extracellular matrix (ECM) erosion. Specifically, natural cellmatrix interaction is a dynamic process that includes secretion, organization, and
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degradation

of

ECM

through

cell-mediated

production

of

matrix

metalloproteinases (MMPs) and serine proteases1,7-11.
Accordingly, a large emphasis has been placed on understanding the
structure and function of these proteases. More than 24 different MMPs have
been identified in vertebrates since MMP-1 was first discovered in tadpole
metamorphosis in 19627,8. This family of proteases is zinc-dependent and
characterized by 4 domains7,8. First, the prodomain is a region containing a
cysteine switch motif (PRCGXPD) that inhibits activity and degradation of the
enzyme until the region is cleaved by an external peptide (e.g. furin). Upon
cleavage, the second domain (catalytic site) is exposed such that the MMP may
actively cleave ECM components. The third domain (hinge region) is a flexible
linker with between the catalytic site and the fourth domain (hemopexin region),
which may be necessary to facilitate substrate binding (e.g. Tissue inhibitors of
MMPs (TIMPs)) and sequestration in the ECM7-9. Importantly, MMPs may be
secreted into the surrounding matrix (e.g. MMP-1, MMP-2, MMP-3) or cellmembrane associated (e.g. MT1-MMP, MT2-MMP, MT3-MMP) with each
individual MMP having different substrate specificities for ECM proteins7-9.
Alternatively, serine proteases account for nearly one third of all known
proteolytic enzymes and are characterized by a nucleophilic serine amino acid
(commonly adjacent to a Asp, His, Ser sequence) that attacks a carbonyl to
induce substrate degradation10,11.

Perhaps the most ubiquitous of serine

proteases, trypsin, is found in vivo (pancreas) and extensively used in vitro to
cleave cell adhesion sites for cell detachment from surfaces10,11.
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The production and activation of these proteases is a highly regulated
process that may be disrupted during diseased states including cancer12,
arthritis13, fibrosis14, atherosclerosis15, myocardial infarction16, wound healing17,
and inflammation18. Consequently, researchers have focused on engineering
protease-mediated degradation into hydrogels. This type of degradation may be
a better strategy to allow for natural tissue replacement as it replicates cellmediated degradation mechanisms, with the goal being hydrogel degradation
controlled through natural changes in protease levels.

Towards this goal, a

number of different hydrogel chemistries have been developed in which the
materials crosslink through protease-degradable amino acid sequences19-27. In
vitro studies have indicated the importance of this degradation mechanism as
protease-degradability

influences

cell

morphology,

migration,

and

differentiation23-25. Translating in vivo, protease-degradable hydrogels have been
applied towards regenerative medicine applications to aid in vascular network
formation26, bone formation20, and tissue function after myocardial infarction27.
The primary method for crosslinking the aforementioned hydrogels is
through Michael addition between a nucleophilic protease-degradable crosslinker
(Michael donor) and an electrophilic α,β unsaturated carbonyl (Michael acceptor).
For example, 4-arm or 8-arm polyethylene glycol (PEG) is one of the most
commonly used macromers whereby the arms may be functionalized with
sulfones, acrylates, methacrylates, maleimides, or other Michael acceptors and
crosslinked by addition of a di-thiol (Michael donor) amino acid sequence6,20,22.
Other hydrophilic chemistries including hydrazide-aldehyde27, azide-alkyne28,
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and cyclodextrin-adamantane29 (non-covalent) have also been developed for
various hydrophilic polymers to generate protease-degradable hydrogels.

By

design, these chemistries spontaneously form hydrogels upon mixing of the
components. Although this gelation scheme may be beneficial for injectability,
these strategies are not translatable to electrospinning where components must
remain soluble until crosslinking is induced post-electrospinning. Thus, proteasedegradability has not previously been engineered into electrospun networks.
Towards this translation, this chapter describes the synthesis of hyaluronic
acid (HA) macromers that contain protease-cleavable and fluorescent peptides
that form hydrogels through a photoinitiated polymerization. Specifically, HA is
chemically

modified

with

novel

protease-degradable

or

non-degradable

methacrylated peptides, such that gelation is controlled through a UV-light
induced radical polymerization.

Protease-mediated degradation is shown

through in vitro assays using a broad range of MMPs (collagenases) as well as a
specific MMP, recombinant MMP-2. Importantly, the chemistry of this material
system allows for translation to electrospinning, the subject of Chapter 5.

4.2 Materials and Methods
4.2.1 Solid-phase peptide synthesis
All materials are from Sigma-Aldrich unless noted otherwise. Proteasedegradable

peptide

(GCNS-GGRMêSMPV-SNGG-Methacrylate),

non-

degradable peptide (GCEE-NGGSGGSN-GGGH-Methacrylate), and thiolated
peptide fluorophores (GCKK-FITC, GCKK-Rhodamine, GCKKG-Cyanine7.5)
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were each synthesized with a thiol to facilitate Michael addition coupling to
MaHA. The protease-degradable sequence is listed in italics where proteasemediated cleavage is known to occur at the indicated arrow, between the central
serine and methionine amino acids. Briefly, peptides were synthesized on
Glycinol 2-Chlorotrityl resin (protease-degradable, non-degradable, GCKKGCyanine7.5) (Novabiochem) or 1,6-Diaminohexane trityl resin (GCKK-FITC,
GCKK-Rhodamine) (Novabiochem) using a PS3 automated solid-phase peptide
synthesizer (Protein Technologies, Inc.) via standard FMOC chemistry. The resin
was deprotected with 20% (v/v) piperidine in N,N-dimethylformamide (DMF), and
FMOC protected amino acids (Novabiochem) were then activated with HBTU
(Novabiochem) and 0.4 M methylmorpholine in DMF before being added to the
reaction vessel in 4 times excess to resin functional groups. To add non-amino
acid terminal functional groups to the peptides, the corresponding carboxylic acid
form of the functional group (methacrylic acid, 5(6)-carboxyflourescein,
Rhodamine B, or Cyanine7.5 carboxylic acid (Lumiprobe)) was added in the last
step of synthesis. Peptides were cleaved in a 10 mL solution of 95%
trifluoroacetic acid, 2.5% triisopropylsilane, and 2.5% DI H2O, precipitated twice
in cold diethyl ether (-80 °C), and allowed to dry overnight.
Peptides were dissolved in DI H2O, flash frozen in liquid nitrogen,
lyophilized, and stored under nitrogen at -20°C until use or analyzed for purity by
matrix-assisted laser desorption ionization – time of flight mass spectroscopy
(MALDI-TOF) to confirm synthesis. Protease-degradable and non-degradable
peptides were further analyzed via 1H NMR (Bruker DMX 360 MHz) and the
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degree of methacrylation per peptide was determined (~100%) by calibrating to
known amino acid peaks for valine (protease-degradable sequence) or histidine
(non-degradable sequence). Thiolated fluorophore excitation and emission
spectra were measured using a Tecan Spectrometer.

4.2.2 Degradation kinetics
Kinetic parameters for protease-degradable peptides and non-degradable
peptides were measured using a modified fluorometric assay as previously
published20,30. Briefly, peptides (50-500 µM) were incubated with 1 U ml-1 Type II
Collagenase (Worthington Biochemical) or 1 nM rhMMP-2 (R&D Systems) in
fluorescence buffer (50 mM tricine, 50 mM NaCl, 10 mM CaCl2, 0.05% Brij-35,
pH 7.4) at 37°C. Substrate cleavage was monitored by reacting 20 µL
fluorescamine (50 mM in acetone) with 75 mL of substrate/enzyme solution and
detecting fluorescence (excitation: 380 nm, emission: 480 nm) on a Tecan
Spectrometer. Initial reaction velocities were determined from plots of
fluorescence vs. time. The slope of each plot was divided by the fluorescence
corresponding to full hydrolysis, and multiplied by the substrate concentration to
give velocity in micromoles per minute. Lineweaver-Burk plots (1/V vs. 1/[S])
were linear for protease-degradable peptides, indicating Michaelis-Menten kinetic
behavior. Kinetic parameters were determined by directly curve fitting plots of
velocity vs. substrate concentration to the Michaelis-Menten equation (to limit
errors induced by Lineweaver-Burk double-reciprocal plots). Fluorescence did
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not increase over time for non-degradable peptides such that their kinetic
parameters could not be determined.

4.2.3 MePHA synthesis
MePHA polymers were synthesized in a modular three-step process. First,
MaHA was synthesized as previously described29.

Briefly, Na-HA (90 kDa,

Lifecore) was dissolved in DI H2O and a Dowex® 50Wx8 ion-exchange resin and
mixed at 600 RPM for 5 hours. The resin was filtered from the reaction vessel
and the solution was titrated to pH 7.02-7.05 with tetrabutylammonium hydroxide,
frozen, and lyophilized to yield HATBA. Next, HATBA was dissolved as a 2 wt%
solution in anhydrous dimethyl sulfoxide (DMSO) (Fisher) and reacted with
equivalent molar amounts of N-(2-aminoethyl)maleimide trifluoroacetate salt and
(Benzotriazol-1-yloxy)tris(dimethylamino)phosphoniumhexafluorophosphate
(BOP) under N2 for four hours before dialyzing (8,000 MWCO, Spectra/Por®)
against cold DI H2O for two weeks. MaHA solutions were frozen, lyophilized, and
analyzed via 1H NMR to determine the degree of HA repeat functionalization with
maleimide groups. Although different degrees of maleimide functionalization
were achieved (5%-35%) all studies reported here were conducted with 10-15%
functionalized MaHA (i.e. 10-15% of HA repeats contain a maleimide linkage) for
consistency between all materials. Second, thiolated peptides were synthesized
as described above. Third, MaHA was dissolved as a 1 wt% solution in DI H2O
and thiolated peptide fluorophore was stoichiometrically added such that
thioether bonds would form in less than 6 maleimide repeats per HA polymer
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chain. 90 kDa HA contains greater than 230 repeat units on average such that
15% modified MaHA contains 35 maleimide repeats, of which less than 6 are
consumed by thiolated fluorophore. After 30 minutes of mixing, methacrylated
peptide (protease-degradable or non-degradable) was added in 1.4 times excess
to maleimide groups and allowed to react for 4 hours at room temperature to
consume all remaining maleimide groups. The solution was titrated to neutral pH
using 5 N sodium hydroxide, dialyzed (8,000 MWCO, Spectra/Por®) against cold
DI H2O for 72 hours, frozen, lyophilized, and stored at -20°C. Final product
conjugation was confirmed via 1H NMR by the loss of maleimide peak and
introduction of methacrylate peaks from the conjugated peptide.

4.2.4 Hydrogel fabrication
All degradation studies were replicated (n=3 or 4 as stated throughout) to
determine statistical significance. Prior to any hydration step, all formulations of
MePHA were sterilized under germicidal UV exposure for 45 minutes and
maintained under sterile conditions thereafter. For rheological studies, solutions
of 2 and 4 weight percent MePHA with 0.05% Irgacure 2959 (I2959) in TTC
buffer (0.05% Triton X-100, 50 mM Tris-HCl, 1 mM CaCl2, pH 7.4) were exposed
to 10 mW cm-2 of UV light (Omnicure s1000 – 365 nm filter) for 15 minutes on an
AR2000 stress-controlled rheometer (TA instruments - 20 mm diameter cone and
plate geometry, 59 min 42 s cone angle, and a 27 µm gap distance) under 0.1%
oscillatory strain. To synthesize isotropic MePHA hydrogels for degradation
studies, 50 µl solutions of 4 wt% or 2 wt% MePHA with 0.05% I2959 in TTC
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buffer were contained in a cylindrical mold (tip of a cut 1mL syringe) and exposed
to 10 mW cm-2 UV light for 15 minutes to induce gelation.

4.2.5 Degradation studies
Isotropic hydrogels (50 µl) were equilibrated at 37°C in 1 ml of TTC for 48
hours in lo-bind tubes and then placed into fresh sterile TTC Buffer, 5nM rhMMP2, or sterile 1-500 U ml-1 Type II Collagenase (stock activity – 335 U mg-1,
Worthington Biochemical) in TTC buffer (n=3 per condition). Units of activity are
given by Worthington Biochemical COA and defined as “one unit liberates one
micromole of L-leucine equivalents from collagen in 5 hours at 37°C, pH 7.5”.
Supernatant was collected and samples were refreshed with the corresponding
media every two days to maintain enzymatic activity. Scaffolds not fully degraded
at the end of studies were degraded in 1 mg ml-1 hyaluronidase to determine total
HA content. The collected supernatant was analyzed via fluorometric
spectroscopy (FITC - excitation: 480 nm emission: 517 nm; RHO – excitation:
550 nm emission: 580 nm; Cyanine7.5 – excitation: 788 nm emission: 818 nm)
and compared to a standard curve of equivalent fluorescent MePHA. Individual
scaffold degradation was formulated into a percentage and then averaged
between groups to generate degradation profiles.
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4.2.6 Statistical analysis.
All experimental data is reported as the mean of 3 or 4 individual samples.
Single factor ANOVAs were performed for data sets with followup Tukey’s HSD
post-hoc testing and statistical significance was considered p<0.05.

4.3 Results and Discussion
4.3.1 Design of protease-sensitive photocrosslinkable HA
HA was chosen as the primary macromer component for this thesis as it is
a bioactive molecule in natural ECM and is microbially sourced to limit
purification concerns associated with ECM proteins sourced from animals.
Furthermore, HA has a repeat structure with several functional groups (e.g.
hydroxyls, carboxyls) amenable to chemical modification and may contain
several hundred repeat units to enable varying degrees of functionalization31,32.
Previous studies have also successfully formed hydrogels from methacrylate
functionalized HA to mimic the microenvironments of many soft tissues31.
Conceptually, the hypothesis was that incorporating a protease-degradable or
non-degradable sequence between the methacrylate group and HA backbone
could generate a starting material that crosslinks through methacrylates and
degrades through the specificity of the designed peptide sequence.
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With this goal in mind, a modular approach was taken to macromer
synthesis consisting of three steps – synthetic modification of HA with
maleimides, synthesis of methacrylated peptides and fluorophore peptides with
terminal thiols as nucleophiles for Michael addition, and modular attachment of
peptides via thiol-maleimide Michael addition. In the first step, maleimide HA
(MaHA) was synthesized by reacting maleimide salt with tetrabutylammoniumHA (soluble in organics) via a BOP coupling agent to form an amide linkage
between the carboxyl group of HA and the amine group of the maleimide salt
(Fig. 4.1). Maleimides are known to undergo near quantitative, rapid (secondsminutes) click reactions with thiols that allows for efficient conjugation of
98

photopolymerizable peptides33. Compared to previously reported esterification
modifications of HA23, the amide linkage between the maleimide group and HA
was chosen to limit hydrolysis of the linkage after peptide conjugation.
Second, thiolated peptides (containing a cysteine amino acid) were
synthesized with terminal methacrylate groups or fluorophores by adding
methacrylic acid or carboxylated fluorophores (Rhodamine B, FITC, Cyanine
7.5), respectively, as the terminal reactant in solid-phase peptide synthesis (Fig.
4.2). Thiolated fluorophores (GCKK-Rho, GCKK-FITC, GCKKG-Cyanine7.5)
were synthesized to directly label HA with fluorescent dyes to accurately quantify
HA erosion from scaffolds in vitro (GCKK-Rho, GCKK- FITC) and in vivo
(GCKKG-Cyanine7.5); therefore, their excitation and emission spectra were
analyzed to aid in subsequent fluorometric spectroscopy (Fig. 4.2B). All peptides
were characterized by MALDI-TOF to confirm expected molecular weights (Fig.
4.3) and 1H NMR on methacrylated peptides confirmed 100% methacrylation
(Fig. 4.4). The protease-degradable peptide was based on previous studies that
indicated enhanced susceptibility to MMP-1 and MMP-2 mediated cleavage
within the central 8 amino acid sequence24. The non-degradable peptide is a
novel sequence that was designed to be resistant to degradation by numerous
enzymes (i.e. MMPs, pepsin, trypsin) and contain the same number of amino
acids as the protease-degradable peptide to aid in comparisons between the two
sequences.
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Figure 4.2: (A) Thiolated peptide crosslinkers (amino acid sequences listed in circles)
designed to contain a thiol at one end (cysteine), a central sequence sensitive to
protease degradation (blue) or insensitive to protease degradation (orange), and a
photopolymerizable end group (methacrylate) to permit UV-initiated polymerization. (B)
Thiolated peptide-fluorophores synthesized via solid-phase synthesis to covalently label
MePHA and their corresponding excitation (dotted lines) and emission (solid lines)
spectra.
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Figure 4.3: MALDI-TOF spectra for protease-degradable (A) or non-degradable
methacrylated peptides (B) confirmed expected molecular weights of 1621 and 1486,
respectively. MALDI-TOF spectra for thiolated fluorophores GCKK-Rho (C), GCKK-FITC
(D), GCKKG-Cyanine7.5 (E) also confirmed expected molecular weights of 958 Da, 891
Da, and 1166Figure
Da, 3:respectively.
MALDI-TOF spectra for protease-degradable (A) or non-degradable methacrylated peptides (B)
confirmed expected molecular weights of 1621 and 1486, respectively. ."MALDI&TOF*spectra*for*thiolated*ﬂuorophores**
GCKK&Rho*(C),*GCKK&FITC*(D),*or*GCKKG&Cyanine7.5*(E)*also*conﬁrmed*expected*molecular*weights*of*958*Da,*891*Da,*and*
1166*Da,*respecOvely
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Figure 4: (A) 1H NMR spectra (D2O) of protease-degradable peptide showing methacrylate peaks (green, 2)

1
Figure
4.4:
(A) peak
H (blue,
NMR6). spectra
of2O)protease-degradable
peptide
showing
calibrated
to a valine
(B) 1H NMR(D
spectra
of non-degradable peptide showing
methacrylate
2O) (D
peaks (green, 2)peaks
calibrated
to a histidine
peak (red, 1). to a valine peak (blue, 6). (B) 1H NMR spectra
methacrylate
(green,
2) calibrated
(D2O) of non-degradable peptide showing methacrylate peaks (green, 2) calibrated to a
histidine peak (red, 1).

To evaluate the proteolytic sensitivity, peptides were placed at varying
concentrations into recombinant human MMP-2 (rhMMP-2) or Type II
collagenase (broad range of proteases) to determine the kinetic parameters for
protease-mediated cleavage using a modified fluorescamine assay20,30. The
protease-degradable peptide followed Michaelis-Menten kinetics (Fig. 4.5, Table
4.1) in rhMMP-2 and collagenase and had kinetic parameters similar to those
previously reported in rhMMP-224. In particular, the protease-degradable peptide
had a higher turnover number (3.2 ± 0.9 s-1) and kcat/Km (1800 ± 900) in rhMMP-2
101

compared to the turnover number (0.65 ± 0.07 s-1) and kcat/Km (210 ± 35) in Type
II collagenase indicating more efficient cleavage of the substrate in rhMMP-2.
This is not surprising given the specificity of rhMMP-2 for the proteasedegradable sequence compared to the broad range of proteases present in Type
II collagenase. In contrast, the non-degradable peptide kinetic parameters were
not measurable as cleavage was not detectable for the duration of the assay (9
hours).

1nM rhMMP-2
1 U/ml

Figure 5: Lineweaver-Burk plot for protease degradable peptide. Kinetic parameters were determined b
Figure 4.5: Kinetic parameters were determined by monitoring substrate cleavage in 1
monitoring substrate cleavage in 1 nM rhMMP-2 or 1 U/ml Type II collagenase with fluorescamine (to quanti
nM rhMMP-2 or 1 U/ml Type II collagenase with fluorescamine (to quantify changes in
changes in amine concentration) (n=3). Only the protease degradable peptide was able to be fit with Lineweave
amine concentration) (n=3). Only the protease-degradable peptide could be fit with
Burk plotsLineweaver-Burk
as the non-degradable
peptide
did not cleave inpeptide
the presence
rhMMP-2
Type II collagenase.
plots, as
the non-degradable
did not of
cleave
in theorpresence
of
rhMMP-2 or Type II collagenase.

Peptide
Protease-degradable
Protease-degradable
Non-degradable
Non-degradable

Enzyme
rhMMP-2
Type II collagenase
rhMMP-2
Type II collagenase

kcat s-1
3.2 ± 0.9
0.65 ± 0.07
N.M.
N.M.

Km µM
2100 ± 900
3090 ± 450
N.M.
N.M.

Kcat/Km s-1 M-1
1800 ± 900
210 ± 35
N.M.
N.M.

Table 1: Kinetic parameters for peptide crosslinkers. N.M.= not measurable. Non-degradable

Table peptides
4.1: Kinetic
for peptide
crosslinkers.
showed no parameters
detectable degradation
during incubation
in rhMMP-2 orNon-degradable
Type II collagenase. peptides
Error
as standarddegradation
deviation of threeduring
separateincubation
non-linear regression
fits.
showed
nolisted
detectable
in rhMMP-2
or Type II collagenase.
Error listed as standard deviation of three separate non-linear regression fits. N.M.= not
measurable.
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In the final step, peptides were conjugated to MaHA by first mixing
thiolated fluorophores with MaHA to consume a small portion of maleimides.
Next, excess methacrylated peptide was added to consume all remaining
maleimide groups, and the product was dialyzed and lyophilized to yield the
macromer, Methacrylated Peptide HA (MePHA) (Fig. 4.6). To demonstrate the
modularity and efficiency of the thiol-maleimide coupling, 1H NMR was performed
on MaHA at various time points during the conjugation process. As shown in Fig.
4.7, the maleimide bond peak on MaHA is unaltered after 6 hours in DI H2O.
However, this peak is not present and methacrylate peaks are introduced when
methacrylated peptide is added in 1.4 times excess for 6 hours, indicating
consumption of the maleimide bond.

For consistency, GCKK-Rho was

conjugated to all non-degradable MePHA (crosslinks through non-degradable
peptide) and GCKK-FITC to all protease-degradable MePHA (crosslinks through
protease-degradable peptide) for all subsequent in vitro characterization.
Although not demonstrated within this chapter, covalent attachment of GCKKGCyanine7.5 permits near-IR imaging of HA for in vivo tracking and is used in
Chapter 5.
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Thiol-Fluorophore

Thiol-Peptide-Methacrylate

Maleimide HA

or
Methacrylated Peptide HA (MePHA)

or
Fluorescent MePHA

or

Figure 6: Synthesis of MePHA. Thiolated peptides (methacrylated peptide or fluorophore) were stoichiometrically
added
to MaHA
to Schematic
react via Michael
addition and
generatesynthesis
the final macromer
(MePHA).
The site of enzymatic
Figure
4.6:
of modular
MePHA
from the
combination
maleimide
cleavage
indicated-bytop)
a boxed
arrow
in the final product.
HA is(MaHA
and
thiolated
peptides (fluorophores or crosslinkers). Protease-

degradable MePHA contains a protease-mediated cleavage site (dotted rectangle) to
facilitate degradation while the fluorophore facilitates monitoring of degradation and in
situ imaging.
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MaHA
MaHA in DI H2O for 6 hours
Methacrylated Peptide
MaHA + Methacrylated Peptide (MePHA)

Figure 7: MePHA chemical characterization. 1H NMR of MaHA after 6 hours in DI H2O (room temperature)

1 of the maleimide group (6.9 ppm). However, when methacrylated peptide is added, the maleimide
indicates
stability
Figure
4.7:
H NMR of MaHA after 6 hours in DI H2O (room temperature) indicates
peak is consumed by thiol-mediated Michael addition, causing the loss of the peak in MePHA and the
stability
of the
maleimide
group peaks
(6.9 (5.6,
ppm).
However, when methacrylated peptide is
corresponding
introduction
of methacrylate
5.9 ppm).
added, the maleimide peak is consumed by thiol-mediated Michael addition, causing the
loss of the peak in MePHA and the corresponding introduction of methacrylate peaks
(5.6, 5.9 ppm).

4.3.2 Isotropic hydrogel formation and characterization
After MePHA synthesis, isotropic, non-fibrous hydrogels were fabricated to
evaluate the sensitivity of the different MePHA formulations (proteasedegradable and non-degradable) to enzyme-mediated degradation. Furthermore,
the formation of isotropic hydrogels allows for comparison to previous reports of
non-fibrous,

protease-degradable

hydrogels20,24,25,27,34,35.

Isotropic

MePHA

hydrogels were formed as 4 wt% or 2 wt% cylindrical discs via UV mediated
radical crosslinking with Irgacure 2959 (I2959) as a radical photoinitiator in TTC
buffer (Tris, Triton X-100, CaCl2). To ensure similar mechanical properties and
gelation kinetics between different MePHA formulations, storage moduli were
measured by oscillatory rheology (Fig. 4.8). Protease-degradable hydrogels at 2
wt% (250 ± 14 Pa) and 4 wt% (1.18 ± 0.46 kPa) showed no statistical differences
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between moduli of equivalent hydrogels of non-degradable MePHA at 2 wt%
(300 ± 60 Pa) and 4 wt% (1.51 ± 0.08 kPa), indicating similar gelation between
different MePHA formulations. For degradation studies, MePHA hydrogels were
incubated in TTC buffer for 48 hours at 37°C and retained their cylindrical shape
(Fig. 4.9). Hydrogels were subsequently placed into varying concentrations of
Type II collagenase (1 to 500 U ml-1), rhMMP-2 (5 nM), or TTC buffer and
monitored for HA release. Collagenase facilitates general comparison with
previous reports of protease-degradable hydrogels eroded with collagenase19,35.
Alternatively, rhMMP-2 was chosen to assess degradation in the presence of a
specific MMP at a concentration that is indicative of previously reported
physiologic concentrations (1-20 nM)36-39.
A

B

C
G’
G’’

G’
G’’

Figure
(A) Storage
modulus
2 wt% and
4 wt%
protease
degradable
Figure 4.8:
8: Rheology
of isotropic
MePHAof
hydrogels.
(A) Storage
modulus
of 2 wt%
and 4 wt% (blue)
proteaseand
non-degradable
(orange)
MePHA
hydrogels
as measured
under
oscillatory
degradable (blue) and
non-degradable
(orange)
MePHA hydrogels
as measured
under 0.1%
0.1% oscillatory
strain. strain.
No
differences
were observed
MePHAbetween
hydrogels ofMePHA
equivalenthydrogels
weight percent.
bars represent
Nostatistical
statistical
differences
werebetween
observed
ofError
equivalent
weight
S.D. (n=3). (B,C) Storage modulus (blue: protease-degradable, orange: non-degradable) and loss modulus (grey)
percent.
represent
S.D. solutions
(n=3).were
(B,C)
Storage modulus
(blue:in situ
proteaseof 2 wt% Error
proteasebars
degradable
MePHA where
UV photopolymerization
was initiated
at 5
minutes (10 mW
cm-2).
degradable,
orange:
non-degradable) and loss modulus (grey) of 2 wt% protease
degradable MePHA where solutions were UV photopolymerization was initiated in situ at
5 minutes (10 mW cm-2).

Isotropic protease-degradable MePHA hydrogels eroded (i.e. 100% of HA
released) within a day to up to 6 days in response to rhMMP-2 and varying
collagenase

concentration

(Fig. 4.9).
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Figure 4.9: 50 µl isotropic hydrogels of protease-degradable (A) and non-degradable (E)
MePHA equilibrated for 48 hours at 37°C retain their cylindrical shape. Scale bar: 5 mm.
Quantification of HA release from 2 wt% MePHA hydrogels (B,C,F,G) or 4 wt% MePHA
hydrogels (D,H) crosslinked with protease-degradable (B-D) or non-degradable (F-H)
methacrylated peptides in 5nM rhMMP-2 (B,F), Type II collagenase (C,D,G,H-listed in
units of activity per ml) or TTC buffer. Hydrogel solutions were refreshed every two days
9: In vitro
isotropic
MePHAand
hydrogel
50 µl quantified
non-fibrous hydrogels
of protease
to Figure
maintain
enzyme
activity
HA degradation.
release was
by release
of degradable
fluorescently
(A) and non-degradable (B) MePHA equilibrated for 48 hours at 37°C retain their cylindrical shape. Scale bar: 5
labeled
HA.
Error
bars
represent
S.D.
(n=3,4).
*p<0.05
vs.
TTC.
#-All
proteasemm. (c,d,e,f) Quantification of HA release from 2 wt% MePHA hydrogels crosslinked with protease degradable
degradable
hydrogels
collagenase
statistically
different
from TTC
at all time
(c,e) or non-degradable
(d,f)inmethacrylated
peptides
in 5nM rhMMP-2
(c,d), varying
concentrations
of Typepoints,
II
collagenase
(e,f-listed
in units
of activity
per ml)+p<0.05
or TTC buffer.
collagenase, or TTC buffer) was
p<0.05.
**p<0.05
500
U/ml
vs. TTC,
50 Media
U/ml(rhMMP-2,
vs. TTC.
refreshed every two days to maintain enzyme activity and HA release was quantified by monitoring release of a
fluorophore covalently bonded to HA. Error bars represent S.D. (n=3,4). *p<0.05 versus TTC. #-All isotropic
protease degradable hydrogels degraded in Type II collagenase were statistically different from control (TTC) at all
time points, p<0.05. **p<0.05 500 U/ml versus TTC, +p<0.05 50 U/ml versus TTC.

dependent degradation rates agree with previously reported isotropic HA
hydrogels crosslinked via addition of MMP-sensitive di-thiol peptides35. When
incubated in buffer, isotropic protease-degradable MePHA hydrogels retained
greater than 80% of their original HA content after 18 days incubation in buffer,
demonstrating the stability of the hydrogel to non-enzymatic degradation.
Conversely, all non-degradable MePHA hydrogels retained greater than 80% of
their original HA content, irrespective of the presence of rhMMP-2, or
concentration of collagenase within the tested range (Fig. 4.9). Together with the
kinetic parameters of the individual methacrylated peptides, this result further
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indicates that erosion of these hydrogels occurs through protease-mediated
cleavage of the peptide crosslinker.

4.4 Conclusions
This chapter developed a generalizable chemical scheme to formulate
fluorescently labeled HA macromers that can crosslink through methacrylated
peptides and degrade through the sensitivity of the incorporated amino acid
sequence. The modular approach presented here further allows for conjugating
other amino acids of interest to enhance bioactivity through cell adhesive amino
acid sequences such as RGD (derived from fibronectin). Indeed, this modularity
has been used to develop other protease-degradable HA hydrogels27,29. For
example, Purcell et al. used the technique developed in this chapter to conjugate
hydrazide functionalized, protease-degradable peptides to HA and form
injectable hydrogels through aldehyde-hydrazide chemistry towards tissue repair
after myocardial infarction27. Rodell et al. also used the technique to conjugate
adamantane functionalized, protease-degradable peptides to HA and generate
shear-thinning, protease-degradable hydrogels through guest-host chemistry
(adamantane-cyclodextrin)29. Although the scheme reported here used HA, the
approach of grafting methacrylated peptides to a polymer via thiol-maleimide
Michael addition is amenable to other polysaccharides or hydrophilic synthetic
polymers.
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In addition to the modular design, this chapter demonstrated enzymatic
degradation of isotropic hydrogels based on the engineered susceptibility of the
amino acid crosslinker. Notably, previous erosion studies of hydrogels
crosslinked with amino acid sequences insensitive to protease-mediated
cleavage were completed in low concentrations of specific recombinant
MMPs20,24, whereas this chapter also demonstrates resistance to enzymemediated degradation in high concentrations of a broad range of proteases.
Thus, this non-degradable sequence may serve as an ideal control for in vitro
and in vivo studies where the identity of all proteases present in the
microenvironment may be unknown.
Towards translation to electrospinning, gelation of MePHA can be
triggered with UV light, a key feature that will be used to form electrospun
hydrogels in the following chapter. In contrast, common chemical schemes that
crosslink hydrogels through addition reactions between peptides and a
functionalized polymer (i.e. 4 arm or 8 arm-PEG)24,40 are non-triggered
spontaneous reactions; therefore, they do not translate to electrospinning
processes. Two photopolymerizable, protease-degradable macromers have been
synthesized previously, namely acrylate-PEG-(peptide-PEG)m-acrylate34, and
acrylate-peptide-PEG-peptide-acrylate19; however, the former contains high
molecular weight between crosslinks (500 kDa) that may limit its ability to form
stable fibers, while the latter contains considerably lower molecular weight
between crosslinks (6.4 kDa) that may limit electrospinning and would require
very high concentrations of to crosslink. In comparison, our approach has a low
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average molecular weight between reactive groups (~15 kDa) and a large
molecular weight (~140 kDa) to allow for translation to electrospinning in Chapter
5.
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CHAPTER 5

Protease-Degradable Electrospun Fibrous Hydrogels

Adapted from: Wade RJ, Bassin EJ, Rodell CB, Burdick JA. Protease-degradable
electrospun fibrous hydrogels. Nature Communications 6, 6639 (2015).

5.1 Introduction
An increased understanding of the contributions of extracellular matrix
(ECM) structural features (e.g., fiber size and orientation) in guiding tissue
function has motivated researchers to create biomimetic scaffolds with increased
structural complexity1. In particular, three methods – self-assembly2,3, phase
separation4,5, and electrospinning6,7 – have emerged as techniques to generate
fibrous scaffolds with electrospinning becoming the most ubiquitous method due
to its ease of setup, scalability, and feasibility with a diverse array of polymers. A
wide variety of natural and synthetic polymers have been electrospun and
demonstrated utility in various biomedical applications including vascular grafts8,
drug delivery9, contraception and sexually transmitted disease prevention10, and
cardiac11,12, skeletal13,14, dermal15, and craniofacial16 tissue formation. Together,
these and other studies have indicated that scaffold structural features can
influence cell morphology14, alignment17, migration18, differentiation19, and tissue
organization13.
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Despite the success of these materials in replicating the anisotropic,
fibrous structure of natural ECM, the majority of electrospun materials are
synthetic

(non-bioactive)

and

hydrophobic

and/or

semi-crystalline

(i.e.

polycaprolactone, poly(lactic acid), poly(lactic-co-glycolic acid)) such that fibers
are rigid with limited water absorption, in stark contrast to the bioactive, flexible,
hydrated state of natural ECM. Moreover, these electrospun scaffolds are either
non-degradable or degrade hydrolytically, through passive release determined by
material crystallinity, hydrophobicity, and stability of the polymer backbone to
hydrolysis. Meanwhile, natural ECM components are bioactive and degrade
proteolytically, through dynamic interactions with matrix metalloproteinases
(MMPs) that are actively regulated in natural ECM remodeling20,21.
As an alternative to synthetic polymers, components of natural ECM such
as proteins have also been electrospun22. Since Matthews et al. electrospun
Type I and Type III collagen in 200223, other natural proteins such as other types
of collagen24, gelatin25, fibrinogen26, and elastin24 have been electrospun. These
electrospun scaffolds exhibit some level of bioactivity, mimic features of the
flexible, hydrated state of natural soft tissue microenvironments, and may be
enzymatically degradable due to their primary amino acid sequence22. However,
these hydrophilic scaffolds require crosslinking to stabilize the structural features
of the scaffold upon introduction to aqueous environments. This crosslinking with
gluteraldehyde27 or other agents22 may present toxicity issues, and modifications
of the natural polymers (e.g. crosslinking of amines) may limit their bioactivity.
Not surprisingly, electrospinning may damage secondary and higher order
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protein structure such that only ~42% of the characteristic spacing between each
polyproline-II helix of natural collagen is retained after electrospinning28.
Structural differences between natural and electrospun proteins are further
compounded by batch-to-batch variations of proteins purified from animal
sources29. From an engineering view, perhaps the most striking limitation of
electrospun natural proteins is the limited ability to alter many of their properties,
including enzymatic degradation.

The primary amino acid sequence and

conformation of the protein dictates the rate of enzymatic cleavage, neither of
which may be effectively controlled through electrospinning.
While isotropic hydrogels have been synthetically crosslinked with
protease-degradable peptides to combine the benefits of enzymatic degradability
with material tunability30-35, previous chemistry and crosslinking relies on
spontaneous gelation after mixing reagents and is not compatible with
electrospinning. To address these material limitations, a protease-degradable,
photopolymerizable form of HA was developed (MePHA) in Chapter 4 with the
degradation tuned by the specific amino acid sequence used to crosslink the
network. In this chapter, MePHA is used to form electrospun hydrogels that
crosslink through photopolymerizable peptides and swell upon hydration. These
biomimetic scaffolds are susceptible to protease-mediated cleavage in vitro in a
protease dose-dependent manner and in vivo in a subcutaneous mouse model
using transdermal fluorescent imaging to monitor degradation. Importantly,
materials containing an alternate and non-protease-cleavable peptide sequence
are stable in both in vitro and in vivo settings. To illustrate the specificity in
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degradation, scaffolds with mixed fiber populations support selective fiber
degradation based on individual fiber degradability. To our knowledge, this
approach represents the first electrospun hydrogel that degrades through
engineered protease sensitivity.

5.2 Materials and Methods
5.2.1 Methacrylated peptide HA (MePHA) synthesis
MePHA was synthesized as described in Chapter 4. Briefly, proteasedegradable

peptide

(GCNS-GGRMêSMPV-SNGG-Methacrylate),

non-

degradable peptide (GCEE-NGGSGGSN-GGGH-Methacrylate), and thiolated
peptide fluorophores (GCKK-FITC, GCKK-Rhodamine, GCKKG-Cyanine7.5)
were each synthesized via solid phase and stoichiometrically added to a 1 wt%
solution of 10-15% modified MaHA (10-15% repeat units contain maleimide) in DI
H2O to generate MePHA. For in vitro studies, protease-degradable MePHA was
covalently labeled with GCKK-Fitc, while non-degradable MePHA was covalently
labeled with GCKK-Rhodamine). For in vivo studies, protease-degradable and
non-degradable were labeled with GCKKG-Cyanine7.5.

5.2.2 Scaffold fabrication
All degradation studies (in vitro and in vivo) were replicated (n=3 or 4 as
stated throughout) to determine statistical significance. Prior to any hydration
step, all formulations of MePHA were sterilized under germicidal UV exposure for
45 minutes and maintained under sterile conditions thereafter. To synthesize
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electrospun fibrous MePHA hydrogels, solutions of 1 wt% MePHA, 4.5 wt% PEO
(900 kDa), and 0.05 wt% I2959 in TTC Buffer were mixed at 110 RPM for 24-48
hours and loaded into syringes. These solutions were then electrospun onto a
rotating mandrel (350 RPM to maintain random fiber orientation during collection)
in a custom environmentally regulated chamber (humidity 20-35%) with the
following collection parameters: applied voltage: 21-26 kV, deflector voltage: 1012 kV, collector voltage: -3 kV, distance from needle to collector – 18 cm, needle
gauge – 18, flow rate: 1.0 ml hr--1. Dual electrospun mats used two separate
syringes facing the rotating collection mandrel from opposite sides.

5.2.3 Fiber characterization
To image electrospun fibrous MePHA hydrogels, fibers were collected
onto aluminum foil and imaged with a FEI Quanta 600 environmental scanning
electron microscope, or collected onto methacrylated coverslips36 and imaged
using

confocal

fluorescent

microscopy

(Zeiss

Axio

Observer

microscope) or wide field fluorescent microscopy (Olympus BX51).

Inverted
Glass

coverslips were methacrylated as previously described36. Briefly, coverslips were
immersed in 10M NaOH for 20 minutes, rinsed with DI H2O, and allowed to dry.
Next, coverslips were coated with 3-(trimethoxysilyl)propyl methacrylate, heated
at 100°C for one hour with an additional 10 minutes at 110°C, before rinsing with
ethanol. To crosslink electrospun MePHA hydrogels, dry scaffolds were exposed
to 30 minutes of 10 mW cm-2 UV light under N2, swollen with 0.05% I2959 in TTC
buffer and re-exposed to 10 mW cm-2 UV light for 1 minute (thin films (10–30 µm)
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for confocal imaging – to limit photobleaching) or 20 mW cm-2 UV light for 30
minutes (for degradation studies). To determine fiber diameters, scaffolds were
imaged in 8 distinct scaffold areas and fiber diameters were quantified using
Image J (>25 fibers per image, 63X magnification – confocal, 9500X
magnification – SEM). Similar to the method previously described37, scaffold
porosity was determined by converting confocal images (63X magnification) of
thin electrospun films to binary, thresholding the images, and quantifying the void
area of the image as a percentage of the total area (ImageJ, >6 images per
condition). Unconfined compression testing was performed on swollen
electrospun hydrogels using a TA Instruments DMA Q800 at constant strain rate
of 10% per minute. Compressive modulus was calculated from the slope of the
stress-strain curve between 5 and 15% strain (n=3).

5.2.4 Degradation studies
Fibrous hydrogels electrospun as thin films and thick mats (1 cm2 area ~ 1
mm thick dry) were equilibrated at 37°C in TTC Buffer for 48 hours in a nontissue culture treated plate and then refreshed with TTC Buffer, 10nM rhMMP-2
(with 0.1 wt% reagent diluent (R&D systems) to limit rhMMP-2 adsorption to well
surfaces), or 5-500 U ml-1 Type II Collagenase (stock activity – 335 U mg-1,
Worthington Biochemical) in TTC Buffer (n=3,4 per condition). Units of activity
are given by Worthington Biochemical COA and defined as “one unit liberates
one micromole of L-leucine equivalents from collagen in 5 hours at 37°C, pH
7.5”. Supernatant was collected and samples were refreshed with the
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corresponding media every two days to maintain enzymatic activity. Scaffolds not
fully degraded at the end of studies were degraded in 1 mg ml-1 hyaluronidase to
determine total HA content. The collected supernatant was analyzed via
fluorometric spectroscopy (FITC - excitation: 480 nm emission: 517nm; RHO –
excitation: 550 nm emission: 580 nm; Cyanine7.5 – excitation: 788 nm emission:
818 nm) and compared to a standard curve of equivalent fluorescent MePHA.
Individual scaffold degradation was formulated into a percentage and then
averaged between groups to generate degradation profiles. Uronic acid (HA
repeat units) release was quantified by colorimetric absorbance as previously
described38 to confirm degradation profiles observed by fluorescent MePHA
release. To visualize degradation, thin film scaffolds were imaged with an
Olympus BX51 microscope at different stages of degradation. Acquisition
parameters (i.e. light intensity, camera exposure, resolution) were kept the same
for all images to enable comparison between groups. Co-electrospun images
were overlaid using Image J, again maintaining equivalent acquisition and
processing parameters between compared images.

5.2.5 Subcutaneous mouse model
To evaluate in vivo degradation of electrospun fibrous hydrogels, 25 mm2
scaffolds (MMP degradable or non-degradable, ~1 mm thick dry) conjugated with
GCKKG-Cyanine7.5 fluorophore (near-IR) were equilibrated in sterile PBS for 48
hours (37°C) and then subcutaneously implanted into the dorsal region of
adolescent BALB/C mice (male). Serial images were taken during a six-week
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period using a LiCore live imaging system (800 nm), and signal intensity
(photons pixel-1 second-1) was measured by integrating equivalent areas over the
region of interest. Quantified signal was normalized to peak intensity for
individual scaffolds and then averaged to obtain degradation profiles for each
scaffold (n=4,3 per condition). At the conclusion of the study, the tissue
containing fibrous hydrogels was excised, fixed in formalin, embedded in paraffin,
sectioned (5 µm slices) through the height of the scaffold region, and stained with
hematoxylin and eosin. The study adhered to the NIH Guide for the Care and
Use of Laboratory Animals and was approved by the University of Pennsylvania's
Institutional Animal Care and Use Committee.

5.2.6 Statistical analysis
All experimental data is reported as the mean of 3 or 4 individual samples.
Single factor ANOVAs were performed for data sets with followup Tukey’s HSD
post-hoc testing and statistical significance was considered p<0.05.

5.3 Results and Discussion
5.3.1 Electrospun fibrous hydrogel formation and characterization
To generate electrospun fibrous hydrogels, solutions of MePHA (1 wt%)
and PEO (4.5 wt%) were mixed with I2959 in TTC buffer and electrospun as thin
films (10-30 µm) on methacrylated coverslips (for optical microscopy) or as
standalone mats (~1 mm dry thickness, for in vitro degradation studies) (Fig. 5.1).
Electrospun scaffolds were exposed to UV light to initiate radical crosslinking
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(Fig. 5.1) and then further crosslinked with additional light exposure upon
hydration to stabilize fibers in their swollen state. Aqueous solutions of HA have a
relatively high surface tension at low HA concentrations which limits molecular
entanglement and the ability to form smooth electrospun nanofibers39; therefore,
PEO was included as a bioinert, hydrophilic polymer to increase molecular chain
entanglement at lower HA concentrations to improve fiber morphology.
I2959
PEO
MeP

HA

Single Fiber View

Initial Solution

Multiple
Fiber View
Pre-crosslinking

FluoP
KC
MePHA

Single Fiber View

Molecular View
Protease cleavage site
kinetic chain

UV(
X0link(

Lead
kV(
Voltage(Source(

Mandrel

Figure 5.1: Schematic of electrospinning and molecular composition of MePHA fibrous
scaffolds. Molecular view highlights the sites of protease cleavage and kinetic chain
formation between methacrylated peptides after crosslinking. Abbreviations: I2959 –
Irgacure 2959 (photoinitiator), PEO – polyethylene oxide, MeP – methacrylated peptide,
HA – hyaluronic acid, FluoP – fluorescent peptide, KC – kinetic chain, MePHA –
methacrylated peptide HA.

Electrospun scaffolds were characterized by unconfined compression
testing and by SEM (dry scaffolds) and confocal microscopy (dry and hydrated
scaffolds) to investigate fiber morphology, diameter, and swelling behavior.
Similar bulk compressive moduli were observed in protease-degradable (2.8 ± 1
kPa) and non-degradable (3.4 ± 0.7 kPa) MePHA scaffolds. Meanwhile, SEM
indicated smooth fiber morphology throughout scaffolds and submicron
diameters for both protease-degradable (320 ± 100 nm) and non-degradable
(270 ± 60 nm) MePHA scaffolds (Fig. 5.2). When analyzing fiber morphology and
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diameter in the dehydrated state, artifacts may be introduced in SEM during
drying (e.g. alcohol dehydration, flash freezing/lyophilization, critical point drying).
Consequently, fiber diameters of fluorescently labeled dry and hydrated scaffolds
were also measured in situ using confocal microscopy to determine the degree of
fiber swelling (Fig. 5.3). Protease-degradable MePHA fiber diameters increased
from 590 ± 100 nm before hydration to 1.27 ± 0.31 µm at equilibrium swelling,
and non-degradable MePHA fiber diameters increased similarly from 640 ± 100
nm before hydration to 1.17 ± 0.29 µm at equilibrium swelling. Scaffold porosity
was also quantified by confocal microscopy and indicated high porosity in both
protease-degradable (82 ± 4 %) and non-degradable (79 ± 4 %) MePHA
scaffolds. No significant differences existed between bulk compressive modulus,
fiber diameters, or porosity of protease-degradable and non-degradable MePHA,
demonstrating that both electrospun hydrogels display similar mechanical
properties and swelling behavior.
B

Protease-degradable

A

E

D

Non-degradable

C

Figure 5.2: Representative SEM images of protease-degradable (A,B) and nondegradable (C,D) electrospun MePHA. (E) Fiber diameters as measured by SEM for
protease-degradable (blue) or non-degradable (orange) MePHA scaffolds. Error bars
represent S.D. No statistical differences between protease-degradable and nondegradable fiber diameters. *p<0.05. Scale bars: A,C – 2 µm, B,D – 25 µm.
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Figure 5.3: Fluorescent confocal microscopy images of protease-degradable (A,B) and
non-degradable (D,E) electrospun MePHA scaffolds in the dry and hydrated states.
(C,F) Quantification of fiber diameters before (dry) and after swelling (hydrated) from
confocal images of protease-degradable (C) and non-degradable (F) MePHA scaffolds.
Error bars represent S.D. *p<0.05. Scale bars: 25 µm.

5.3.2 In vitro degradation
To investigate the enzyme-mediated degradation of electrospun proteasedegradable and non-degradable MePHA, fibrous scaffolds were placed into TTC
buffer, rhMMP-2 (10 nM), or Type II collagenase (5 - 500 U ml-1) and HA release
was monitored (Fig. 5.4). Protease-degradable MePHA scaffolds showed a
collagenase concentration dependent burst release of degradation products
within the first 48 hours, with greater than 80% of HA released from the networks
across all collagenase concentrations at 2 weeks; however, in the absence of
collagenase these scaffolds retained over 75% of MePHA content after three
weeks (Fig. 5.4A). In comparison, non-degradable MePHA scaffolds all retained
greater than 75% of MePHA content after three weeks, regardless of collagenase
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Figure 5.4: In vitro HA release profiles of electrospun protease-degradable (A,B) or nondegradable (C,D) MePHA scaffolds in varying concentrations of Type II collagenase
(A,C) or rh-MMP2 (B,D) in TTC buffer. HA release was quantified by monitoring release
of a fluorophore covalently bonded to HA. Error bars represent S.D. (n=3). #-All
protease-degradable scaffolds in Type II collagenase (500-5 U/ml) were statistically
different from control (0) at all time points (2-22 days). Media was refreshed every two
days for all scaffolds. p<0.05. *p<0.05 500 U/ml vs. 0 (C).

concentration (Fig. 5.4C), showing similar degradation profiles to those observed
in isotropic, non-fibrous hydrogels (Chapter 4). Similar trends were also observed
in rhMMP-2 as protease-degradable scaffolds released nearly 30% of HA after 8
days compared to 6% release of HA in non-degradable scaffolds (Fig. 5.4B,4D).
Interestingly, all protease-degradable scaffolds degraded more rapidly at early
time points but slowed in degradation at later time points. HA release from
protease-degradable MePHA at later time points in collagenase and rhMMP-2
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was greater than the passive release observed in TTC buffer, suggesting that
protease mediated degradation was still occurring within the scaffolds for the
duration of the study, albeit at slower rates.
To ensure that the chemical structure of the protease-degradable peptide
was not damaged by UV exposure during crosslinking (thus altering the
sensitivity of the peptide), methacrylated protease-degradable peptides were
exposed to equivalent UV treatment and analyzed via MALDI-TOF. No changes
in molecular weight with UV exposure were observed (Fig. 5.5A). To ensure the
profiles were not the result of fluorophore cleavage from the HA backbone,
degradation was also analyzed via uronic acid assay (Fig. 5.5B), confirming the
same general profile observed via fluorometric analysis. Previous models of
hydrolytic degradation of hydrogels formed through multi-vinyl crosslinks40
indicate that at early time points, erosion occurs primarily through release of the
crosslinking molecule from the network, followed by a plateau of degradation
products until kinetic chains are finally released very late upon reverse gelation.
The erosion of the protease-degradable electrospun MePHA scaffolds reported
here follows a similar profile, suggesting that HA release (crosslinking molecule)
dominates the initial degradation profile with a corresponding general plateau in
degradation rate at later time points until all kinetic chains are released from the
network.
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Figure 5.5: (A) Protease-degradable peptide was exposed to equivalent UV exposure
as electrospun mats (10 mW/cm2 for 30 minutes dry followed by 20 mW/cm2 for 30
minutes while hydrated) and showed no discernible change in mass (initial MW: 1621).
(B) Protease-degradable electrospun MePHA scaffolds degraded in 500 U/ml Type II
collagenase or TTC buffer (0) were analyzed via uronic acid release and confirm the

observed degradation profiles obtained via fluorometric analysis. *p<0.05 vs. 0.
To observe fiber degradation in situ, thin films of fluorescent proteasedegradable and non-degradable MePHA were attached to methacrylated glass
slides and imaged at different times within collagenase (500 U ml-1) or TTC buffer
(Fig. 5.6). Similar to the trends observed in free-swelling mats, proteasedegradable MePHA fibers eroded in collagenase but remained stable in TTC
buffer, while all non-degradable MePHA scaffolds remained intact for the
duration of the study. To further visualize fiber degradation, multi-fiber scaffolds
were created by co-electrospinning separate solutions of protease-degradable
and non-degradable MePHA (Fig. 5.7). This process generates fibrous hydrogels
with biphasic (protease-mediated and passive) degradation and permits
visualization of protease-degradable and non-degradable fiber erosion within the
same scaffold (Fig. 5.7B,C).

Accordingly, we observed enzyme-mediated
127

A

Day 0

B

Day 10 - TTC

C

D

Day 0

E

Day 10 - TTC

F Day 10 - Collagenase

Non-degradable

Protease-degradable

Day 10 - Collagenase

Figure 5.6: Representative images of thin film electrospun protease-degradable (A-C) or
non-degradable (D-F) MePHA scaffolds at day 0 and after incubation at 37°C in TTC
buffer or 500 U/ml Type II collagenase for 10 days. Media (collagenase or TTC buffer)
was refreshed every two days to maintain enzyme activity. Scale bars: 100 µm.
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Figure 5.7: (A) Schematic of co-electrospinning setup to form fibrous scaffolds that
contain both protease-degradable (green) and non-degradable (red) MePHA fibers.
(B,C) Representative wide-field fluorescent microscopy images of co-electrospun
MePHA at day 0 (B) and after 10 days incubation at 37°C in 500 U/ml Type II
collagenase (C). Media (collagenase or TTC buffer) was refreshed every two days to
maintain enzyme activity. Scale bars: 100 µm, Zoom – 25 µm.
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degradation of the protease-degradable fibers, whereas non-degradable fibers
retained their structure after 10 days incubation in collagenase (500 U ml-1).

5.3.3 In vivo degradation
In vivo erosion of electrospun scaffolds was investigated by covalently
attaching a near-infrared peptide dye (GCKKG-Cyanine7.5) to MePHA,
subcutaneously implanting scaffolds in a murine model, and monitoring the
corresponding loss in signal intensity over a 6 week period (Fig. 5.8). Proteasedegradable MePHA scaffolds demonstrated faster erosion in vivo over the first
three weeks (losing nearly 50% of the NIR signal) with considerably slower
erosion thereafter. Thus, the in vivo erosion follows a similar trend to in vitro
degradation profiles, with the fastest rates of degradation at earlier times and
progressively slower degradation at later times. Relative protease levels may
also contribute to the observed in vivo erosion profile since MMP activity is
known to increase during natural ECM remodeling immediately following tissue
injury41. It is worth noting that in vivo erosion requires degradation and clearance
of HA from the tissue, whereas in vitro degradation is monitored in an aqueous
environment with fewer diffusion barriers to HA release from the network. In
comparison to protease-degradable MePHA scaffolds, non-degradable MePHA
scaffolds eroded at a more linear rate and retained greater HA content
throughout the duration of the study, further offering evidence that proteases
mediate the observed degradation of protease-degradable MePHA scaffolds in
vivo. It was not possible to identify distinct scaffold margins histologically, as the
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scaffolds were encompassed within cellular tissue for both protease-degradable
and non-degradable formulations (Fig. 5.9). Notably, the differences in
degradation between protease-degradable and non-degradable MePHA in vitro
were not as pronounced in the subcutaneous in vivo model. The observed
differences may be due to several factors including super-physiological protease
levels, the absence of protease inhibitors, and limited barriers to diffusive release
of HA in vitro. In comparison, mechanical stimulation, blood flow perfusion, cell
release of soluble and insoluble signals, and clearance from the site of
implantation will influence in vivo degradation.

A

B

Day 3

Week 2

Week 6

Day 3

Week 2

Week 6

Figure 5.8: (A) In vivo erosion of protease-degradable (blue circles) and non-degradable
(orange squares) electrospun fibrous MePHA in a subcutaneous mouse model
quantified by signal decay of a Cyanine7.5 dye covalently bonded to HA before scaffold
formation. Error bars represent S.E. (n=3,4). (B) Representative serial in vivo optical
images used to quantify HA release from the site of implantation.
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A

B

Figure 5.9: Hematoxylin and eosin staining of explanted subcutaneous tissue containing
either protease-degradable (A) or non-degradable (B) electrospun MePHA hydrogels
after 6 weeks. Cells are visible throughout the entirety of the tissue. Scale bar: 100 µm.

5.4 Conclusions
Fibrous hydrogels are gaining widespread attention in biomedical
applications due to their ability to mimic many features of the extracellular matrix;
however, most fiber systems are either rigid polymers that lack sensitivity to
enzymes or are natural polymers with disrupted biological activity during
processing or limited sourcing. Current strategies that focus on engineering
protease sensitive surface coatings42 or protease sensitive surface linkers43 lack
the ability for the electrospun network itself to degrade in response to proteases.
To address these limitations, a new material (MePHA) was introduced that can
form electrospun scaffolds that degrade through the sensitivity of the
incorporated amino acid sequence. In comparison to other electrospun materials
that may require harsh organic solvents, MePHA can be electrospun from a nonorganic solvent so that growth factors or other soluble signals may be
incorporated within fibers for enzyme-mediated release from the network. This
release may also be made biphasic by generating a co-electrospun scaffold of
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protease-degradable and non-degradable MePHA (Fig. 5.7).

Enzymatically

mediated dual-phase erosion could be beneficial in controlling release of the
network in response to temporal changes in the microenvironment like those
observed in the immune response or during wound healing20. As a fibrous
hydrogel, the system is best suited to soft-tissue applications and may not be
suitable for load bearing tissue applications (e.g. musculoskeletal).
Importantly, this work represents the introduction of protease-mediated
degradation as a mechanism for erosion in electrospun fibrous hydrogels.
Previous reports have demonstrated protease-mediated degradation in fibrous
scaffolds of self-assembling peptide-amphiphiles (PAs) designed to contain an
MMP cleavable central domain44 and in β-sheet forming multidomain peptides
(MDPs) with a central three amino acid MMP cleavable motif45. These reports
have shown that MMP cleavable PAs lose 70% of their mass at 2 weeks in 2 mg
ml-1 collagenase (Type IV)44, and that β-sheet forming MDPs lose 95% of their
mass at 2 weeks in 3 mg ml-1 collagenase (Type IV)45. While our studies were
conducted in a different type collagenase (Type II-higher tryptic levels), the
electrospun scaffolds reported here lose 75% mass at 2 weeks in significantly
lower concentrations of collagenase, 0.015 mg ml-1 (5U ml-1 – Type II). Selfassembling peptides and PAs are beneficial for their ability to generate
nanoscale diameters (~6-8 nm) and their ability to form in situ, making them an
attractive platform as injectable fibrous materials44,45; however, mechanical
robustness and complex design, synthesis, and scalability may limit their
widespread use. Conversely, electrospun scaffolds have significantly larger fiber
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diameters and are not directly injectable; yet, the technique is easy to setup,
scalable, and applicable to many polymers. Therefore, incorporating proteasemediated degradation into electrospun scaffolds with a generalizable approach
may be translatable to a number of materials and applications.
Despite the widespread use of electrospun scaffolds in biomedical
applications and the importance of protease-mediated cleavage in biological
processes, engineered protease-degradation had yet to be explored in
electrospun hydrogels. This chapter makes use of the previously developed
modular approach from Chapter 4 to generate electrospun scaffolds that degrade
through peptide crosslinks and demonstrates their in vitro degradation and in vivo
erosion profiles. These results present a novel degradation mechanism for
engineered electrospun hydrogels, an approach that may benefit in vitro and in
vivo investigations by synthetic inclusion of biochemically relevant degradation
within biophysically relevant scaffolds.
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CHAPTER 6

Nanofibrous Hydrogels with Spatially Patterned Biochemical
Signals to Control Cell Behavior

Adapted from: Wade RJ, Bassin EJ, Gramlich WM, Burdick JA. Nanofibrous
Hydrogels with Spatially Patterned Biochemical Signals to Control Cell Behavior.
27, 1356-1362 (2015).

6.1 Introduction
Biomaterials are being developed to investigate and control cellular
interactions with their surroundings; however, the majority of engineered systems
present signals (e.g. mechanics, topography, adhesion) in a spatially uniform
manner, despite the role that spatially controlled signals – both biophysical and
biochemical – play in a number of different processes in vivo1-3. For example,
spatial organization of soluble signals occurs as early as gastrulation when
morphogen gradients activate various signaling pathways (e.g. sonic hedgehog,
WnT, activin)4-7 to guide tissue development. This organization continues in adult
tissues where spatial regulation of growth factors directly influences processes
such as chondrogenesis8, angiogenesis9, and immune responses10. Beyond
soluble factors, spatially controlled signaling of insoluble extracellular matrix
(ECM) proteins is also important as localized fibronectin deposition directs neural
138

crest formation

11

and tumor angiogenesis,12 vitronectin expression in the ventral

neural tube promotes motor neuron differentiation,13 and spatial alignment of
collagen fibers contributes to soft tissue functions of the cornea,14 articular
cartilage,15 and arterial wall16. Notably, these ECM proteins all contain amino
acid sequences known to induce integrin-mediated cell adhesion,17 suggesting a
broader role for cell adhesion in spatially dictating cell behavior.
A variety of patterning techniques have been previously developed to
engineer materials with precisely defined features, including the patterning of
ECM proteins18. Studies using microcontact printing, a technique where proteins
are “stamped” onto a substrate using a preformed master mold, have indicated
that spatial patterning of cell adhesive proteins influences cellular processes
including spreading, differentiation, proliferation, and death19,20. Other patterning
techniques such as soft lithography,21 3-D printing,22 and microfluidic devices23
have also been successful in forming patterns and gradients of ECM proteins to
control cell-material interactions. In particular, photopatterning has emerged as a
promising technique in which a desired reaction (e.g. crosslinking,24 bond
scission,25 covalent attachment26) is spatially controlled to specific regions
exposed to light,27 without associated changes in surface topography that are
typical of mechanical techniques like microcontact printing, 3-D printing, and soft
lithography.

Using

photopatterning,

hydrogel

mechanics,28,29

biomolecule

attachment,30 and porosity25 have all been spatially patterned in 3-D.
While these material systems have allowed the spatial presentation of a
range of biochemical and biophysical features, they are inherently non-fibrous,
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whereas natural ECM is composed of nanofibrous proteins that provide structural
cues to guide cell behavior31.

Studies have indicated that these structural

features including fiber diameter, morphology, alignment, and stiffness affect cell
adhesion,

migration,

differentiation,

and

proliferation32-37.

Consequently,

structural features have been patterned into nanofibrous materials – often
through electrospinning – to control both the morphology of individual fibers (e.g.
ribbon,38 helical coils,39 hollow core,40 porous,41) and the topography of the entire
nanofibrous scaffold. Several methods including selective deposition of fibers
through specialized collectors,42-44 microcontact printing,45 direct melt writing,46
photolithography,47 and dissolution printing48 have demonstrated the ability of
cells to respond to patterned electrospun fibrous topography. Importantly,
patterns formed by these techniques are characterized by differences in
topography such that regions exist with and without fibers or with altered fiber
orientation and fiber density. These biophysical patterns differ from biochemical
patterns or gradients in which the pattern is formed from localization of
biomolecules without associated changes in topography. Biochemical patterns
may be more indicative of natural ECM signaling that occurs through gradients
and spatial localization of biomolecules;1-3,48 however, current material systems
are limited in their ability to incorporate nanofibrous architectures with spatially
regulated biochemical features to investigate cell-material interactions.
To address these limitations, this chapter describes the synthesis and use
of norbornene-functionalized hyaluronic acid (HA) to generate electrospun
nanofibrous hydrogels that can be spatially patterned with biomolecules via thiol140

ene chemistry. The unique structural and biochemical features of these scaffolds
are then used to guide and investigate cell behavior. Notably, these electrospun
scaffolds are formed from hydrophilic precursors, requiring crosslinking to
stabilize the structure upon hydration.

This results in a scaffold with water-

swollen

hydrogel

fibers,

microenvironments.

indicative
In

of

contrast,

a

commonly

that

mimics

electrospun

soft-tissue

polymers

(e.g.

polycaprolactone, poly(lactic acid), poly(lactic-co-glycolic acid)) contain semicrystalline/hydrophobic domains and remain rigid fibers with limited water
absorption when placed in aqueous environments.

6.2 Materials and Methods
6.2.1 NorHA synthesis
All materials were from Sigma Aldrich unless otherwise noted. To make
HA soluble in dimethyl sulfoxide (DMSO), sodium HA (NaHA, 90 kDa, Lifecore)
was dissolved in DI H2O as a 2 wt% solution with a Dowex® 50Wx8 ionexchange resin (3:1 resin to HA ratio by weight) and mixed at 600 RPM for 5
hours. The resin was filtered from the reaction vessel and the solution was
titrated to pH 7.02-7.05 with tetrabutylammonium hydroxide (TBA-OH), frozen,
lyophilized, and analyzed via 1H NMR. Next, HA-TBA (2 wt%), 5-norbornene-2carboxylic

acid

(3:1

M

ratio

to

HA-TBA

repeat

units),

and

4-

(dimethylamino)pyridine (1.5 M ratio to HA-TBA repeat units) were dissolved in
anhydrous DMSO under N2 atmosphere at 45°C. After dissolving (approximately
1 hour), di-tert-butyl dicarbonate (Boc2O) was added (0.4 M ratio to HA-TBA
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repeat units) through a syringe to the reaction vessel and the reaction was
allowed to proceed for ~20 hrs at 45°C. The reaction was quenched with 5X
excess cold (4°C) DI H2O then dialyzed against DI H2O for 3 days (Spectra/Por,
8,000 MWCO). NaCl was added (1g NaCl per 100 mL), and the solution was
precipitated into cold (4°C) acetone. The precipitate was re-dissolved in DI H2O,
dialyzed for one week, flash frozen in liquid N2, lyophilized, and stored at -20°C
until further use.

1

H NMR confirmed norbornene functionalization (~20%

functionalization, i.e. 20% of HA repeat units functionalized with norbornene).

6.2.2 Peptide synthesis
Thiolated peptide fluorophores (GCDD-Rho, GCEEE-FITC, GCDDDMethoxycoumarin) were each synthesized with a thiol to facilitate thiol-ene
conjugation to NorHA and a fluorophore to permit visualization of formed
patterns. Briefly, peptides were synthesized on Glycinol 2-Chlorotrityl resin
(Novabiochem) using a PS3 automated solid phase peptide synthesizer (Protein
Technologies, Inc.) via standard FMOC chemistry. The resin was deprotected
with 20% (v/v) piperidine in N,N-dimethylformamide (DMF), and FMOC protected
amino acids (Novabiochem) were then activated with HBTU (Novabiochem) and
0.4 M methylmorpholine in DMF before being added to the reaction vessel in 4
times excess to resin functional groups. To add non-amino acid terminal
functional groups to the peptides, the corresponding carboxylic acid form of the
functional group (5(6)-carboxyflourescein, Rhodamine B, 7-methoxycoumarin-4acetic acid) was added in the last step of synthesis. Peptides were cleaved in a
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10 mL solution of 95% trifluoroacetic acid, 2.5% triisopropylsilane, and 2.5% DI
H2O, precipitated twice in cold diethyl ether (-80 °C), and allowed to dry
overnight. Peptides were dissolved in DI H2O, flash frozen in liquid nitrogen,
lyophilized, and stored under nitrogen at -20°C until use or analyzed for purity by
matrix-assisted laser desorption ionization – time of flight mass spectroscopy
(MALDI-TOF, LTQ-FT hybrid mass spectrometer - Thermo Electron) to confirm
synthesis.

6.2.3 Glass coverslip preparation for electrospinning
To attach electrospun NorHA hydrogels to a substrate suitable for
patterning and cell culture experiments, glass coverslips were thiolated and used
to collect nanofibers during electrospinning. Briefly, glass coverslips (22x22mm)
were soaked in 10M NaOH for 20 minutes, rinsed thoroughly with DI H2O, and
allowed to dry at room temperature. Next, coverslips were coated with (3mercaptopropyl)trimethoxy siloxane, heated for 1 hour at 100°C followed by an
additional 10 minutes at 110°C and then rinsed with subsequent washes of
methylene chloride and 70 % (v/v) ethanol in DI H2O, before being allowed to
dry. All coverslips were stored under inert atmosphere (N2) and used to collect
electrospun NorHA within 24 hours.

6.2.4 Electrospun scaffold formation
Solutions of 3.25 wt% NorHA, 2.5 wt% PEO (900 kDa), 1 wt% bovine
serum albumin (BSA), and 0.05% (v/v) I2959 were mixed with a 0.4
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stoichiometric ratio of dithiothreitol (DTT) to norbornene groups (i.e. 0.4
thiols:norbornenes) in PBS at 110 RPM for 48 hours and loaded into syringes for
electrospinning. Solutions were kept in the dark prior to electrospinning to limit
unwanted crosslinking. Limiting the ratio of thiols (DTT) to norbornene groups
ensures that unreacted norbornene groups are available post crosslinking for
subsequent patterning of thiolated molecules with remaining norbornene groups.
Solutions were electrospun onto a metallic rotating mandrel (~350 RPM for
random fiber orientation collection, ~2500 RPM for aligned fiber collection) with
thiolated glass coverslips on the surface of the mandrel in a custom,
environmentally regulated chamber (15-30% humidity) with the following
parameters: applied voltage: 26.5-28 kV, deflector voltage: 12-14 kV, collector
voltage: -3 kV, distance from needle to collector – 18 cm, needle gauge – 18,
flow rate: 1.0 ml/hr, collection time: 5-20 minutes. To crosslink nanofibers,
electrospun NorHA scaffolds were exposed (in the dry state) to 10 mW cm-2 UV
light (Omnicure s1000 – 365 nm) for 15 minutes under inert atmosphere (N2). All
NorHA scaffolds for cell culture were sterilized under germicidal UV and
contained in sterile conditions thereafter.

6.2.5 Crosslinking and patterning of NorHA nanofibrous hydrogels
To crosslink and attach fibers to a glass substrate for imaging and cell
culture experiments, NorHA was electrospun (50 µm thick after swelling) onto
thiolated glass coverslips and exposed (in the dry state) to UV light (Omnicure
s1000 – 10 mW cm-2, 320-390 nm) for 15 minutes under inert atmosphere (N2).
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For photopatterning of thick scaffolds, fibers were collected as free-swelling films
and exposed to equivalent crosslinking and patterning conditions as fibers
collected on thiolated glass. Scaffolds were sterilized via germicidal UV light for
45 minutes and maintained under sterile conditions thereafter. Scaffolds were
then inverted and hydrated face down into a custom-built shallow well (1.5 ml)
with a solution containing the thiolated molecule to be patterned. For non-cell
culture experiments, solutions contained thiolated peptide fluorophore (0.25 mM
GCDD-Rho, 0.25 mM GCEEE-FITC, or 2.5 mM GCDDD-Methoxycoumarin), 1
wt% bovine serum albumin (BSA – to limit non-specific attachment of thiolated
peptides), and 0.05% (v/v) I2959 in PBS. For cell-culture studies, 0.5 mM
thiolated RGD (sequence: GCGYGRGDSPG, GenScript) was included as a cell
adhesive biomolecule and 0.25 mM GCDD-Rho was included to indicate RGD
location. Photomask transparencies (CAD/Art Services, Inc.) were placed on the
backside of the inverted coverslip and the scaffold was irradiated through the
photomask and glass coverslip for 90 seconds with UV light (10 mW cm-2).
Patterned scaffolds were moved into individual wells of a 6 well plate, incubated
at 37°C in PBS, and washed three times daily for two days to remove any
unreacted thiolated molecules. The ability to control surface density of
biomolecules

was

demonstrated

by

altering

UV

intensity,

fluorophore

concentration, or exposure time to UV light while keeping all other conditions
equivalent and analyzing fluorescence intensity of 10 patterned sections. To
demonstrate the patterning of multiple ligands, previously patterned scaffolds
(after several washes) were again inverted face down into a well of a different
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thiolated fluorophore and the photopatterning process (UV irradiation and
washing) was repeated to sequentially introduce thiolated peptide fluorophores.

6.2.6 Scaffold characterization
To image electrospun NorHA hydrogels, fibers were collected onto
aluminum foil and imaged (dry) with a FEI Quanta 600 environmental scanning
electron microscope (SEM), or collected onto thiolated coverslips and imaged
(hydrated) using confocal laser fluorescent microscopy (Zeiss LSM 510 Meta
Confocal Microscope) or wide field fluorescent microscopy (Olympus BX51). To
determine fiber diameters, scaffolds were imaged in 6 distinct scaffold areas and
fiber diameters were quantified using Image J (>25 fibers per image, 63X
magnification – confocal, 9500X magnification – SEM). Fluorescence intensity
profiles were generated by drawing a horizontal line across images and
analyzing pixel intensity using ImageJ. Fiber angle was quantified by measuring
the direction of individual fibers (40X wide field, >20 fibers per image, >150
fibers) in relation to a standard vertical line arbitrarily set at 0 degrees.

6.2.7 Cell culture
NIH 3T3 fibroblasts or HUVECs (Lonza) were seeded at a density of
5,000-10,000 cells cm-2 in growth media (3T3 – DMEM 1X +Glutamax
supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin:
HUVECs – EGM™-2 Bulletkit™, Lonza), rinsed with PBS after 30 minutes
incubation at 37°C, and cultured for 3 days in growth media (refreshed on day 2).
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Cells were fixed in 4% formalin for 15 minutes, rinsed twice in PBS,
permeabilized/blocked for 10 minutes (0.25% Triton X-100, 0.5% BSA in PBS),
and stained for F-actin for 45 minutes (FITC-phalloidin, Life Technologies).
Scaffolds were rinsed twice with PBS, incubated for 10 minutes in DAPI (Life,
Technologies) to stain nuclei and imaged. Cell counts per area (nuclei mm-2)
were measured by thresholding images of nuclei (20X magnification, DAPI) in
ImageJ and analyzing the number of nuclei via the built in function in ImageJ (6
distinct images per region of interest: – RGD, + RGD). Cell aspect ratio, defined
as the maximum orthogonal length of a cell to the width of each cell, was
manually measured in ImageJ (20X magnification, >15 cells per image, >60 cells
per region of interest) and reported as a histogram. Cell area was measured by
thresholding images (F-actin, nuclei) in ImageJ and analyzing the area of
individual cells via the built in function in ImageJ (20X magnification, >15 cells
per image, >60 cells per region of interest).

6.2.8 Statistical analysis
Statistical differences between compared groups were determined using
single factor ANOVA with a p value less than 0.05 indicating significance.

6.3 Results and Discussion
6.3.1 NorHA synthesis and electrospun scaffold formation
Norbornene-functionalized HA (NorHA, Fig. 6.1) was synthesized by an
esterification of the primary hydroxyl group of HA-TBA (Fig. 6.1A) with 5147

norbornene-2-carboxylic acid. The extent of the modification (~20% of HA repeat
units modified with norbornene groups) was determined using

1

H NMR

spectroscopy by comparing the norbornene functional group peak (Fig. 6.1B-red)
to the methyl peak of an HA repeat unit (Fig. 6.1B – blue). HA was chosen as the
starting material due to the ease of chemical modification of the repeat structure
and naturally low cell adherence in the absence of adsorbed or covalently
attached cell-adhesion molecules. To generate nanofibrous hydrogels, solutions
of NorHA (3.25 wt%), polyethylene oxide (PEO, 2.75 wt%), bovine serum
albumin (BSA, 1 wt%), Irgacure 2959 (I2959 – UV initiator, 0.05 wt%), and
dithiothreitol (DTT) in phosphate buffered saline (PBS) were electrospun (Fig.
6.2A) as thin films onto thiolated coverslips (to facilitate scaffold attachment).
PEO was included as a carrier polymer to improve fiber formation during
electrospinning, and BSA was included to limit non-specific adsorption of
thiolated peptides during patterning. SEM imaging of fibers (Fig. 6.2B) confirmed
smooth fiber morphology, random fiber orientation, and submicron fiber
diameters (220 ± 50 nm).

6.3.2 NorHA scaffold patterning
The

electrospun

scaffolds

were

crosslinked

and

patterned

with

biomolecules via a process outlined in Fig. 6.3. Compared to the specificity of
photoreactive

groups

like

benzophenones,

arylazides,

and

diazirines,49

norbornene functional groups are specific in their selectivity to thio-radicals as
compared to norbornene radicals or non-radical thiols, which permits selective
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Figure 6.1: (A) HA-TBA is an organic soluble form of HA in which the amount of
tetrabutlyammonium (TBA, green) conjugation is determined by 1H NMR calibration to
the HA methyl peak (blue). (B) The presence of alkene hydrogens in NorHA (red) is
similarly determined by calibration to the HA methyl peak (blue).
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Figure 6.2: (A) Electrospinning process and (B) morphology of NorHA nanofibers post
electrospinning (Scale bar: 5µm).

crosslinking (through the number of di-thiols) and patterning (through the number
of mono-thiols) of biomolecules in a step-wise process50,51. First, crosslinking
was initiated in dry scaffolds by exposure to UV light (320-390 nm) under inert
atmosphere

(scaffolds

dissolved

upon

hydration

without

UV

mediated

crosslinking). By controlling the thiol:norbornene ratio of the initial solution (0.4)
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via the concentrations of DTT and NorHA, only a portion of the norbornene
groups within the fibers were consumed during di-thiol mediated crosslinking,
which retained norbornene groups for subsequent patterning. Next, the scaffolds
were hydrated in a solution containing the photoinitiator I2959 and a monothiolated biomolecule and exposed to UV light through a photomask, permitting
thiol-ene reactions at locations exposed to light. To visualize pattern formation,
thiolated fluorophores were synthesized via solid-phase peptide synthesis.
Subsequent washes with PBS removed any thiolated biomolecules, yielding a
patterned nanofibrous hydrogel.
A

UV Light
(crosslink network)

Swell with
thiolated molecules

1. Apply photomask
2. UV light (react thiols)

Wash with PBS
(remove unreacted thiols)

Figure 6.3: Schematic illustrating gross fiber appearance (top row) and the
corresponding molecular reactions (bottom row) associated with the steps to crosslink
and pattern biochemical ligands in nanofibrous hydrogels. Crosslinking occurs in the dry
state via UV light initiated thiol-ene reactions of a di-thiol and norbornene groups on
NorHA (to stabilize the nanofibrous structure upon hydration). Subsequent patterning is
achieved by exposing scaffolds to UV light through a photomask in the presence of a UV
initiator and thiolated biomolecules to react with remaining norbornene groups.
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To demonstrate patterning, thiolated peptide fluorophores (Red: GCDDRho, Green: GCEEE-FITC, Blue: GCDDD-Methoxycoumarin) were synthesized
via solid-phase peptide synthesis and used in all subsequent studies to confirm
the photopatterning reaction (Fig. 6.4). When patterned using a photomask with
either 50 µm diameter circles or line widths, the measured width of the scaffold
pattern was 57 ± 5 µm for circles and 55 ± 6 µm for lines, consistent for high
fidelity between the photomask and visualized pattern (Fig. 6.5). In addition, a
horizontal line intensity profile within a patterned region showed intensity peaks
and valleys that were consistent with the nanofibrous heterogeneity of the
scaffold (Fig. 6.5C). Altering experimental photopatterning conditions allows for
precise control over surface density of biomolecules (Fig. 6.6). In particular,
increasing UV intensity during patterning (from 10 mW cm-2 to 20 mW cm-2),
increasing the biomolecule solution concentration (from 25 µM to 250 µM), or
increasing the duration of UV exposure (from 60 seconds to 90 seconds)
correlate with greater surface density of biomolecules on the scaffolds.
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Figure 6.4: Matrix assisted laser desorption ionization – time of flight spectroscopy
(MALDI-TOF) to confirm synthesis of thiolated peptide fluorophores. (A) GCDD-Rho.
Expected molecular weight (MW): 876.5 Da. MALDI-TOF MW: 876.3 Da. (B) GCEEEFITC. Expected MW: 966.3 MALDI-TOF MW: 967.2 (C) GCDDD-Methoxycoumarin.
Expected MW: 873.2 MALDI-TOF MW: 1587.25 (corresponds to two peptides
complexed to a sodium ion).
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Figure 6.5: Photomask and corresponding patterns after UV light-mediated covalent
attachment of GCEEE-FITC to an electrospun NorHA hydrogel. (B) and (D) are each
one focal plane in a confocal image. (C) Intensity profile of a horizontal line across the
image (arbitrary units). Scale bars: (B,D) 25 µm, (C) 100 µm.

Hydrated fiber diameters were measured (740 ± 140 nm) by confocal
microscopy and confirmed the swollen nature of the nanofibers when compared
to the initial dry fiber diameters (220 ± 50 nm). While previous approaches to
pattern electrospun scaffolds have focused on altering topography by forming
grooves or pores,42-47,52 the presented technique spatially patterns biomolecule
attachment without changes in surface topography. To ensure that nanofibrous
architecture was unchanged between regions with patterned biomolecules (areas
in green in Fig. 6.5) and regions without biomolecules (areas in black in Fig. 6.5),
an electrospun scaffold was formed with a thiolated peptide-fluorophore in the
initial solution so that the hydrated fiber diameters could be measured without
152

any secondary patterning.

These scaffolds were swollen in buffer and fiber

diameters (730 ± 110 nm) were similar to fiber diameters observed in patterned
scaffolds, indicating similar fiber dimensions regardless of the patterned
biomolecule attachment.
A

UV Intensity
10 mW cm-2

20 mW cm-2

*

UV Intensity (mW cm-2)
Molecule Concentration

B

250 µM

25 µM

*

Molecule Concentration (µM)

C

Exposure Time
90 seconds

60 seconds

*

Exposure Time (s)

Figure 6.6: Changes in biomolecule conjugation through external inputs. By increasing
(A) UV intensity during conjugation, (B) molecule concentration in the patterning
solution, or (C) exposure time of UV light during conjugation, the density of biomolecules
on the scaffold may be systematically altered. Patterning conditions were as follows
unless noted in the figure: UV intensity: 10 mW cm-2, molecule concentration: 250 µM,
exposure time: 60 sec. Scale bars: 100 µm. *p<0.001.
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Cellular processes are often influenced by more than one biomolecule,53,54
which motivates the localization of several biomolecules into scaffolds for more
complex cell-material studies. Therefore, we evaluated the patterning of NorHA
scaffolds with multiple biomolecules by photopatterning three thiolated peptide
fluorophores.

Specifically, GCDD-Rho was patterned onto a scaffold, the

scaffold was washed with PBS to remove unreacted thiolated peptides, and the
patterning/washing process was repeated for both GCEEE-FITC and GCDDDMethoxycoumarin. Wide field fluorescent microscopy (Fig. 6.7) illustrates the
patterning of multiple biomolecules, as all three peptide fluorophores retained
their distinct pattern within the same scaffold. Notably, regions where the
patterns overlap indicate that unreacted norbornene groups were available after
initial thiol-ene patterning for subsequent patterning of additional biomolecules.

+

+

Figure 6.7: Demonstration of patterning multiple ligands onto the same electrospun
NorHA hydrogel. Patterning included 200 µm lines of thiolated peptide fluorophore
(GCDD-Rho), 200 µm lines of a second thiolated peptide fluorophore (GCEEE-FITC),
and 100 µm circles of a third thiolated peptide fluorophore (GCEE-Methoxycoumarin).
The overlaid image demonstrates patterning of three different biomolecules onto the
same nanofibrous scaffold. Scale bars: 100 µm.
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While the majority of electrospun scaffolds are opaque upon hydration
(due to hydrophobic and/or semi-crystalline materials), electrospun NorHA
scaffolds transform from opaque films to swollen, translucent hydrogels after
crosslinking and hydration (Fig. 6.8A). This property suggests that patterns are
not localized to the surface, but may be transmitted throughout the bulk of the
scaffold. To determine pattern fidelity with depth, thick scaffolds (1.5 mm thick
after hydration) were incubated in a thiolated fluorophore solution for 30 minutes
and then photopatterned with 200 µm lines through the entire scaffold. Although
the pattern was visible in the presence of a fluorescent light without
magnification, increased light from out of plane fluorescence and a limited depth
of focus prohibited imaging within the interior of the bulk scaffold. Therefore, the
scaffold was imaged from the top and bottom surfaces to show the depth of the
pattern. Visible heterogeneity from the nanofibrous architecture is visible
throughout the scaffold (Fig. 6.8B) with confocal images showing that the pattern
was maintained through the thickness of the scaffold, albeit with more diffuse
pattern boundaries at the greatest depths from the original UV exposure.

6.3.3 Cell response to nanofibrous topography and spatial presentation of RGD
One of the most ubiquitously studied biomolecules in cell-material
interactions is RGD, an amino acid sequence found in ECM proteins such as
fibronectin, vitronectin, laminin, and collagen that is known to induce integrinmediated adhesion of cells to surfaces. Given its importance in various cellular
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Figure 6.8: (A) Scaffolds appear as opaque films (0.15 mm thick) before hydration. After
crosslinking and hydration for 2 days in PBS, scaffolds swell in size (1.5 mm thick) and
become translucent hydrogels. Scale bars: 5 mm. (B) Pattern depth in a thick scaffold.
200 µm lines were patterned through the top of the scaffold and z-projections at the top
and bottom of the scaffold indicate patterning to a depth of 1.5 mm. Scale bars: 50 µm.

processes,17 regions of RGD were photopatterned in a nanofibrous scaffold to
alter cellular adhesion and morphology. A thiolated RGD peptide was included
with GCDD-Rho to visually indicate pattern formation (Fig. 6.9, PBL-Polymeric
Biomaterials Lab). 3T3 fibroblasts were then seeded onto scaffolds, cultured for
three days, and stained for F-actin (FITC-phalloidin) and nuclei (DAPI).
Fluorescent images illustrate cells adhered preferentially to regions containing
RGD, replicating the shape of the pattern with high fidelity (Fig. 6.9B-D).
Quantification of cell density further confirmed the observed differences in cell
adhesion (Fig. 6.10A) where regions containing photopatterned RGD had
significantly higher cell density compared with unpatterned regions (not exposed
to UV light) and bare NorHA scaffolds (not containing RGD during UV exposure).
For the limited number of cells that were adherent on regions without RGD, the
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cell aspect ratio (measure of cell elongation, Fig. 6.10B) and cell area (Fig.
6.10C) was drastically different than regions containing RGD. Cells were
considerably more elongated with larger cell areas in regions containing RGD
compared to regions without RGD, agreeing with previous studies of cell
adhesion on isotropic, non-fibrous hydrogels containing RGD55,56.

To ensure

fiber morphology was unaltered during culture, scaffolds were imaged prior to
and after incubation in 3T3 growth media for three days and no changes in fiber
morphology were observed. This general cell behavior was also observed in
scaffolds seeded with human umbilical vein endothelial cells (Fig. 6.11), offering
evidence for the broad applicability of the material system to investigate other cell
types.
A

Photomask

B

PBL
C

D

*

Figure 6.9: (A) Photomask (white areas indicate areas UV light transmittance) used to
covalently attach thiolated RGD to the nanofibrous scaffold (PBL – Polymeric
Biomaterials Lab). (B-D) 3T3 fibroblasts adhere to the RGD pattern with high fidelity.
Scale bars: (B,D) 100 µm, (C) 500 µm. Staining in all images - Green: F-Actin (FITCPhalloidin), Blue: Nuclei (DAPI), Red: RGD (GCDD-Rho).
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+ RGD
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Figure 6.10: (A) Cell adhesion quantified by measuring cell density (nuclei per area). (B)
Cell elongation quantified by aspect ratio (maximum orthogonal length divided by the
width of an individual cell). (C) Cell morphology quantified by cell area. (p<0.05).
A

Photomask

D

B

Photomask

PBL
C

Zoom

Figure 6.11: (A-C) Photomask and corresponding cell adhesion and morphology of
human umbilical vein endothelial cells (HUVECs) in response to patterned RGD. White
areas of the photomask (red areas of fluorescent images) indicate areas with covalently
attached RGD.
Scale bars: (B) 100 µm, (C) 500 µm. (D-F) Photomask and
corresponding cell adhesion of cells in response to patterned 200 µm lines of RGD on
nanofibrous scaffolds. Scale bars: (E) 200 µm, (F) 100 µm. Staining in all images Green: F-Actin (FITC-Phalloidin), Blue: Nuclei (DAPI), Red: RGD (GCDD-Rho).

In addition to spatially regulated biomolecule attachment, the nanofibrous
architecture of electrospun NorHA scaffolds facilitates control of cell morphology
through structural cues. To evaluate the influence of these structural features,
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scaffolds were generated with unaligned nanofibers (random fiber orientation as
in previous examples) or aligned nanofibers (formed through increased mandrel
speed during fiber collection), and thiolated RGD was uniformly presented
throughout the scaffold. The angles of the longitudinal axis of fibers were
measured for scaffolds and confirmed alignment or random orientation
depending on the speed of the mandrel during fiber collection (Fig. 6.12). Cells
were preferentially elongated in the direction of fiber alignment (Fig. 6.12A),
whereas cells were randomly oriented in the absence of fiber alignment (Fig.
6.12B). This is in agreement with previous studies where cells preferentially align
parallel to fiber direction in nanofibrous scaffolds15,37.

Fiber Alignment

NorHA fiber angle
Cell angle

0°
90°

No Fiber Alignment

B

A

NorHA fiber angle
Cell angle

0°
90°

Figure 6.12: (A) Cells orient and elongate with aligned nanofibrous topography on
NorHA scaffolds with uniform RGD, (B) whereas cell orientation and elongation is
abrogated in the absence of aligned nanofibers. Scale bars: 100 µm. Staining in all
images - Green: F-Actin (FITC-Phalloidin), Blue: Nuclei (DAPI), Red: RGD (GCDD-Rho).

This ability to modulate cell alignment via structural features was then
combined with the ability to spatially regulate RGD attachment. Specifically, 100
µm lines of RGD were patterned parallel to fiber alignment or perpendicular to
fiber alignment. When RGD was patterned parallel to fiber alignment, cells
elongated in the direction of fiber alignment and localized into regions containing
RGD (Fig. 6.13 A-D). Interestingly, when RGD was patterned perpendicular to
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fiber alignment, cells maintained their preferential elongation in the direction of
fiber alignment and localized into patterned regions containing RGD (Fig. 6.13 EH). Thus, cell morphology and elongation may be tuned independent of the
spatial localization of cells. The observation of cells maintaining elongated
morphology in the direction of nanofiber alignment when presented with a
perpendicular pattern of cell adhesion further points to the importance of
including structural features with spatially localized biochemical features in
studies investigating cell behavior.
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Figure 6.13: (A-B) Cells orient and elongate with aligned nanofibrous topography on
100 µm wide cell adhesive lines of RGD parallel to nanofiber orientation. Scale bars: (A)
200 µm, (B) 100 µm. (C) Counts of nuclei (DAPI) as a function of horizontal position, and
(D) angle of cells from image (A). (E-F) Cells elongate and orient with aligned
nanofibrous topography (horizontal) but are spatially restricted (vertically) when RGD is
patterned in 100 µm lines perpendicular to nanofiber orientation. Scale bars: (E) 200 µm,
(F) 100 µm. (G) Counts of nuclei (DAPI) as a function of horizontal position, and (H)
angle of cells from image (E). Staining in all images: Green: F-Actin (FITC-Phalloidin),
Blue: Nuclei (DAPI), Red: RGD (GCDD-Rho).

160

6.4 Conclusions
This chapter presented a novel technique to generate, crosslink, and
spatially pattern electrospun hydrogels with biomolecules to guide cell behavior.
Previous patterning techniques relied on patterns of topography such that
regions with or without topographical cues guided cell behavior42-48. While
beneficial in demonstrating the importance of topography in guiding cell behavior,
these biophysical patterns do not reflect natural ECM where biochemical patterns
are most likely to influence cell behavior. Towards generating the biochemical
heterogeneity of natural ECM, this chapter patterned biochemical signals within
uniformly nanofibrous NorHA hydrogels.
Patterns with spatial resolution as low as 50 µm were achieved, and the
technique was amenable to patterning multiple biomolecules into a single
scaffold. Additionally, biomolecule attachment was controlled through multiple
processing parameters (UV light intensity, thiolated fluorophore concentration,
duration of UV light exposure) to alter biomolecule density on scaffolds. The
thiol-ene chemistry described in this chapter also translates to patterning of other
thiolated biomolecules of interest while smaller patterns may be possible with
improved photomasks or other patterning techniques (e.g., multi-photon
patterning). Furthermore, patterns were not limited to the surface of scaffolds as
patterns were able to form through the depth of thicker scaffolds (1.5 mm). Cell
adhesion and morphology were modulated by spatially patterned RGD such that
cell density, elongation, and area increased in regions with RGD, while cells
retained their orientation with nanofiber alignment within patterned regions.
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Importantly, this platform allows for independent control of biophysical cues
(nanofibrous structure, alignment) and spatially altered biochemical cues (RGD,
thiolated peptide) such that more complex cell-material interactions may be
investigated in a synthetically produced material system.

Furthermore, the

technology is amenable to a range of other signals, such as fiber mechanics, the
incorporation of electrostatic interactions, and the binding of full proteins (after
diffusion into the scaffold), in a spatially patterned manner.
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CHAPTER 7

Detection of Protease Activity on Nanofibrous Hydrogels

7.1 Introduction
Extracellular matrix (ECM) proteases have a significant biological role in
normal tissue function and during response to disease or injury1-3. In particular,
matrix metalloproteinases (MMPs) are a zinc-dependent family of secreted or
cell-membrane bound proteins that hydrolyze various ECM components including
collagen, fibronectin, elastin, and laminin1.

This ability to breakdown ECM

proteins makes MMPs important regulators in tissue resorption and in facilitating
cell migration through tissues. For example, macrophages utilize MMP-12 to
degrade elastin and laminin during basement membrane penetration4, while
neurite outgrowth is enhanced through MMP-2 and MMP-9 mediated
degradation5,6.
ECM degradation via MMPs also plays a role in diseased tissue states.
Studies of myocardial infarction have indicated a temporal increase in MMP-2,
MMP-8, MMP-13, and MT1-MMP (membrane type) that can lead to degradation
of the myocardium, which results in thinning of the left ventricular wall and poor
cardiac function7. Other studies of tumor biology have indicated that metastasis
in lung8, breast9, cervical10, liver11, colon12, and other cancers2 is also associated
with increased MMP levels in the localized cancer microenvironment.

While

these increases in MMP expression are indicative of maladaptive processes,
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examples like MMP-1 mediated re-epithelialization by keratinocytes during
wound healing13 and activation or release of growth factors in the ECM (e.g.,
VEGF14, TGF-β15, IGF-116) demonstrate the complexity of MMP expression
required for tissue homeostasis.
To better understand the biological role of MMPs, several techniques have
been developed to quantify the abundance and activity of MMPs both in vitro and
in vivo. For analyzing relative abundance, immunoblotting is a commonly used
technique whereby proteins from an extract are separated by electrophoresis in a
polyacrylamide gel, transferred to a membrane, and stained using specific target
antibodies17. Perhaps a more important marker than the amount of protease is
the protease activity, which can be measured by gelatin or casein zymography.
In this technique, proteases are separated within an SDS (sodium dodecyl
sulfate) gel that contains gelatin or casein (or other substrate), incubated with a
non-ionic surfactant (e.g., Triton X-100) to remove SDS and allow for proteasemediated degradation of gelatin or casein, then stained with Coomassie Blue to
visualize degradation products18,19. Although well established for measuring the
MMP activity of tissue extracts, more complex techniques are required for directly
measuring MMP activity within the cellular microenvironment.
Consequently, fluorescent proteins including collagen20, fibronectin21, and
laminin22 have been developed for in situ cell experiments whereby degradation
is measured by the release of fluorescence into the surrounding area and loss of
fluorescence at the cell interface.

Further increasing in complexity, several

Förster resonance energy transfer (FRET) based substrates have recently been
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developed that function by maintaining low fluorescence until degradation
separates the donor fluorophore from the acceptor (which initially quenches
fluorescence)23. DQ-gelatin (dye-quenched) and DQ-collagen are one class of
commercially available substrates in this category that are labeled with enough
fluorescein to be self-quenching, increasing in fluorescence only after
degradation of the protein backbone between fluorescein molecules23,24. Smaller
peptide based substrates are also commercially available (Mca-PLGL-Dpa-ARNH2), where Mca ([7-Methoxycoumarin-4-yl]acetyl) is effectively quenched by
Dpa (N-3-[2, 4-Dinitrophenyl]-L-2,3-diaminopropionyl) until cleavage occurs
between the glycine and leucine of a short amino acid sequence25,26. Building on
this foundation, several other groups have begun incorporating FRET systems
directly into hydrogels for measuring cell activity in in vitro27-32. For example,
Packard et al. generated a biotinylated protease-degradable (GPLGIAG) peptide
doubly labeled with rhodamine 6G that was attached to a neutravidin labeled
type I collagen gel to observe 3-D cell migration27.

A similar self-quenching

peptide (LGPA) using BODIPY dyes was also developed for incorporation into a
PEG-diacrylate system29. Most recently, a fluorescein donor and dabcyl acceptor
(dark quencher) was synthesized between a protease-degradable sequence
(GGPQG-IWGQK) for use in 4-arm PEG hydrogels to measure protease activity
directly using a spectrometer31,32.
The number of methods dedicated to measuring protease detection hints
at the perceived importance of better understanding protease activity; yet,
limitations exist within the aforementioned methods.
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Gelatin zymography

requires extraction of tissues, which is not ideal for direct measurement at the
living

cell-material

or

cell-tissue

interface.

Fluorescent

proteins

are

advantageous as known degradation substrates but their sites of covalent
labeling are unknown and their biological role in cell signaling may alter MMP
activity20.

Dye-quenched proteins have similar challenges and studies have

shown increased fluorescence due to mechanical rearrangement without
associated degradation27. Peptide substrates may have the broadest utility as
they can be molecularly engineered for substrate affinity and functionalized with
different chemistries; however, the translation of peptide substrates to fibrous
scaffolds has not been achieved.
Towards this goal, this chapter describes the design, synthesis, and utility
of

protease-degradable

and

non-degradable

peptide

fluorophores

for

immobilization on electrospun fibrous hydrogels and visual detection of protease
activity. Protease-degradable fluorophores attached to electrospun norbornene
modified HA (NorHA) scaffolds are shown to be susceptible to collagenase
degradation in vitro, whereas non-degradable fluorophores (serving as a control)
are not degraded in the presence of collagenase. Further investigation using
mesenchymal tumor cells (HT1080) seeded on scaffolds reveals similar results
whereby protease-degradable fluorophores are cleaved from the surface
compared to scaffolds with non-degradable fluorophores. To further explore
protease detection, a new FRET fluorophore (FRET-VPMS) is also introduced,
compared to commercially available substrates (DQ-gelatin, Mca-PLGL-Dpa-AR-
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NH2), and analyzed for its ability to monitor protease activity in solution and
immobilized onto NorHA fibrous hydrogels.

7.2 Materials and Methods
7.2.1 NorHA synthesis
All materials were from Sigma Aldrich unless otherwise noted. NorHA was
synthesized as described in Chapter 6. Briefly, HA-TBA (tetrabutylammonium
hydroxide) was functionalized with norbornene via esterification between 5norbornene-2-carboxylic acid and the primary hydroxyl repeat unit on HA using
4-(dimethylamino)pyridine and di-tert-butyl dicarbonate (Boc2O) to catalyze the
reaction. Norbornene functionalization was confirmed by 1H NMR to be ~20%
(i.e. 20% of HA repeat units functionalized with norbornene).

7.2.2 Peptide synthesis and characterization
Thiolated peptide fluorophores (GCNS-GGRMêSMPV-SNGG-FITC, GCEENGGSGGSN-GGGH-FITC,

GK(Dabcyl)GRMêSMPV-GC-FITC)

were

synthesized via solid-phase peptide synthesis as previously described in
Chapters 4 and 6. Briefly, peptides were synthesized on Glycinol 2-Chlorotrityl
resin (Novabiochem) using a PS3 automated solid phase peptide synthesizer
(Protein Technologies, Inc.) via standard FMOC chemistry with all peptides
terminally functionalized with 5(6)-carboxyflourescein in the last step of
synthesis. To generate a fluorescence quenched peptide, FMOC-Lys-(Dabcyl)OH (EMD Millipore) was incorporated as a known dark quencher of fluorescein in
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the peptide, (GK(Dabcyl)GRMêSMPV-GC-FITC), which is referred to as FRETVPMS hereafter.

Peptides were cleaved in a 10 mL solution of 95%

trifluoroacetic acid, 2.5% triisopropylsilane, and 2.5% DI H2O, precipitated twice
in cold diethyl ether (-80 °C), and allowed to dry overnight. Peptides were
dissolved in DI H2O, flash frozen in liquid nitrogen, lyophilized, and stored under
nitrogen at -20°C until use or analyzed for purity by matrix-assisted laser
desorption ionization – time of flight mass spectroscopy (MALDI-TOF, LTQ-FT
hybrid mass spectrometer - Thermo Electron) to confirm synthesis.
To analyze protease-mediated cleavage of FRET-VPMS in solution (prior
to scaffold attachment), the peptide was dissolved at 4 mM in dimethylformamide
and diluted 100X to 40 µM in TTC buffer (0.05% Triton X-100, 50 mM Tris-HCl, 1
mM CaCl2, pH 7.4). The solution was then further diluted by 2X in the solution of
choice (TTC, TTC with Type II collagenase (Worthington Biochemical, 260 U/mg
activity), TTC with fetal bovine serum (FBS), TTC with Type II collagenase and
FBS) to a final working concentration of 20 µM. 100 µL of the FRET-VPMS
solution of interest was incubated at 37°C, loaded into a 96 well plate, and
fluorescence was monitored using a Tecan Spectrometer (excitation: 450 nm
emission:

512

nm).

Two

commercially

available

protease-degradable

fluorophores, DQ-gelatin (Life Technologies) and Mca-PLGL-Dpa-AR-NH2 (R&D
Systems), were analyzed at similar concentrations (DQ-gelatin: 25 µg ml-1, McaPLGL-Dpa-AR-NH2: 20 µM) to enable comparison with FRET-VPMS (DQ-gelatin
– excitation: 450 nm emission: 512 nm, Mca-PLGL-Dpa-AR-NH2 – excitation:
320 nm emission: 405 nm). Absolute fluorescence (measured in triplicate) was
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divided by the initial fluorescence of the fluorophore in a non-protease containing
solution at time zero and plotted as a function of time.

7.2.3 Electrospun scaffold formation and peptide attachment
Scaffolds were formed as previously described in Chapter 6. Glass
coverslips (22x22 mm) were thiolated (to permit covalent attachment to the
surface upon crosslinking), attached to a metallic rotating mandrel, and used to
collect electrospun solutions of NorHA (solution parameters: 3.25 wt% NorHA,
2.5 wt% PEO (900 kDa), 1 wt% bovine serum albumin (BSA), 0.05% (v/v) I2959,
and 0.4 stoichiometric ratio of dithiothreitol (DTT) to norbornene groups). For
electrospun scaffolds containing DQ-gelatin, an additional 100 mg ml-1 DQgelatin was included in initial solution.

Electrospinning conditions were

comparable to Chapter 6 with the following parameters: humidity: 15-30%,
mandrel speed: ~350 RPM, applied voltage: 26.5-28 kV, deflector voltage: 12-14
kV, collector voltage: -3 kV, distance from needle to collector – 18 cm, needle
gauge – 18, flow rate: 1.0 ml/hr, collection time: 30-45 minutes. Electrospun
NorHA scaffolds were crosslinked (dry) with UV light (10 mW cm-2, Omnicure
s1000 – 365 nm) for 15 minutes under inert atmosphere (N2), sterilized under
germicidal UV (45 minutes) and contained in sterile conditions thereafter. Next,
scaffolds were hydrated in a PBS solution containing 0.05% (v/v) I2959, 1 wt%
BSA, 0.5 mM thiolated RGD (sequence: GCGYGRGDSPG, GenScript), and 0.5
mM of the particular peptide of interest (protease-degradable fluorophore, nondegradable fluorophore, FRET-VPMS).
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Scaffolds were then uniformly (not

patterned as in Chapter 6) exposed to UV light (10 mW cm-2, Omnicure s1000 –
365 nm) for 90 seconds to facilitate thiolated molecule attachment, and washed
with PBS three times daily for 2 days at 37°C to remove unattached molecules
from the surface.

7.2.4 Peptide fluorophore degradation
After equilibration, electrospun scaffolds were imaged using wide-field
fluorescent microscopy (4x) to visualize fluorophore intensity prior to any
exogenous addition of proteases. Scaffolds were then placed into different
concentrations of Type II Collagenase (50, 5, 0.5, 0.05, 0 U/ml) in TTC buffer,
incubated at 37°C for 24 hours, then imaged again under equivalent processing
and acquisition parameters.

Average scaffold intensity – prior to protease

addition and after 24 hours – was determined by measuring the average pixel
intensity (arbitrary units, ≥ 5 imaged sections per condition) via ImageJ (NIH).
Measurements from post 24-hour images were then divided by the initial average
pixel intensity and plotted as a normalized percentage.

7.2.5 Cell culture
Scaffolds were imaged using wide-field fluorescent microscopy (4x),
placed into 6 well non-tissue culture treated plates (to limit non-scaffold cell
attachment) then seeded with HT1080 cells (human fibrosarcoma cell line,
ATCC) at a density of 5,000 cells cm-2 in growth media (alpha-MEM
supplemented with 10% FBS and 1% penicillin/streptomycin).
174

Cells were

allowed to attach for 1 hour, refreshed with growth media, and thereafter
refreshed every other day with growth media. After 7 days of culture, scaffolds
were imaged again under equivalent acquisition parameters (4x, wide-field
fluorescent microscopy) as pre-cell seeding. To enhance contrast, images were
equivalently thresholded and average pixel intensity was measured using
ImageJ. For confocal imaging, cells were fixed in formalin, stained for F-actin
(rhodamine-phalloidin, Life Technologies) and nuclei (DAPI, Life Technologies),
and then imaged at 63X using a Leica TCS SP8 confocal microscope.

7.2.6 Statistical analysis
Statistical differences between compared groups were determined using
single factor ANOVA with a p value less than 0.05 indicating significance.

7.3 Results and Discussion
7.3.1 Peptide fluorophore synthesis
Building from the peptides described in Chapter 4, protease-degradable
and non-degradable fluorophores were synthesized with three distinct regions
(Fig. 7.1A, 7.1B). First, a thiol near the C terminus was incorporated to facilitate
thiol-ene conjugation to NorHA. Second, the central amino acid sequence was
derived from the work in Chapters 4 and 5, such that the protease-degradable
fluorophore is cleaved between the serine and methionine residues while the
non-degradable fluorophore is not observed to undergo protease-mediated
degradation. Lastly, the peptides were functionalized at the N-terminus with
175

A

B
Protease-degradable fluorophore

protease

C

Non-degradable fluorophore

Single fiber with
degradable fluorophore

Addition of proteases

Cleavage and fluorophore
removal from fiber

Figure 7.1: Structure and MALDI-TOF for protease-degradable fluorophore (A, MW:
1912 Da) and non-degradable fluorophore (B, MW: 1778 Da). (C) Schematic of protease
degradation of fluorophores on NorHA scaffolds. Proteases induce cleavage and
release of fluorophores from the surface, which causes decreased fluorescence at the
fiber surface.

fluorophores (in contrast to previous chapters where fluorophores were
synthesized separately). In this way, protease-degradable and non-degradable
fluorophores could be conjugated to NorHA fibrous hydrogels as in Chapter 6
(Fig. 7.1C) with RGD again included for cell adhesion. Then, in the presence of
proteases, the protease-degradable fluorophore would cleave and decreased
fluorescence would be observed on the fiber. Also, this method permits
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quantification of released fluorescent molecules by measuring fluorescence in
the supernatant.

As in previous chapters, the non-degradable fluorophore

served as a non-protease sensitive control.

Importantly, this strategy only

requires degradation of a single peptide and results in lower molecular weight
release products (~18 kDa) compared to the studies conducted with MePHA in
Chapter 4, which requires multiple sites of degradation and removal of larger
molecular weight degradation products (~130 kDa).

7.3.2 Peptide fluorophore attachment and degradation
Protease-degradable or non-degradable fluorophores (with thiolated RGD
in each solution) were attached to electrospun fibers using a light-mediated thiolene reaction between norbornene groups and thiol containing peptides (similar to
the process described in Chapter 6).

Scaffolds were washed to remove

unattached fluorophores, and then imaged prior to being placed into solutions of
different collagenase concentrations. After 24 hours of incubation at 37°C,
scaffolds were imaged again and quantified for change in fluorescence (Fig. 7.2).
As expected, scaffolds containing a protease-degradable fluorophore had a
concentration dependent response to collagenase, with 50 U/ml causing >80%
reduction in fluorescence compared to TTC buffer alone (~100% original
fluorescence). This protease-dependent degradation was not observed in NorHA
scaffolds with a non-degradable fluorophore where fluorescence remained ≥80%
for all conditions regardless of collagenase concentration.
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Thus, the non-

degradable fluorophore served as a non-degradable control, similar to the use of
the sequence as a non-degradable crosslinker in Chapters 4 and 5.

Protease-degradable

A

Protease-degradable

B

Protease-degradable + 10% FBS

0

0.05

0.5
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0
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0.5
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50

0

0.05

0.5

5

50

0

0.05

0.5

5

50

Collagenase concentration (U/ml)

Non-degradable

C

Non-degradable

+ 10% FBS
Protease-degradable

D

Collagenase concentration (U/ml)

Figure 7.2: (A) Change in fluorescence intensity (normalized to day 0) after incubation
for 24 hours at 37°C in varying collagenase concentrations. (B,C,D) Representative
images from quantification in (A) showing visualized changes in fluorescence. Error bars
represent S.D. Scale bars: 200 µm.
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Although it is a common practice to analyze protease-degradation under
these ideal buffered degradation conditions, cell-material experiments often
dictate analyzing protease activity in non-ideal conditions (e.g., growth media,
inclusion of competing protein substrates).

Perhaps the greatest difference

between these ideal conditions and direct cell-culture experiments is the use of
serum (e.g., FBS) in cell media. Previous studies have indicated that FBS can
both neutralize solubilized proteases by blocking degradation sites and act as a
competing substrate for protease detection33. In contrast, other studies have
reported that FBS itself can degrade protease substrates31,32, which is not too
surprising given the relatively uncharacterized nature of the components within
FBS. To determine the response of protease-degradable fluorophores to FBS,
scaffolds were incubated under equivalent conditions as before except 10 wt%
FBS (concentration found in the majority of cell culture growth media) was
included in the solution (Fig. 7.2C). The collagenase concentration dependent
response from non-FBS conditions was abrogated with scaffolds retaining nearly
100% of their initial fluorescence intensity across all collagenase concentrations.
Interestingly, no detectable differences in degradation were observed between
protease-degradable fluorophore scaffolds in TTC buffer or TTC buffer with FBS,
pointing at the relative stability of the protease-degradable fluorophore to
unwanted degradation from FBS components.
The stability in FBS is ideal for long-term cell culture; however, the loss of
degradability with the inclusion of FBS (even at high collagenase concentrations)
indicates that soluble proteases may not be detectable on these scaffolds in the
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presence of FBS. While this could be a hindrance for detecting cell secreted
proteases (e.g., MMP-1, MMP-2), the effects of membrane bound proteases
such as MT1-MMP are much more localized in their activity at the membrane
surface34,35.

Indeed, systematic genetic deletion of individual MMP variants

(MMP-2, MMP-3, MMP-8, MMP-9, MMP-13, MT1-MMP, MT3-MMP) in fibroblasts
and tumor cells cultured in 10% serum growth media revealed that only deletion
of MT1-MMP blocked degradation and invasion into collagen substrates33. Thus,
the stability of the protease-degradable fluorophore in FBS coupled with the loss
of degradation in FBS may enable the detection of cell membrane bound
proteases shown to be important in cell migration.
To evaluate if cell-mediated protease-activity was detectable in NorHA
fibrous hydrogels, scaffolds with protease-degradable fluorophores or nondegradable fluorophores were seeded with HT1080 cells and cultured to 7 days.
HT1080 cells are a fibrosarcoma cell line commonly used as a model cancer cell
type and which are known to produce elevated MMP levels33,36,37. Imaging of cell
scaffolds before and after seeding revealed enhanced degradation (measured by
loss of fluorescence) on scaffolds with protease-degradable fluorophores
compared

to

scaffolds

with

non-degradable

fluorophores

(Fig.

7.3).

Fluorescence was reduced by 60% in scaffolds with the protease-degradable
fluorophore compared to 25% reduction in scaffolds with the non-degradable
fluorophore. Notably, these differences were observed after one week in culture,
an extended period of time that prohibits viewing localized degradation from
individual cells. Accordingly, confocal images of scaffolds (Fig. 7.4) illustrate
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highly cellularized surfaces on scaffolds with either protease-degradable or nondegradable fluorophores. Collectively, these images (Fig. 7.3, Fig. 7.4) highlight
the spatial heterogeneity of the surfaces, further making it difficult to detect the
very localized fluorophore degradation expected in these networks.
Day 7

Protease-degradable

Day 0

*

Day 0

Day 7

Day 7

Non-degradable

Day 0

n.s.

Figure 7.3: Representative images of NorHA scaffolds with protease-degradable (blue)
or non-degradable (orange) fluorophores prior to HT1080 cell seeding (Day 0) and postone week of cell culture (Day 7). Quantification of average pixel intensity is plotted at
Day 0 and Day 7 with increased fluorescence loss observed in protease-degradable
scaffolds. Error bars represent S.D. *p<0.05. Scale bars: 500 µm.
A

B
Protease-degradable fluorophore

Non-degradable fluorophore

Figure 7.4: Representative confocal images of HT1080 cells on NorHA scaffolds with
protease-degradable (A) or non-degradable (B) fluorophores after one week. Staining:
Red – (F-actin, rhodamine phalloidin); Blue – (nuclei, DAPI). Scale bars: 25 µm.
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A

protease

C

protease

protease

B

Figure 7.5: (A) Structure and MALDI-TOF for FRET-VPMS peptide (MW: 1776 Da), and
(B) schematic of protease mediated cleavage in solution causing a direct increase in
fluorescence. (C) Schematic of designed protease degradation on NorHA fiber surfaces
where the fluorophore remains attached to the surface (vial thiol-ene bond) after
degradation to cause an increase in fluorescence.

7.3.3 FRET peptide synthesis and characterization
Since the detection of protease activity is measured by loss of
fluorescence, out-of plane fluorescence within the scaffold may confound
measured pixel intensities. This becomes more plausible given that localized
degradation is expected at the fiber-cell interface and not within the fiber itself as
the DTT crosslinks are not readily degraded. In contrast, a FRET system may be
of greater utility in detecting protease activity such that protease activity causes
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an increase in fluorescence (ideally with limited background signal). Therefore, a
FRET based peptide (FRET-VPMS) was synthesized (Fig. 7.5A) with a thiol and
a similar sequence as the protease-degradable fluorophore; however, a dark
quencher group (dabcyl) was included that serves to limit emission from the
peptide until the peptide is cleaved and the quencher is no longer in close
proximity to the fluorescent donor (Fig. 7.5B).

By design, the thiol was

incorporated at the N-terminus containing fluorophore to ensure that upon
cleavage, the fluorophore would remain at the fiber surface (Fig. 7.5C).
Before attaching to NorHA scaffolds, the protease-degradability of FRETVPMS was analyzed in various collagenase concentrations. Solution based
measurements permit the direct comparison with commercially available FRET
systems (DQ-gelatin, Mca-PLGL-Dpa-AR-NH2) that are not compatible with
attachment to fibrous hydrogels.

FRET-VPMS showed a collagenase

concentration dependent increase in fluorescence (Fig. 7.6A), such that
concentrations as low as 0.5 U/ml were statistically different than control
conditions (TTC) over the tested timespan. Interestingly, FRET-VPMS intensity
of control solutions decreased initially (~15 minutes) implying some additional
quenching may have occurred.

Although the FRET-VPMS peptide intensity

increased nearly 3 fold in 25 U/ml collagenase, this sensitivity paled in
comparison to the sensitivity of Mca-PLGL-Dpa-AR-NH2 (23 fold original
intensity) and DQ-gelatin (22 fold original intensity) under equivalent conditions.
Compared with FRET-VPMS, DQ-gelatin contains unknown sites of degradation
and has limited ability to engineer substrate specificity since it is a full protein.
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Figure 7.6: (A) Change in fluorescence intensity as a function of time (intensity divided
by intensity at t=0) with varying collagenase concentrations for three FRET substrates,
FRET-VPMS (blue), Mca-PLGL-Dpa-AR-NH2 (grey), and DQ-gelatin (green). (B)
Change in fluorescence intensity (intensity divided by intensity at t=0) after one day
incubation in either 5 U/ml or no collagenase as a function of FBS concentration in
solution for all three FRET substrates. Error bars represent S.D.
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Meanwhile, Mca-PLGL-Dpa-AR-NH2 is also a FRET peptide system but does not
contain a thiol, has a different fluorophore-quencher pair (Mca-Dpa), and has a
shorter number of amino acids between the fluorophore and quencher (4 amino
acids) compared to FRET-VPMS (10 amino acids). FRET efficiencies (E) are
related to r, the distance between the quencher (acceptor) and fluorophore
(donor) as follows (Equation 7.1)23:

E=

!!!

!!! !!!

(7.1)

where R0 is termed the Förster radius and depends on the quantum yield of the
fluorophore and the spectral overlap between the fluorophore emission and
quencher absorption. Although dabcyl-fluorescein is a common fret pair (R0 = 47
Å)38, fret pairs with higher R0 like dabcyl-Alexa Fluor 488 (R0 = 49 Å)39, QSY 7Alexa Fluor 488 (R0 = 64 Å)39, or QSY 21-Alexa Fluor 568 (R0 = 75 Å)39 may
increase sensitivity of FRET-VPMS. The dependence on the sixth power of r
also means that a shorter amino acid sequence greatly increases sensitivity of
the FRET system simply by bringing the fluorophore and quencher closer
together (decreasing r). Therefore, decreasing the distance between fluorophore
and acceptor in FRET-VPMS is another way to increase sensitivity.
To assess the stability and protease-mediated degradation of FRET
fluorophores in FBS, FRET-VPMS, DQ-gelatin, or Mca-PLGL-Dpa-AR-NH2 were
placed into solutions containing FBS for 24 hours at 37°C (Fig. 7.6B). FRETVPMS remained relatively stable in non-collagenase containing solutions with
low amounts of FBS (1 wt%); however, FRET-VPMS fluorescence increased 3
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fold in solutions with higher amounts of FBS (10%), indicating the ability for FBS
to cause increased fluorescence.

Interestingly, FRET-VPMS in collagenase

solutions (5 U/ml) had increased fluorescence compared to their controls, which
revealed the ability for collagenase to cleave the substrate even in the presence
of FBS (whereas protease-cleavage was blocked by FBS in the previously
described peptide-degradable fluorophores).

In comparison, Mca-PLGL-Dpa-

AR-NH2 increased 23 fold in fluorescence in non-collagenase solutions
containing 10% FBS, with no statistical difference between collagenase or noncollagenase solutions. Accordingly, Mca-PLGL-Dpa-AR-NH2 may not be an ideal
substrate for analyzing protease activity in solutions containing FBS. Meanwhile,
DQ-gelatin was the most stable FRET system tested in non-collagenase
solutions containing FBS and still had a nearly 20 fold increase in 5 U/ml
collagenase containing 10% FBS.
FRET-VPMS was then attached to NorHA scaffolds as previously
described to evaluate its ability to cleave when immobilized on a surface. After a
two day incubation to remove unattached peptide, FRET-VPMS was incubated
for one day at 37°C in 50 or 0 U/ml collagenase; yet, no increase in fluorescence
was observed (Fig. 7.7A).

To determine if this result was concentration

dependent, UV light attachment was performed in various concentrations of
FRET-VPMS (0.5 mM, 0.1 mM, 0.05 mM), but changes in fluorescence were still
not observed in the presence of 50 U/ml collagenase (Fig. 7.7B).

Another

possibility for the discrepancy could be instability during the 2-day incubation to
remove unattached fluorophore from the scaffold surface. Therefore, NorHA
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Figure 7.7: (A) Representative images and quantification of change in fluorescence
intensity (normalized to day 0) of FRET-VPMS (0.5 mM) attached to the surface of
NorHA scaffolds after 24 hours incubation at 37°C in 50 U/ml or 0 U/ml collagenase. (B)
Change in fluorescence intensity of different FRET-VPMS concentrations attached to the
surface of NorHA scaffolds incubated at 37°C for 2 days prior to placement in
collagenase for 24 hours, (C) or without a 2 day incubation period (placed directly into
collagenase after FRET-VPMS attachment). (D) Change in fluorescence intensity as a
function of time (intensity divided by intensity at t=0) with varying collagenase
concentrations for FRET-VPMS (in solution) after 90 seconds of UV exposure (10 mW
cm-2). Error bars represent S.D. *p<0.05. n.s.=not significant. Scale bars: 500 µm.

scaffolds were immediately imaged after FRET-VPMS attachment and then
incubated for 24 hours at 37°C in different collagenase concentrations (Fig.
7.7C).

Elimination of the pre-incubation resulted in decreased fluorescence

among all concentrations (0.5 mM, 0.1 mM, 0.05 mM) and collagenase
concentrations (50 U/ml, 0 U/ml) tested, most likely due to release of unattached
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FRET-VPMS from the surface.

In addition, there was no increase in

fluorescence between individual concentrations tested at 50 U/ml or 0 U/ml,
signifying that collagenase cleavage of FRET-VPMS did not occur.

Since

photobleaching during UV light-mediated attachment could lead to decreased
fluorophore intensity, FRET-VPMS (in solution) was exposed to equivalent UV
light exposure (10 mW cm-2, 90 seconds) and placed into collagenase solutions
(Fig. 7.7D).

Fluorescence changes were similar to FRET-VPMS without UV

exposure (Fig. 7.7A), implying that UV exposure was also not causing the
inability for FRET-VPMS to increase fluorescence when attached to a fiber.
Compared to FRET-VPMS cleavage in solution, cleavage of FRET-VPMS
attached to NorHA scaffolds may be inhibited by the close proximity to the fiber
surface. This proximity may spatially limit the ability for proteases to fit into the
cleavage site, thus limiting degradation.
As an alternative, Mca-PLGL-Dpa-AR-NH2 does not contain a thiol (for
thiol-ene conjugation) and was not stable to FBS degradation, making the
sequence non-ideal for translation to future cell studies. DQ-gelatin also does
not contain a thiol for attachment, but is stable to FBS degradation and shows
extremely large changes in fluorescence with collagenase (even in the presence
of FBS), albeit with unknown sites of degradation and previously reported
fluorescence changes due to mechanical rearrangement in cell studies27. To see
if DQ-gelatin could be incorporated within NorHA scaffolds, solutions containing
DQ-gelatin were mixed and electrospun into fibrous hydrogels. After equivalent
crosslinking procedures as before, scaffolds were incubated in 50 or 0 U/ml
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collagenase and imaged to observe changes in fluorescence. NorHA scaffolds in
50 and 0 U/ml both lost more than 80% of their original intensity (Fig. 7.8), most
likely indicating that DQ-gelatin was not well incorporated and providing further
evidence for the need for covalent attachment of protease substrates to fiber
surfaces.
0 U/ml

DQ-gelatin

50 U/ml

n.s.

Collagenase (U/ml)

Figure 7.8: (A) Representative images and quantification of change in fluorescence
intensity (normalized to day 0) of DQ-gelatin electrospun into NorHA scaffolds after 24
hours incubation at 37°C in 50 U/ml or 0 U/ml collagenase. Error bars represent S.D.
*p<0.05. n.s.=not significant. Scale bars: 500 µm.

7.4 Conclusions
This chapter described the use of peptide fluorophores for the
visualization of protease activity on NorHA fibrous hydrogels. In the first
approach, protease-degradable and non-degradable amino acid sequences were
terminally functionalized with fluorophores and attached to electrospun NorHA
hydrogels via thiol-ene chemistry. Protease-degradable fluorophores cleaved in
the

presence

of

exogenously

added

collagenase,

causing

decreased

fluorescence at the fiber surface, while fluorescence from non-degradable
fluorophores was not affected by collagenase. The collagenase concentration
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dependent degradation was blocked when FBS was included; yet, the limited
degradation of protease-degradable fluorophores within FBS solutions may make
the sequence ideal for long-term cell culture. Accordingly, HT1080 cells cultured
on NorHA scaffolds induced a greater loss of fluorescence in scaffolds with
protease-degradable fluorophores compared to those with non-degradable
fluorophores. Spatial resolution of protease activity of individual cells was not
achieved as the sensitivity and length of time required to observe degradation
prohibited quantification of degradation at shorter times.
In turn, a FRET peptide substrate was developed (FRET-VPMS) as an
alternative way to visualize protease activity. This substrate contained a similar
amino acid sequence as the protease-degradable fluorophore, but included a
dabcyl-quenching group such that upon peptide cleavage, the quencher is
removed and fluorescence increases. Investigations of solution mediated
degradation revealed sensitivity down to 0.5 U/ml collagenase after 40 minutes,
and studies in solutions containing FBS indicated persistence of collagenase
degradation even in the presence of FBS. This sensitivity was not observed after
attaching FRET-VPMS to fibrous scaffolds, possibly due to limited access to the
cleavage site after attachment to the fiber surface. Thus, future investigations to
improve the sensitivity on fibrous scaffolds may require increased mobility and
separation of the FRET peptide from the fiber surface.
For comparison, two commercially available substrates (DQ-gelatin, McaPLGL-Dpa-AR-NH2) were exposed to similar conditions and revealed higher
sensitivity to collagenase degradation. However, sites of substrate degradation
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cannot be engineered into DQ-gelatin, and it was not compatible with thiol-ene
chemistry for attaching to electrospun NorHA scaffolds. While Mca-PLGL-DpaAR-NH2 was also not translatable to NorHA scaffolds, the amino acid sequence
was very unstable in the presence of FBS, making it non-ideal for cell-culture
applications.

Finally, attempts to retain DQ-gelatin in NorHA scaffolds by

inclusion during solution mixing were unsuccessful, again demonstrating the
need for covalent attachment of peptide substrates to the surfaces of scaffolds.
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CHAPTER 8

Summary, Limitations, and Future Directions

8.1 Summary
As the fields of tissue engineering and regenerative medicine have
evolved, studies on the interactions between cells and their surrounding
microenvironment have become important to elucidate the role that biophysical
and biochemical signals play on controlling cell behavior. Chapter 1 explored
various important attributes of the natural extracellular matrix (ECM) and
discussed how these signals have been incorporated into biomaterials.

In

particular, biophysical properties (mechanics, porosity, fibrous topography) and
biochemical properties (integrin-mediated adhesion, molecule sequestration, and
enzymatic degradation) were examined to introduce numerous ECM signals into
scaffolds. Several of these signals (adhesion and protease degradation) were
subsequently engineered into fibrous hyaluronic acid (HA) hydrogels that present
relevant topography signals from the ECM in the context of this dissertation.
Although Chapter 1 briefly touched on the most common methods of fibrous
scaffold formation, Chapter 3 further explored these methods in detail.
Electrospinning, phase-separation, and self-assembly were discussed as
techniques to form fibrous materials and the applications and benefits/limitations
of each technique were explained.
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Given the advantages of electrospinning outlined in Chapter 3 (low-cost,
scalability, compatibility with a wide range of polymers), Chapter 4 described a
synthetic strategy to create protease-degradable HA macromers (Methacrylated
Peptide HA – MePHA) that were capable of both isotropic hydrogel and
electrospun hydrogel formation.

HA was chemically modified with maleimide

groups (Michael addition acceptor) such that solid-phase synthesized thiolated
peptides (Michael addition donor) containing either methacrylates (to permit UVlight radical crosslinking) or fluorophores (to track network degradation) were
modularly conjugated to HA using ‘click’ chemistry.

Notably, the modular

synthesis described in Chapter 4 is amenable to a number of terminally
functionalized synthetic peptides for generalized applicability in creating
protease-degradable hydrogels1,2. Methacrylated peptides were designed and
characterized for their degradability (protease-degradable and non-degradable
sequences) through Michaelis-Menten kinetics with recombinant human matrix
metalloproteinase-2 (rhMMP-2) showing enhanced catalytic efficiency (kcat/Km –
1800 ± 900 s-1 M-1) compared to collagenase (210 ± 35 s-1 M-1). Conversely, a
molecularly

designed

non-degradable

peptide

sequence

showed

no

measureable susceptibility to protease-degradation in rhMMP-2 or collagenase.
When formed into isotropic hydrogels, no differences were observed in gelation
kinetics and storage moduli between protease-degradable and non-degradable
MePHA while only protease-degradable hydrogels degraded in response to
rhMMP-2 and collagenase.
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Next, for the first time, protease-degradability was designed into
electrospun hydrogels in Chapter 5 using the MePHA formulations from Chapter
4. Protease-degradable and non-degradable MePHA fibers were submicron in
diameter as assessed by scanning electron microscopy (SEM) and confocal
microscopy, then swelled after UV-light induced crosslinking and hydration to
~1.2 µm as measured by confocal microscopy. Porosity and compressive moduli
were also similar between protease-degradable and non-degradable MePHA. In
vitro degradation was monitored (fluorophore labeled HA release, uronic acid
release,

confocal

microscopy)

and

indicated

a

concentration-dependent

degradation of protease-degradable MePHA in the presence of collagenase and
rhMMP-2 while fibers remained stable in buffer over the course of 3 weeks.
Meanwhile, non-degradable MePHA fibers remained stable, independent of the
presence of collagenase or rhMMP-2.

Co-spinning of the two MePHA

formulations served to further demonstrate differences in degradability within a
single scaffold. Similar trends were observed in vivo as protease-degradable
MePHA fibrous scaffolds showed increased degradation, particularly in the first
week, over a 6-week period compared to non-degradable MePHA scaffolds.
Chapter 6 then moved from the protease degradability to spatial
localization of biomolecules within fibrous hydrogels.

Importantly, previous

reports of patterned electrospun scaffolds involved alterations in topography, not
biochemical signals that are more indicative of natural ECM heterogeneity3-9. To
generate this natural biochemical spatial heterogeneity, norbornene modified HA
(NorHA) was synthesized and electrospun with dithiolthreitol (di-thiol) into fibrous
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hydrogels such that crosslinking occured through conjugation between
norbornene and thiyl radicals in the presence of UV-light and a photoinitiator.
This conjugation strategy allowed for subsequent photolithographic patterning of
scaffolds with solid-phase synthesized thiolated fluorophores at high feature
resolution (~50 µm). This process was repeated to demonstrate the ability to
pattern multiple biomolecules on the scaffold, and confocal microscopy indicated
that patterns propagate in 3-dimensions through thick (~1.5 mm) scaffolds. By
patterning a cell adhesion amino acid sequence (thiolated RGD) into the scaffold,
cell morphology of 3T3 and HUVEC cells was controlled with high spatial control.
Regions with RGD contained increased cell density, cell area, and higher aspect
ratios (measure of maximum orthogonal length divided by width of the cell) when
compared to regions without RGD. Utilizing increased rotation speeds of the
collecting mandrel, fibers were aligned, and cells responded to topography, not
surprisingly, by displaying a narrow spindle-like morphology parallel with fiber
alignment. In contrast, cells were randomly aligned with increased cell area on
scaffolds with fibers of random orientation. By patterning 100 µm lines of RGD
perpendicular or parallel to fiber alignment, cells were shown to remain oriented
with the fiber direction while simultaneously adhering to the patterned regions of
RGD. This platform thus allows for the first time, spatial biochemical patterning
within uniformly nanofibrous scaffolds to guide and investigate cell-material
interactions.
Although previous reports had developed methods for protease detection
in isotropic hydrogels, Chapter 7 combined the development of protease198

degradable and non-degradable fluorophores from Chapters 4 and 5 with the
thiol-ene chemistry developed in Chapter 6 towards the detection of protease
activity in fibrous hydrogels.

Protease-degradable fluorophores attached to

NorHA scaffolds were degraded in the presence of collagenase while nondegradable fluorophores remained stable (non-degraded) to collagenasemediated degradation. Protease-degradable fluorophores were stable in
solutions of FBS; yet, the presence of FBS blocked protease activity of
exogenous collagenase. HT1080 cells were then cultured on NorHA scaffolds
and showed increased fluorescence loss (i.e., degradation) on scaffolds with
protease-degradable fluorophores compared to non-degradable fluorophores
after one week. The inclusion of FBS in the cell culture media suggests that
localized degradation most likely occurs through membrane bound MMPs (MTMMPs), as others have reported10,11.
As an alternative approach to visualize degradation, a FRET peptide
(FRET-VPMS) substrate was developed in Chapter 7 and analyzed for proteasedegradation.

In solution, this substrate showed considerable sensitivity to

collagenase degradation, albeit, less than two commercially available substrates
(DQ-gelatin, Mca-PLGL-Dpa-AR-NH2) that are not translatable to electrospun
fibrous scaffolds. Collagenase-mediated degradation of FRET-VPMS persisted
even in the presence of FBS, but this collagenase sensitivity was not observed
after immobilization on the surface of NorHA fibers. The most sensitive substrate
to collagenase and with stability in FBS, DQ-gelatin, was electrospun into
scaffolds but was not retained within the network after hydration, further
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validating the need for covalent incorporation of peptide substrates to
electrospun networks.

8.2 Limitations and Future Directions
8.2.1 Specific Aim 1: Design and synthesize photocrosslinkable, proteasedegradable HA macromers to form isotropic and electrospun fibrous hydrogels.
The synthetic strategy presented within Chapter 4 is beneficial in its
modular design; however, the need to functionalize HA with maleimide groups
has several limitations. First, the efficiency of the amidation reaction between
HA-TBA

and

N-(2-Aminoethyl)maleimide

had

a

maximum

modification

percentage of ~45% (e.g., 45% repeat units functionalized with maleimide).
While only lower modification percentages were used in this thesis (~10-15%),
studies requiring higher modification necessitate new synthetic routes for
maleimide attachment. Furthermore, this modification may alter the way in which
HA is perceived in the cell microenvironment.

The amide formation at the

carboxyl group eliminates the negative charge of modified repeat units, and the
large molecular weight of the methacrylated peptides (~14-17 kDa per chain)
means that 30-40% of the molecular weight of MePHA is the mass of the
methacrylated peptides. The synthetic design also requires a single thiol to be
contained within the conjugating molecule to ensure specificity between the
Michael addition donor (thiol) and acceptor (maleimide). Therefore, this design
may not be suitable for chemistries that interact with thiols (e.g., vinyl sulfones,
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acrylates), for molecules containing di-sulfide bridges, or for molecules with thiols
at an active site.
Despite these limitations, future directions could focus on using different
peptide sequences specific to other molecules of interest (e.g., cadherins) or
adding different chemical functionalities to the ends of peptides. Indeed, the
strategies presented in Chapter 4 have been directly translated to generate
covalent (hydrazide-aldehyde)1 and non-covalent (adamantane-cyclodextrin)2
protease-degradable, injectable hydrogels (Fig. 8.1), further demonstrating the
broad appeal of the approach. As for isotropic hydrogels, recent studies have
investigated cell responses to sequential changes in mechanics caused by nondegradable kinetic chain formation in UV-light initiated networks12,13. MePHA
would provide greater utility for these 3-D encapsulation studies whereby
mechanics can be sequentially increased with either a protease-degradable or
non-degradable kinetic chain to better distinguish the role of mechanical and
degradation-mediated cues in directing cell behavior.
As for the translation to fibrous hydrogels, those with electrospinning
experience can attest that it is a finicky process that requires optimization of
solution parameters (polymer concentration, solvent, mixing time) and processing
parameters (applied voltage, distance to collector, needle gauge, temperature)
such that small variations can generate scaffolds with different fiber morphology
and structure. For HA electrospinning from water-based solutions, high humidity
limits water evaporation over the collecting distance and is known to cause
negative surface charge upon fiber formation14. This surface charge leads to
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fiber repulsion with non-uniform fiber collection15, and thus necessitated the
building of an environmentally regulated chamber to control humidity during
electrospinning (an easier task to control in the winter compared to Philadelphia
summers).
B

A
Hydrazide

Adamantane

Protease-degradable

Protease-degradable

Thiol-maleimide

Thiol-maleimide

Figure 8.1: (A) Design of hydrazide modified, protease-degradable HA and (B)
adamantane modified, protease-degradable HA. Each system was designed similar to
MePHA where terminal functionality (hydrazide or adamantane) was added to a
protease-degradable amino acid sequence (equivalent to protease-degradable
sequence in this thesis) and the peptide ‘clicked’ onto a maleimide modified HA. Mixture
of protease-degradable hydrazide-HA (A) with aldehyde modified HA in a dual-barrel
syringe crosslinks the network to form an injectable hydrogel3. Mixture of proteasedegradable adamnatane-HA (B) with cylclodextrin modified HA forms a shear-thinning,
injectable hydrogel4.

In addition to challenges with fiber structure, protease-degradable fiber
degradation proceeded rapidly in collagenase but was notably slower in rhMMP2, suggesting the need for future improvement to increase MMP sensitivity.
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Protease-mediated degradation also proceeded at faster rates during early time
points with notable decreases at later time points.

This trend is similar to

previous models of degradation of hydrogels formed by multi-vinyl crosslinks
where initial degradation products are primarily crosslinking molecules, followed
by a plateau in erosion products before final release of kinetic chains at reverse
gelation16. Therefore, a detailed study of erosion products (e.g., kinetic chains or
HA) would be beneficial in better understanding the mechanism of HA release
from these novel scaffolds. As with other studies of protease-degradation in nonelectrospun networks2,12,13,17-21, in vitro studies were conducted under ideal
buffered conditions for exogenously added proteases such that future directions
could explore the effects of changes in solution components (e.g., serum
containing, without Ca2+) and cell-mediated degradation. Recent studies have
demonstrated the promise of releasing bioactive molecules from protease
degradable non-fibrous hydrogels towards the goal of tissue regeneration1,17,22,23.
Building off these studies, future work could investigate the inclusion of biological
molecules (e.g., TGF-β, SDF-1α, TIMPs) within fibers to enhance the bioactivity
of the scaffolds for targeted applications.

Taking advantage of the bi-phasic

degradation of co-spun scaffolds, a growth factor targeting initial inflammation
could be incorporated into the protease-degradable fiber population with the nondegradable population containing a growth factor targeting longer-term
remodeling cell pathways. As fibrous hydrogels, MePHA networks are best used
for soft-tissue applications and may not be suitable for load-bearing tissues
without mechanical reinforcement.

Moreover, these fibrous hydrogels are
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implantable, not injectable, and may not be an appropriate scaffold for deep
tissue delivery.

8.2.2 Specific Aim 2: Spatially pattern biochemical signals within electrospun,
fibrous HA hydrogels to control cell behavior.
Although the previously discussed challenges in electrospinning MePHA
also exist when electrospinning NorHA, the norbornene group presents extra
challenges due to its hydrophobicity.

NorHA with norbornene modifications

greater than 20% were incapable of forming homogeneous solutions during
mixing, and electrospinning required higher voltages (≥27 kV) to form stable
fibers compared to MePHA (≤21 kV). Patterning resolution via photolithography
was limited to ~50 µm, but future work could improve on this resolution using 2photon lithography. The utility in patterning multiple biomolecules towards cellmaterial interactions was not shown, and this could be an area of future
exploration through cell response to gradients of biological molecules (e.g.,
VEGF, TGF-β).
While cell density and morphology was significantly altered between
regions with and without RGD, a certain level of cell attachment exists even
without modification, such that all studies required fairly high cell densities to
observe patterned cell adhesion. These patterns were also slightly larger (100
µm) than the typical cell diameter (~50 µm), allowing cells to orient parallel or
perpendicular to pattern direction in response to fiber alignment. Consequently,
future studies would benefit by investigating cell morphology changes to
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subcellular diameter size patterns (~25 µm).

In this realm, studies on the

influence of fibrous topography on stem cells24,25 could be expanded using
NorHA scaffolds to restrict cell morphology and analyze associated changes in
differentiation.
Perhaps the greatest challenge in electrospinning is the inability of cells to
penetrate into the network as cells tend to move in 2-dimensions across the
surface of the scaffold.

Although RGD was patterned in 3-D (propagating

through the depth of scaffolds) this limitation was observed as cells remained
adhered at the surface of the network. NorHA scaffolds were primarily used as
an in vitro tool to control cell behavior; yet, these scaffolds could be beneficial in
soft-tissue interfaces such that natural spatial signaling of biological molecules
could be pre-engineered into NorHA to mimic the natural ECM heterogeneity.
Incorporation of a more mechanically robust fiber component like PCL through
co-spinning could also make these scaffolds more suitable for musculoskeletal
tissues known to have distinct spatial protein expression profiles across
interfaces26.

8.2.3 Specific Aim 3 : Design and evaluate protease-sensing electrospun, fibrous
HA hydrogels to investigate cellular protease activity.
The methods of Chapter 7 are a novel way to translate the detection of
proteases into fibrous hydrogels; however, the approach has several limitations.
The protease-degradable fluorophores were not sensitive enough to detect
protease-cleavage until later time points (one week). Since cells will inevitably
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migrate along the surface of the scaffold, this means the accumulated loss in
fluorescence will be of the entire cell population. While previous work has
identified the protease-degradable substrate as optimized for protease
degradation, substrate sensitivity will need to be improved in the future to obtain
visualization of single cell degradation. Ultimately, with increased sensitivity, the
role of structural features in fibrous hydrogels (mechanics, fiber diameter,
alignment) could be investigated to determine changes in MMP expression with
controlled changes in substrate features.
The natural heterogeneity of the fiber surface can also complicate analysis
since imperfections in fiber morphology or diameter may lead to differences in
initial fluorophore attachment. This is partially overcome by imaging in the same
scaffold region but is a general drawback of electrospun networks.

These

studies used HT1080 cells for cell culture, a cell line known to have increased
MMP expression8,27,28, which may limit the utility of the method for cell types that
express MMPs in lower quantities. The FRET-VMPS fluorophore showed
sensitivity to collagenase degradation in solution, was relatively stable to FBS
degradation, but did not function as designed once attached to NorHA scaffolds.
Future designs could look at both increasing sensitivity in solution and after
attachment to scaffolds. As described in Chapter 7, increasing the Förster radius
(Ro) by using different quencher-fluorophore pairs could increase FRET
efficiency. Since FRET efficiency is also inversely proportional to the sixth power
of the radius between the fluorophore and quencher, decreasing the distance
between the fluorophore and quencher (by reducing the number of amino acids
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in the degradable sequence) could be a way to increase sensitivity.

For

attachment to surfaces, creating a longer, flexible linker between the peptide
substrate and the site of attachment may improve enzymatic access.

For

example, FRET-VPMS could be designed with the site of scaffold attachment
(thiol) separated from the region between the fluorophore and quencher (site of
enzymatic degradation) by a flexible alkane group.

8.3 Conclusions
This dissertation designed, synthesized, and described the utility of novel
fibrous hydrogels as biomedical scaffolds.

In particular, several synthetic

chemistries (thiol-maleimide addition, methacrylate crosslinking, UV light induced
thiol-ene formation, solid-phase synthesis) were combined to generate materials
with previously unrealized biocomplexity. The design of MePHA facilitated both
isotropic and fibrous hydrogel formation with the peptide crosslinker design
dictating degradation rates in vitro and in vivo.

The unique susceptibility of

norbornene to thiyl-radical addition allowed for the formation of electrospun
NorHA fibrous hydrogels with spatially localized adhesion sequences to modulate
cell behavior.

Finally, degradable and non-degradable fluorophores were

developed to investigate protease activity on fibrous hydrogels. These materials
collectively hold promise in vitro as scaffolds to further understand the
complexities of cell-material interactions and in vivo as protease-degradable
scaffolds for natural tissue replacement.
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